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ABSTRACT 
 
Apicomplexans are responsible for major human diseases such as 
toxoplasmosis caused by Toxoplasma gondii (T. gondii) and the deadliest form of 
malaria caused by Plasmodium falciparum (P. falciparum). The genomes of these 
pathogens are now sequenced ushering in a new era of drug development.  A major 
hurdle to exploiting this genome resource is that a large number of the encoded genes 
are “hypotheticals” and have yet to be characterized. Hypothetical proteins comprise 
roughly half of the predicted gene complement of T. gondii and P. falciparum and 
represent the largest class of uniquely functioning proteins in these parasites.   
Following the idea that functional relationships can be informed by the timing of 
gene expression, we devised a strategy to identify the core set of apicomplexan cell 
division cycling genes with important roles in parasite division, which includes many 
uncharacterized proteins.  We assembled an expanded list of orthologs from the T. 
gondii and P. falciparum genome sequences (2781 putative orthologs), compared their 
mRNA profiles during synchronous replication, and sorted the resulting set of dual cell 
cycle regulated orthologs (744 total) into protein pairs conserved across many 
eukaryotic families versus those unique to the Apicomplexa.  The analysis identified 
more than 100 ortholog gene pairs with unknown function in T. gondii and P. falciparum 
that displayed co-conserved mRNA abundance, dynamics of cyclical expression and 
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similar peak timing that spanned the complete division cycle in each parasite.  The 
unknown cyclical mRNAs encoded a diverse set of proteins with a wide range of mass 
and showed a remarkable conservation in the internal organization of ordered versus 
disordered structural domains.  A representative sample of cyclical unknown genes (16 
total) was epitope tagged in T. gondii tachyzoites yielding the discovery of new protein 
constituents of the parasite inner membrane complex, key mitotic structures and 
invasion organelles.  These results demonstrate the utility of using gene expression 
timing and dynamic profile to identify proteins with unique roles in Apicomplexa biology.  
Additionally, we selected one of these newly identified membrane proteins to 
further characterize in both T. gondii and P. falciparum.  We named the protein inner 
membrane complex protein 16 (IMC16) due to its IMC localization however; this protein 
uniquely preferentially targets the developing daughter IMC early in budding and is 
completely absent from the mother IMC in dividing parasites.  IMC16’s membrane 
association cannot be attributed to an alveolin domain and its partial solubility suggests 
this protein may need more than post-translational modifications to anchor it into the 
membrane.  Proteomic work to determine possible protein interactions highlight a 
possible phosphorylation by cyclin dependent protein kinase 1 (CDPK1) in the 
cytoplasm and dephosphorylation by IMC2a to allow it to associate with the IMC similar 
to the phosphorylation/dephosphorylation mechanisms used by glideosome associated 
protein 45 (GAP45) to help associate and anchor the glideosome to the IMC. 
	   1	  
 
 
 
 
 
CHAPTER ONE: 
Introduction 
 
Apicomplexans  
Apicomplexans are eukaryotic pathogens that belong to the super phylum 
Alveolata, which are characterized by a system of flattened Golgi vesicles (alveoli) 
located under the plasma membrane. The super phylum includes free living and 
parasitic organisms. Other examples of phyla within the Alveolate super phylum include 
Chromera (marine photosynthetic protozoa), Ciliates (protozoa containing cilia), and 
Dinoflagellates (marine flagellates).  Apicomplexans are an ancient family that branched 
from the eukarya more than 500 million years ago [1].  The phylum Apicomplexa 
contains more than 5,000 species [1] including many important parasites of medical and 
veterinary significance.  The phylum includes major human pathogens such as 
Plasmodium, opportunistic pathogens such as Toxoplasma gondii, Cryptosporidium 
parasites causing diarrheal disease, Eimeria parasites affecting poultry, and Theileria 
and Babesia are major pathogens affecting livestock.  Plasmodium species are the 
causative agent of malaria and T. gondii the causative agent of toxoplasmosis represent 
two modern endpoints of the phylum. Plasmodium species are in the order 
haemosporida and T. gondii is in the order coccidia.  In addition to the traditional 
eukaryotic organelles such as a nucleus, endoplasmic reticulum (ER), Golgi and 
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mitochondria; the parasites of this phylum are defined by an array of unique organelles 
including an apicoplast, an apically located polar ring that serves as a microtubule-
organizing center and a set of secretory organelles including micronemes, rhoptries and 
dense granules used for invasion (Fig. 1.1). The apicoplast is a non-photosynthetic 
plastid evolving from the relic of an algal cell carrying a chloroplast that was engulfed by 
a protist and functions in isoprenoid and fatty-acid synthesis [2,3,4,5,6,7].   
 
Disease Relevance 
Malaria is one of the oldest and most significant infectious diseases of all time 
[8].  In 2012, there were approximately 207 million cases of malaria and about 627,000 
deaths worldwide (www.who.int).  Approximately half of the world’s population is at risk 
of contracting malaria however, people in sub-Saharan Africa and South East Asia are 
most affected by the disease and in Africa a child dies every minute due to malaria 
(www.who.int). Besides alarming mortality rates, malaria also causes significant 
morbidity and economic burden where direct costs are estimated to be at least $12 
billion annually (www.cdc.gov).  Malaria can be categorized into uncomplicated or 
severe cases.  Uncomplicated cases display symptoms such as: fever, chills, body 
aches, nausea, and malaise.  At its name suggests, severe malaria results in much 
more serious consequences including organ failure, coma, seizures, respiratory 
distress, severe anemia, and abnormal bleeding.  Symptoms are caused by the asexual 
erythrocytic stage parasites and malaria is transmitted through the bite of a female 
Anopheles mosquito infected with Plasmodium parasites.  There are five Plasmodium 
species that cause malaria in humans: falciparum, vivax, malriae, ovale, and knowlesi.  
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The most deadly form of malaria is caused by Plasmodium falciparum (P. falciparum) 
parasites.  P. falciparum’s long life-span and strong human biting propensity contribute 
to its deadly nature.  
Toxoplasma gondii (T. gondii) parasites are related to Plasmodium parasites and 
cause toxoplasmosis; a disease that can lead to a variety of symptoms including flu-like 
symptoms, ocular disease, miscarriage, hydrocephaly and death depending on the 
immune system of the host.  T. gondii infects approximately 30% of the human 
population worldwide [9]. Symptoms of toxoplasmosis in healthy individuals are often 
mild and are limited to flu-like symptoms due to the immune system preventing the 
parasites from causing illness.  However, the parasites remain in the systems of these 
healthy individuals and can become active if these individuals become immune 
compromised or suppressed.  Toxoplasmosis is of primary concern to immune 
compromised and immune suppressed individuals such as those with HIV/AIDS, 
receiving organ transplants, undergoing chemotherapy for cancer treatment, and 
pregnant women.  Infection from T. gondii can cause symptoms such as fever, 
headache, confusion, seizures, poor coordination and ocular disease in the 
immunocompromised or immunosuppressed.  The most common forms of transmission 
are through eating or drinking contaminated food or water, or through congenital 
transmission.  Approximately 23% of the U.S. population 12 years and older have been 
infected and up to 95% of some populations in the world have been infected with T. 
gondii according to the CDC’s website (www.cdc.gov).  Congenital toxoplasmosis, in 
which a mother becomes infected while pregnant, can result in ocular disease, severe 
neurological birth defects, hydrocephaly and miscarriage.  Since the parasite is passed 
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in the cat’s feces pregnant women are warned against handling cat liter due to the risk 
of infection.  Typically if a mother is infected before becoming pregnant the child will be 
protected because the mother has developed immunity. However, infection is more 
likely to be transmitted congenitally and cause severe birth defects when women 
become infected after becoming pregnant. Repeated cycles of invasion, replication and 
host cell lysis in P. falciparum and T. gondii contribute to the pathogenesis of malaria 
and toxoplasmosis respectively and the associated host tissue destruction and 
inflammation.  
 
Diagnosis, Treatments and Resistance 
Serology testing, polymerase chain reaction (PCR) and microscopy are used to 
diagnose malaria. Drug resistance testing is also available and can help doctors 
prescribe the most effective treatment.  Treatment of malaria depends on many factors 
including the species of parasite(s) causing malaria, area of the world the disease was 
contracted which could indicate which drugs the parasites would be resistant to, disease 
severity, age, weight and if the patient is pregnant or not. The complexities of the 
malaria parasite (complex life cycle, polymorphic antigens, and malaria affects mainly 
people in low-income countries) have made the malaria vaccine development process 
arduous.  While GlaxoSmithKline’s RTS,S/AS01 vaccine candidate for malaria is 
currently in Phase III clinical trials, a completely successful vaccine currently does not 
exist to prevent malaria in humans and results from this clinical trial only show moderate 
effects with declining efficacy over time [10].  Many current anti-malarial drugs target the 
parasites asexual stages, as this is the stage causing clinical symptoms of the disease. 
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The current recommendation for treatment is with artemisinin-based combination 
therapy (ACT).  
Toxoplasmosis is diagnosed by serological testing measuring T. gondii specific 
immunoglobulin G (IgG).  In pregnant women to estimate the time of infection 
immunoglobulin M can also be measured.  Most healthy individuals do not need 
treatment because their immune systems work to protect them, although they cannot 
clear the infection.  There is no vaccine available for humans at this time however, there 
is a vaccine used in sheep in Europe to reduce the neonatal mortality [11,12].  Many 
drugs used to treat toxoplasmosis and malaria are the same because the parasites that 
cause these diseases belong to the same phylum and they share many biochemical 
similarities.  In immune compromised people toxoplasmosis is treated with combination 
therapy of sulfonamides and pyrimethamine, which show a synergistic effect [13] and 
can also be used to treat malaria however resistance to these therapies is a concern for 
currently treating malaria.  Spiramycin is used in Europe and Canada to treat pregnant 
women with toxoplasmosis to reduce transmission of the parasite from mother to fetus 
and has been shown to be less toxic and not cross the placenta [14].   
Only a few classes of antimalarial therapeutics currently exist, and most of the 
therapeutics has been in use for decades.  Resistance to some anti-malarial drugs has 
begun to emerge almost simultaneously as the therapeutic was introduced [15,16].  
Resistance of P. falciparum to previous generations of anti-malarial drugs became 
widespread to chloroquine in the 1970’s and sulfadoxine-pyrimethamine in the 1980’s. 
Currently, ACT’s are recommended as the first-line of treatment of malaria [17] 
however; resistance to artemisinin has recently begun to emerge [18].  New treatments 
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are needed due to the growing emergence and spread of resistance to current anti-
malarial drugs and currently there is no therapeutic to which the parasites haven’t 
already begun to develop resistance.  The emergence of drug resistance, widespread 
resistance to available insecticides, and massive population movements makes the 
long-term maintenance of the eradication effort difficult.  With such an expansive history 
of rapidly developed resistance to drugs there will always be a need for new antimalarial 
and toxoplasmosis therapies because the parasites are already becoming resistant to 
the drugs that are currently available.  Most therapeutics target parasite specific 
biochemical pathways but cell biological features are their most distinctive attributes 
[19].  With malaria and toxoplasmosis continuing to be significant global health 
diseases, developing a better understanding of the basic biology of these parasites is 
paramount to developing novel therapeutics.    
 
Apicomplexans Have Complex Life Cycles 
P. falciparum is capable of infecting two different hosts: humans (intermediate 
host) and female Anopheles mosquitos (definitive host).  In humans, the parasite grows 
and multiplies in the liver first and then is able to invade and undergo asexual replication 
within red blood cells.  The asexual replication stages include rings, trophozoites, and 
schizonts that will rupture the erythrocytes and merozoites will be released.  Some of 
these merozoites will differentiate into sexual blood stage parasites called gametocytes, 
which are capable of being ingested by a mosquito during a blood meal.  Microgametes 
and macrogametes form zygotes in the mosquito’s stomach.  Zygotes become motile by 
developing flagella and invade the midgut of the mosquito where they develop into 
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oocysts. Oocysts grow, rupture and release sporozoites in the mosquitos midgut. These 
sporozoites travel to the salivary glands where the mosquito is able to infect the next 
human host during a blood meal to perpetuate the life cycle.  
The life cycle of T. gondii is even more complicated as the parasites are 
promiscuous in the intermediate hosts they infect. The definitive host where sexual 
replication occurs for T. gondii is the cat however; all warm-blooded vertebrates can be 
infected and act as an intermediate host.  Ingesting water, plants or soil infected with 
oocysts that are shed in the cat’s feces can cause infections in intermediate hosts.  
Sporozoites transform into tachyzoites shortly after being ingested. Tachyzoites are the 
parasites fast replicating stage. Tachyzoites can infect almost any cell in the body. 
Responding to signals that are not well understood, tachyzoites differentiate into the 
slow growing phase of the parasite called bradyzoites that localize into tissue cysts. 
Tissue cysts are invisible to the immune system and impervious to drug treatment.  In 
immunocompromised patients the bradyzoites contained within the tissue cyst 
recrudesce back into the tachyzoite re-initiating acute toxoplasmosis. Cats can become 
infected after ingesting intermediate hosts (such as mice) that have tissue cysts or by 
ingesting sporulated oocysts.  Other animals may also become infected with T. gondii 
after ingesting sporulated oocysts in the environment. Transmission can occur from 
eating undercooked meat from animals with tissue cysts, consuming contaminated food 
or water, congenitally via the placenta from mother to fetus or more rarely through blood 
transfusion or organ transplant.  The replication rate of the asexual life cycle stages of 
P. falciparum and T. gondii are responsible for causing malaria and toxoplasmosis 
clinical symptoms respectively, and due to the growing emergence of drug resistance 
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new therapeutic targets from the asexual life cycle stages of these parasites is needed. 	  
 
Apicomplexa Nuclear Division  
In the asexual erythrocytic stage of P. falciparum replication (Fig. 1.2 A), an 
extracellular merozoite begins by invading a red blood cell of the human host. Within the 
red blood cell the merozoite begins as a ring stage containing a thick rim of cytoplasm.  
The parasite progresses into a trophozoite, characterized by its irregular outline and 
then undergoes 3-multiple rounds of DNA synthesis (S phase), mitosis (M phase) and 
nuclear division to produce a schizont.  Karyokinesis is critical event in the life of a cell.  
It involves the replication and segregation of chromosomes into two daughter cells 
allowing the cell to divide and pass on its genetic material to its progeny. Karyokinesis is 
highly conserved, as all cells will need to pass on their genetic material to perpetuate 
the lifecycle.  However unlike in higher eukaryotes, P. falciparum nuclear division 
involves limited chromosome condensation, maintains the nucleolus [20], and is 
asynchronous until the final round of division.  Repeated rounds of synthesis and 
mitosis without cytokinesis are used to make multinuclear cells as part of the replication 
strategy in P. falciparum [21].  The schizonts typically contain between 16-22 nuclei 
[22,23] and allows P. falciparum parasites to produce numbers of nuclei beyond the 
geometric expansion that is observed in T. gondii but makes it more difficult to 
determine the exact timing between traditional synthesis and mitosis phases and 
predicted the number of daughters that will be produced [21].  There is no required set 
number of nuclei before cytokinesis can begin in P. falciparum however, schizonts 
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typically contain an even number of final nuclei [24] suggesting the parasites’ final round 
of mitosis is synchronized as is noted in other apicomplexans [25,26].  
In T. gondii, replication (Fig. 1.2 B) includes a single major G1 period followed by 
an S phase, M phase and cytokinesis. Replication begins with widening and doubling of 
the Golgi in the G1 phase [27,28,29].  Duplication of the centriole occurs at the G1/S 
boundary.  Experimental evidence of a dominant 1.8 N sub-population indicates 
chromosome replication slows or pauses late in S phase and spindle poles and spindles 
are assembled [28,30].  The two daughter buds are nucleated near the centrosomes at 
this time.  Nuclear replication takes place within the nuclear envelope (closed mitosis) 
similar to P. falciparum with limited chromosome condensation and while the nucleolus 
is maintained [20,28].  Spindle pole duplication occurs within the nuclear envelope fold 
and migrate separately forming a centrocone.  Chromosome replication occurs shortly 
after spindle assembly.  Centrosomes migrate to the apical side of the nucleus during S 
phase and become aligned with the centrocone [31].  
Replication in P. falciparum and T. gondii differ in terms of their time point and 
number of progeny of karyokineses [25,32] however, they are similar in that they both 
contain nuclear division within the nuclear envelope (closed mitosis) with limited 
chromosome condensation.  Also, despite P. falciparum nuclear division being 
asynchronous until the final round of division and T. gondii nuclear division being 
synchronous, the cell cycles (~48 h for P. falciparum and ~8 h for T. gondii) consists of 
an overall growth and nuclear division phase for both P. falciparum and T. gondii.  
Although it has recently been proposed that the centrosome is a master regulator of cell 
division that tethers cellular components and regulates spatial and temporal control of 
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cell division [33], more work is needed to prove this hypothesis. Additionally the 
parasite’s mechanisms of sensing and adapting to its host cell environment are not 
currently understood.   
 
Building the Cytoskeleton and Invasion Apparatus  
Apicomplexan parasites have a highly flexible cell division cycle that allows the 
number of daughters produced to be scaled to suit different host niches [33].  In both P. 
falciparum and T. gondii, replication occurs by assembly of daughter cells within the 
intact mother cell.  P. falciparum divides by schizogony in which multiple daughters form 
within a single mother and multiple rounds of nuclear replication are followed by 
parasite budding at the periphery [25] and T. gondii divides by endodyogeny where two 
daughter parasites are assembled within the intact mother cell during each round of 
replication [31,34] (Fig. 1.2).  
In P. falciparum, during the final round of synchronized mitosis daughter buds 
appear at regularly spaced intervals around the mother parasite’s periphery [23]. The 
daughters are assembled in a scaffold of cytoskeleton components (Fig. 1.3) including 
subpellicular microtubules, and the inner membrane complex (IMC), which is the 
patchwork of alveoli in apicomplexans that is integral to replication, motility and 
invasion.  Budding takes place at the plasma membrane and the multi-nucleated 
schizont does not contain an IMC [35].  IMC development is associated with nuclear 
division to guarantee organelle packaging and provide each daughter parasite with an 
IMC as it develops [36]. Organelles are assembled in the newly developing daughters in 
a highly ordered sequence of events beginning with apical organelles.  Micronemes, 
	   11	  
rhoptries and dense granules form de novo during budding to give each new daughter 
cell the necessary components for invasion. Cytokinesis initiates before mitosis is 
complete adding to complexity of the cell division process [33].  A cleavage furrow forms 
around each developing daughter and a nucleus, apicoplast, and mitochondrion are 
divided into each daughter before complete separation occurs.  A constriction ring 
separates the approximately 22 haploid merozoites leaving the mother’s residual body 
and rupturing the invaded host red blood cell to release these new merozoite daughter 
cells for additional rounds of invasion and replication. 
Budding in T. gondii tachyzoites initiates in late S phase (coinciding with a 
approximately 1.8 N DNA content) [31].  In T. gondii, the centrosome forms the 
nucleation point for the daughter cytoskeleton buds [37].  Budding is driven by the 
assembly of the daughter cytoskeleton, which acts as a scaffold for assembly of the 
internal daughter cells [20,25,34].  The daughter cytoskeleton includes an internal 
subpellicular microtubule and IMC protein scaffold that the newly developing daughters 
can assemble on (Fig. 1.3). IMC proteins used to build the budding daughters are 
probably derived from the Golgi and would explain the necessity of early division of the 
Golgi during budding [25].  The new daughter cytoskeleton is first observed by IMC15 
and MORN1 staining next to the centrosomes.  An actin-like protein called ALP1 has 
been implicated in vesicle transport and IMC protein delivery to the budding daughters 
[38].  Micronemes, rhoptries and dense granules form de novo during budding to give 
each new daughter cell the necessary components for invasion.  The ER is one of the 
last organelles to enter daughter cells and mitochondrion is the last organelle to enter 
the daughter.  After all organelles have entered the growing daughters the basal end of 
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the parasite contracts to close them.  Proteolytic cleavage and cross-linking of the IMC 
filaments are modifications that occur once the cytoskeleton has matured.  At late 
stages of endodyogeny, the mother cell filaments are destabilized and disassembled.  
The mother cell plasma membrane (Fig. 1.3) is recycled and assembles with the 
daughters late in the budding stage.  The daughters typically stay connected through a 
cytoplasmic bridge until they egress from the host cell.  Upon emergence of the 
daughters, the residual body is the only remnant of the mother cell and contains 
organelle fragments and leftover cytoskeleton components that are discarded to be 
digested and recycled.   
Replication in P. falciparum and T. gondii differ in terms of their time points of 
karyokineses and cytokinesis [25,32] however, they are similar in that they both contain 
nuclear division within the nuclear envelope, build new daughter parasites internally 
onto a cytoskeleton scaffold, and daughters consume the mother cell.  Although in P. 
falciparum, nuclear division is asynchronous until the final round of division, the cell 
cycles (~48 h for P. falciparum and ~8 h for T. gondii) consist of an overall growth phase 
and replication phase for both P. falciparum and T. gondii.  While the field has made 
great strides in discovering the cell biology involved in cell division, the exact 
mechanisms that regulate the various division processes are only beginning to be 
understood and much work is still needed to elucidate the regulation of cytokinesis and 
how the parasites match the number of newly developed haploid nuclei with the correct 
number of daughter buds. 
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Invasion  
Since T. gondii and P. falciparum are obligate intracellular parasites they must 
invade new host cells in order to acquire nutrients, survive and replicate.  Invasion 
mechanisms seem to be highly conserved in apicomplexan parasites with results in one 
member of the phylum correlating to other members of the phylum.  There are some 
differences in species-specific surface proteins and invasion proteins that each 
organism has adapted to fit their specific host niche however, the overall process and 
participants are similar.  Three sets of secretory organelles (micronemes, rhoptries and 
dense granules) are unique to the phylum, created de novo during replication, and are 
sequentially secreted in order to facilitate invasion.  The current model of invasion is 
well characterized however; the molecular mechanisms that govern these steps are less 
understood.   
Invasion is a rapid (less than 20 seconds) and active process [39] unique to 
apicomplexan parasites and begins with attachment and reorientation.  In the currently 
accepted model, invasion is closely linked to motility.  The asexual stages of these 
parasites lack cilia or flagella but are able to move via circular gliding, helical rotation or 
upright twirling motility to find new host cells to invade.  Circular gliding is a counter 
clockwise movement, helical gliding is a horizontal twirling movement and twirling is 
when the parasite produces clockwise spinning.  Helical gliding is the only long-distance 
form of motility observed in vitro however; Plasmodium sporozoites use circular gliding 
in vivo for long-distance migration [40].  An actomyosin motor complex composed of 
myosin A (MyoA), myosin light chain (MLC1), and the glideosome associated proteins 
GAP45 and GAP50 facilitates motility (Fig. 1.4).  The glideosome components MyoA, 
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MLC1 and GAP45 are a soluble complex until the dephosphorylation of GAP45 enables 
assembly of the full complex and association with GAP50 to anchor the glideosome 
within the IMC [41]. The MyoA motor moves on short F-Actin filaments connected by an 
unknown protein.   
Invasion also involves specific molecular interactions between parasite derived 
ligands and host cell receptors.  T. gondii and P. falciparum actively invade host cells 
without breaching the host cell’s structural integrity by creating a tight junction which 
acts as a seal between the parasite and host cell’s membrane [42] but does not result in 
fusion.  This tight junction involves complexes of micronemes and rhoptry neck proteins 
and acts as a fixed point of reference through which the parasite invades.  Rhoptry neck 
protein 2 (RON2), which is secreted and inserts into the host cell plasma membrane 
and microneme protein AMA1 bind to form the tight junction.  AMA1 is predicted to 
interact with actin via an unknown partner to generate the force transmission required 
during host cell invasion.  Under the current invasion model, formation of the tight 
junction commits the parasite to invasion.  The tight junction expands as the parasite 
invades and then closes at the posterior end of the parasite when entry is complete 
[43,44].  This allows for fusion of the host membrane behind the parasite and pinching 
off of the parasite-containing vacuole within the cytoplasm of the host cell.   
The parasites penetrate into a vacuole called the parasitophorous vacuole by 
invagination of the host plasma membrane [45].  The parasitophorous vacuole 
membrane does not fuse with host cell lysosomes and does not acidify creating a 
defense mechanism for the parasite to the host cell’s own defense mechanisms.  The 
parasite also reorganizes the structural organization of the host cell to facilitate its own 
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growth [46] and parasite rhoptry kinases hijack host cell functions to help evade the 
immune system [47].  Rhoptry bulb proteins are involved in the formation of the 
parasitophorous vacuole membrane and dense granules are involved in maintenance 
once the parasites are completely located within the host cell.  
Interestingly, recent knockout data suggests that motility is not coupled to 
invasion in these parasites and host cell invasion still occurs while blocking motility 
[48,49].  This suggests that the current model may need to be revised, multiple 
redundancies may exist to compensate for the individual knockouts, or another invasion 
mechanism may exist that can partially compensate [50].  More work will need to be 
done to determine the exact mechanisms involved in motility and invasion and if 
redundancies exist.   
 
Parasites Deliver Proteins “Just in Time” 
Cell cycle regulated genes have been identified in both yeast and human cells by 
analyzing periodicity in genome wide transcriptomes [51,52].  Monocistronic 
transcription of genes allowed for the identification of promoter elements that are 
typically in close proximity to the transcription start site.  Genes are contiguous along 
the chromosomes and are rarely co-regulated in P. falciparum [53] and T. gondii. 
Synchrony models are robust for P. falciparum and T. gondii and can be used to help 
study the transcriptome.  In 2002, we entered the genome era for Apicomplexa research 
with the complete sequencing of the P. falciparum genome [54,55,56].  Shortly after the 
transcriptome for P. falciparum was also published [53], introducing the first insights into 
the functional genomics of apicomplexans.  At least 60% of the genome is 
	   16	  
transcriptionally active in the asexual intraerythrocytic cycle of P. falciparum parasites 
and there are a low proportion of constitutively transcribed genes [53].  Genes typically 
peak once per cell cycle. Despite a loss of conservation in the order of the genetic loci 
[57], gene expression patterns have remarkably been conserved in these parasites and 
proteins with similar functions have similar transcript expression profiles [58].  “Just in 
time” delivery of proteins at the time they are needed and in the amount they are 
needed [53] characterizes the P. falciparum transcriptome.  The timing of mRNA 
accumulation occurs not only in cell cycle genes but also genes encoding structural 
genes that are needed to build structures at a precise time during the cell cycle. 
Conserved ancient eukaryotic genes typically peak in expression in the G1 phase and 
Apicomplexa specific genes typically peak in the S/M phase.  Gene expression in the 
S/M subtranscriptome is influenced by the functional requirements of daughter 
formation and genes peaking in the S/M phases encode for many structural and 
invasion proteins [58].  Building budding daughter cells requires self-assembly and self-
organization of a variety of structural and invasion proteins that are assembled into the 
developing daughters during the precise S/M phase of the cell cycle they are required.  
In general, the timing of mRNA expression for a gene in the asexual cell cycle of T. 
gondii and P. falciparum parasites correlates well with the function of the resulting 
protein [53,58].  Transcriptome and proteomics data indicate mRNA levels have a 
higher correlation to protein changes in P. falciparum than in yeast or higher eukaryotes 
[53].  Transcription is a major mechanism controlling gene expression in P. falciparum 
and T. gondii unlike in higher eukaryotes where progenitor cells have to differentiate into 
a variety of different types of cells.  The peculiar cell division mechanisms observed in 
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apicomplexans that occur in the replication and division phase of the cell cycle [22] 
involve many apicomplexan genes that have unknown functions.  The overwhelming 
number of unknown proteins in these parasites (38-58%) is a challenge, as they do not 
have recognizable domains, making it difficult to accurately predict their function.  
Originally designated as hypothetical gene products in Apicomplexa parasites many of 
these proteins are now identified as expressed proteins through multiple high 
throughput proteomics survey [59,60].  Few studies have employed a strategy to 
experimentally investigate unknown proteins on a large scale leaving principally the 
computationally approaches the task of assigning predicted function [17,61,62,63].  The 
major drawback to in silico approaches is reliance on known processes in other cells.  
An accepted strategy to characterize unknown proteins is to establish some level of guilt 
by association (similar expression profile or protein-protein interaction from global 
interactome).  Although much has been discovered by way of the transcriptome and 
proteome data many genes remain to be “hypothetical” or uncharacterized.  These 
unknown genes represent novel biology that is waiting to be discovered and may 
provide important information about parasite replication and invasion.  
 
Focus of This Study 
 In this thesis, we demonstrate a functionally unbiased approach based on cell 
cycle co-expression with no prerequisite of function that would enable us to identify new 
proteins involved in parasite division and invasion.  This bioinformatics approach was 
validated with experimental evidence to describe a way to prioritize the vast amount of 
hypothetical genes for research. Through this approach we have defined the core cell 
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division cycling (CDC) genes conserved in T. gondii and P. falciparum asexual stage 
parasites.  We identified cell cycle orthologs between T. gondii and P. falciparum mRNA 
data with similar mRNA expression timing.  The bioinformatics approach and our 
strategy to identify novel structural and invasion genes was experimentally validated in 
order to test our hypothesis. To validate our approach, a selection of unknown CDC 
genes was tagged in the T. gondii tachyzoite stage, revealing novel unknown proteins 
are housed in nearly every subcellular compartment of the highly organized tachyzoite 
cell.  We further characterized one of these novel structural proteins we identified 
through our bioinformatics approach.  Molecular biology and genetic tools allowed us to 
characterize timing and location of this novel membrane protein to build clues to 
possible function and biochemical analysis of the structure further defined this protein 
as a partially soluble member of the cytoskeleton.  We employed knockout approaches 
and identified potential protein binding partners to gain insight into possible functions of 
this novel cytoskeleton protein.  We have generated a large amount of data regarding 
cell cycle genes that are either orthologs between T. gondii and P. falciparum or species 
specific for their individual host niche that will be useful to the field and identified 16 
novel proteins that include many novel structural and invasion factors that can be used 
for future research on division and invasion of apicomplexans.  A better understanding 
of the invasion and structural proteins in Apicomplexa parasites could potentially lead to 
the development of novel parasite specific therapeutics. 
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Figure 1.1: Ultrastructure of T. gondii (left) and P. falciparum (right).  Eukaryotic 
parasites P. falciparum and T. gondii both contain many typical eukaryotic organelles 
including a nucleus, endoplasmic reticulum (ER), Golgi and a mitochondrion.  These 
parasites also contain Apicomplexa specific organelles including an apicoplast, an 
apically located polar ring and secretory invasion organelles including micronemes, 
rhoptries and dense granules.  Apicomplexans belong to the super phylum alveolates, 
which are characterized by a system of flattened Golgi vesicles located under the 
plasma membrane.  The inner membrane complex (IMC) is the patchwork of plasma 
membrane associated alveoli in apicomplexans.  It is important to note that P. 
falciparum lacks a conoid and a basal complex but does have three apical polar rings 
similar to T. gondii and a basal polar ring.  The apical polar rings serve as a 
microtubule-organizing center in these parasites.  
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Figure 1.2: Replication cycles of T. gondii and P. falciparum.  A. P. falciparum 
parasites divide by schizogony where multiple daughters form within a single mother.  
Nuclei replicate asynchronously for multiple rounds until the last synchronous round, 
which is followed by mitosis and cytokinesis at the periphery. B. Asexual stages of T. 
gondii divide by endodyogeny where two daughter parasites are assembled within the 
intact mother cell during each round of replication.  In endodyogeny, each round of DNA 
replication is followed by mitosis and cytokinesis. Modified version of schematic from 
Francia et al. (2014) Nature Reviews Microbiology. 
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Figure 1.3: Schematic representation of the structures in the T. gondii and P. 
falciparum cytoskeleton.  The cytoskeleton is comprised of an outer plasma 
membrane, the underlying inner membrane complex (IMC), the IMC protein meshwork 
composed of 8-10 nM wide filaments, which contain intermediate filament-like proteins 
that line the cytoplasmic side of the alveoli and the sub-pellicular microtubules which are 
the innermost structures that serve as a scaffold on which the rest of the cytoskeleton is 
assembled. The conoid and basal complex is not conserved across different 
apicomplexan parasites including P. falciparum but both T. gondii and P. falciparum do 
have apical and basal polar rings.   
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Figure 1.4: Schematic representation of a cross section of the T. gondii and P. 
falciparum cytoskeleton including the glideosome.  The cytoskeleton is comprised 
of an outer plasma membrane, the underlying inner membrane complex (IMC) and 
microtubules.  The IMC proteins contain alveolin domains and are intermediate filament-
like proteins.  Within the IMC, there are intramembrane particles (IMP) that are 
hypothesized to further stabilize the cytoskeleton.  The motility apparatus called the 
glideosome is anchored in the IMC and is composed of myosin A, myosin light chain 1 
(MLC1) and the gliding associated proteins (GAP45 and GAP50) that help anchor the 
complex to the membrane.  The myosin A motor moves on short F-Actin filaments 
connected by an unknown protein.  The microneme protein apical membrane antigen 1 
(AMA1) interacts with the rhoptry neck protein 2 (RON2), which is secreted and inserts 
into the host cell plasma membrane.  AMA1 is predicted to interact with actin via an 
unknown protein to generate the force transmission during host cell invasion. Modified 
schematic from Lebrun M. et al. (2006) In Toxoplasma gondii: The Model Apicomplexan 
– Perspectives and Methods.  
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CHAPTER TWO: 
Identifying Novel Cell Cycle Proteins in Apicomplexa Parasites 
Through Co-expression Decision Analysis 
 
Note to Reader  
Portions of this chapter, in part or in entirety, have been previously published in: 
Butler CL, Lucas O, Wuchty S, Xue B, Uversky VN, et al. (2014) Identifying Novel Cell 
Cycle Proteins in Apicomplexa Parasites through Co-Expression Decision Analysis. 
PLoS ONE 9(5): e97625. doi:10.1371/journal.pone.0097625 and are used with 
permission from indicated publishers. 
 
Introduction 
Apicomplexa are a phylum of unicellular, obligate intracellular parasites that 
includes pathogens of medical and veterinary importance. Significant human diseases 
such as toxoplasmosis caused by Toxoplasma gondii and the deadliest form of malaria, 
caused by Plasmodium falciparum are two examples.  The rapid asexual growth of 
parasites resulting in the cellular lysis and inflammation is at the center of these 
diseases, where the burden of growth is paramount in disease pathology [64,65] and 
drug resistance is a constant concern.  Therefore, understanding the mechanisms 
responsible for growth and invasion of these parasites is important for discovering new 
therapeutic targets and maintaining an active pipeline of new clinical treatments.  
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Apicomplexa parasites have evolved unique and effective strategies for 
intracellular replication.  T. gondii and P. falciparum diverged several hundred million 
years ago [1] and represent two modern endpoints of the apicomplexan evolution 
(coccidia and haemosporida families).  The T. gondii tachyzoite stage and the P. 
falciparum merozoite growing in human red blood cells are the major Apicomplexa 
model organisms for which growth synchrony models are robust [66,67] and advanced 
molecular genetics can be performed.  T. gondii tachyzoites undergo endodyogeny 
where binary division produces two internal daughters within the mother cell [31].  P. 
falciparum merozoites undergo schizogony, where multiple rounds of nuclear replication 
are followed by parasite budding to produce infectious parasites [25].  Endodyogeny 
and schizogony are similar in that they both produce new daughter parasites internally, 
which consumes the mother cell, and each division cycle (~48 h for P. falciparum and 
~8 h for T. gondii) consists of a single major G1 period followed by one or more S/M 
phases concluding with concerted cytokinesis. 
  The sequencing of the P. falciparum genome in 2002 was the beginning of 
genomics for parasites of this phylum [54] and was quickly followed by the first insights 
into the functional genomics of the P. falciparum intraerythrocytic cell cycle the next 
year [53].  One of the major insights of this first transcriptome effort introduced the 
concept of “just-in-time” delivery of proteins during the parasite division cycle.  
Remarkably, all cyclical mRNAs (~40% of transcripts) showed single peak expression 
that unfolds in a progressive cascade across the 48 h intraerythrocytic cycle [53].  We 
confirmed that this elaborate cascade also occurs in the distantly related apicomplexan 
T. gondii [58].  The relatively simple binary division of the T. gondii tachyzoite also 
	   25	  
revealed that cell cycle transcription unfolds in two major waves where mRNAs 
encoding ancient genes that include many DNA replication, transcription and translation 
genes show maximum expression levels in the G1 phase, while the unique 
apicomplexan genes involved in building invasion and internal daughter structures peak 
in the S/M phases [58].  While these waves are not as apparent in P. falciparum cell 
cycle transcription [53] the order of mRNA expression follows a similar evolutionary 
segregation of cell cycle timing [58]. 
   The peculiar cell division mechanisms observed in apicomplexans that occur in 
the S/M/C phase of the cell cycle [22] involve many apicomplexan genes that have 
unknown functions.  The overwhelming number of unknown proteins in these parasites 
(38-58%) is a challenge, as they do not have recognizable domains, making it difficult to 
accurately predict their function.  Originally designated as hypothetical gene products in 
Apicomplexa parasites many of these proteins are now identified as expressed proteins 
through multiple high throughput proteomics surveys [59,60].  Few studies have 
employed a strategy to experimentally investigate unknown proteins on a large scale 
leaving principally the computationally approaches the task of assigning predicted 
function [17,61,62,63].  The major drawback to in silico approaches is reliance on 
known processes in other cells.  An accepted strategy to characterize unknown proteins 
is to establish some level of guilt by association (similar expression profile or protein-
protein interaction from global interactome).  Here we demonstrate a functionally 
unbiased approach based on cell cycle co-expression with no prerequisite of function 
that would enable us to identify new proteins involved in parasite division.  Through this 
approach we have defined the core cell division cycling (CDC) genes conserved in T. 
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gondii and P. falciparum.  A selection of unknown CDC genes was tagged in the T. 
gondii tachyzoite stage, revealing novel unknown proteins are housed in nearly every 
subcellular compartment of the highly organized tachyzoite cell. 
 
Results 
Identifying cell division cycling (CDC) genes 
There are 6,372 predicted protein-coding genes in the P. falciparum genome with 
2,432 (38.2%) of these genes (strain HB3, www.plasmodb.org, V8.0) encoding unique 
family proteins many of which have no ortholog outside the Apicomplexa phylum (many 
are designated hypothetical or putative proteins). A similar genetic landscape 
characterizes T. gondii (strain ME49, www.toxodb.org, toxoDB V7.1) genome sequence 
where computer annotation predicts 8,102 genes.  Here an even higher occurrence of 
hypothetical proteins is annotated (58.2%, n=4,717 in ME49 strain).  These large groups 
of proteins likely hold the key to important parasite biology, yet a basic challenge is to 
know which unknown proteins should be investigated in order to uncover important new 
biology.  We hypothesized that defined mRNA co-expression could provide a rationale 
for making some of the tough experimental choices.  The assembly of new infectious 
parasites in P. falciparum and T. gondii is directed by an ordered cell cycle 
transcriptome that delivers proteins in a "just-in-time" sequence [53,58].  Each cyclical 
transcript reaches a peak once per cycle whether the cell cycle length is 8 h in T. gondii 
tachyzoites or 48 h in the P. falciparum merozoites.  In T. gondii, the timing of cell cycle 
transcripts is organized in two waves that separate mRNA peak expression in two 
distinct G1 and S/M/C subtranscriptomes [58].   
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We exploited this remarkable shared sequence of gene expression by 
incorporating this information into a decision tree with three principle binary choices: 
step 1) T. gondii and P. falciparum orthologs or not, step 2) conserved cyclical mRNA or 
not, and step 3) novel protein or not.  We performed this analysis by first defining 
conserved ortholog protein-coding genes in T. gondii and P. falciparum using an 
expanded list (see Materials and Methods) that employed modified parameters allowing 
orthologs to be called based on more limited regions of conserved protein topology and 
not restricted by length.  This process yielded 2,781 orthologous pairs from the 
complete set of T. gondii and P. falciparum predicted genes (see Fig. 2.1A and 
Appendix Table A.1).  In the next step we determined how many orthologs were 
encoded by a periodic transcript.  The cell cycle transcriptomes utilized were the 3,241 
cyclical transcripts in the P. falciparum HB3 strain (synchronized by two consecutive 
sorbitol treatments for three generations, for a total of six treatments) that have one 
peak of maximum expression with an amplitude >1.5 [53], and the 2,850 cubic b-spline 
modeling of mRNAs expressed in synchronized T. gondii RHTK+ tachyzoites [58].  This 
second step in our decision tree identified 744 orthologs that encode dual regulated cell 
division cycling (drCDC) mRNAs  (Fig. 2.1A).  This analysis also identified 354 orthologs 
that encoded CDC mRNAs in T. gondii, but not in P. falciparum, and conversely 1,153 
orthologs had the reverse relationship (i.e. P. falciparum CDC, not CDC in T. gondii; see 
Appendix Table A.1 for all gene lists and annotations).  There were few notable gene 
clusters in the 354 CDC T. gondii orthologs that are constitutive in P. falciparum (see 
Appendix Table A.1).  The orthologs expressed by CDC transcripts only present in P. 
falciparum encoded for many ribosomal and histone proteins, which was first noted to 
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be constitutive in T. gondii [58].  It is possible the P. falciparum synchrony model is 
more sensitive to changes in mRNA due to its longer length and frequent sampling (46 
hours of the 48 h intraerythrocytic cycle), or alternatively the scale of new parasites 
produced by the P. falciparum merozoites influences this difference.  A single P. 
falciparum merozoite division cycle produces 16-26 new parasites compared to the 
simple 2-fold production of daughter parasites in the T. gondii tachyzoite cell cycle.  By 
default CDC genes encoding non-orthologs were also identified here and are 
associated with important biology observed in these parasites (Appendix Table A.1).  
The 1,344 CDC genes exclusive to P. falciparum included merozoite surface proteins, 
P. falciparum export proteins, and VAR and rifin (RIF) proteins involved in antigen 
variation for which there is no equivalent mechanism in T. gondii.  Similarly, the 1,752 T. 
gondii-specific CDC genes include surface antigens and SAG1-related sequence (SRS) 
domain proteins as well as secreted proteins required for T. gondii invasion that are 
housed in the apical microneme and rhoptry organelles, which is consistent with the 
unique compositions of apical organelles responsible for transmission in unique host 
cell environments [68,69].   
The 744 drCDC mRNAs encoding orthologous protein pairs dual regulated in P. 
falciparum and T. gondii included well-recognized cell cycle factors such as 
dihydrofolate reductase thymidylate synthase (DHFR-TS) and DNA and RNA 
polymerases (see Fig. 2.1B for a partial list of canonical drCDC genes).  The peak 
timing of these canonical drCDC mRNAs are conserved in many eukaryotes with 
transcription/translation and DNA replication genes having peak expression in the G1 
phase, and genes encoding cytoskeletal structural proteins such as actin and tubulin 
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peaking during S/M/C phase of the cell cycles.  The relative timing of canonical drCDC 
mRNAs provided reference points to align the synchrony models of T. gondii RHTK+ 
tachyzoites (8.75 h cycle length) [58,66] and sorbitol-treated merozoites of P. falciparum 
(48 h cycle length) [67].  The two parasite cell cycles were aligned here at the G1/S 
transition by DHFR-TS mRNA peak expression and generated two basic bins of G1 (bin 
1) versus S/M/C mRNA timing (bin 2) (Fig. 2A).  Due to the method of synchrony that 
arrests RHTK+ tachyzoites in late G1/early-S transition (thymidine block and release) 
[58,66], the T. gondii G1 (bin 1) corresponds to the 4.6-8.75 h post-thymidine release, 
while the S/M/C (bin 2) is 0-4.5 h post-thymidine release. The P. falciparum synchrony 
method enriches for the beginning ring stage, and thus, the G1 (bin 1) is 0-34 h post-
infection and the 35-48 h post-infection time points represent parasites in S/M/C (bin 2).  
Further partition of G1 was accomplished by aligning the peak timing of mRNAs 
encoding transcription and translation (early G1) from those mRNAs encoding known 
DNA replication factors (late G1) in T. gondii and P. falciparum.  Early G1 for T. gondii 
was defined as 4.6-6.5 h and 1-14 h for P. falciparum; late G1 for T. gondii was defined 
as 6.6-8.75 h and 15-34 h for P. falciparum.  To ensure that drCDC genes encoded 
mRNAs with conserved cell cycle timing, we generated a data matrix based on each 
pair of orthologous drCDC genes (744 total) and their peak mRNA expression timing 
was aligned to the matched cell cycles (Fig. 2.2B).  We summed the number of ortholog 
pairs sharing the same peak mRNA timing and represented the total number of mRNAs 
with similar peak expression in both species as color intensity on the linear gradient 
(see color legend Fig. 2.2B).  The bottom left quadrant of this matrix graph corresponds 
to drCDC orthologs with maximum expression in the G1 phase.  As noted in earlier 
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studies [58] transcripts that peak in the first half of G1 are enriched for proteins involved 
in transcriptional and translational mechanisms (Fig. 2.2B, dashed circle 1), while late 
G1 is characterized by the expression of genes required for chromosome replication 
(Fig. 2.2B, dashed circle 2).  This profile is conserved in many eukaryotes and both T. 
gondii and P. falciparum follow this pattern.  The top right graph quadrant corresponds 
to mRNAs with cyclical profiles that peak in the S/M/C phases.  The specific patterns of 
co-expression for each of these mRNA subsets are shown in the full expression profiles 
across the synchronous growth timeframes (Fig. 2.2C).  Distinct co-expression profiles 
characterize each mRNA group, as can be observed in P. falciparum and T. gondii 
genes.  In T. gondii, G1 mRNAs are much less dynamic than their P. falciparum 
counterparts.  As with the ribosomal and histone genes above, this difference is not fully 
understood, but could be related to the different biotic production of each division cycle.  
The P. falciparum S/M/C mRNAs displayed tight peak expression compared to S/M/C T. 
gondii mRNAs.  Here there were two distinct T. gondii patterns, the majority of mRNAs 
peaked around 3 h, while a minor population was maximum at the G1/S boundary (8.75 
h time point) and declined immediately post-thymidine release.  Generally mRNA 
expression for asexual stage apicomplexans correlates well with the peak of the 
encoded protein [53,70].   Altogether, these results demonstrated that the mRNA 
profiles as well as the peak times were shared in each cell cycle class indicating that 
both timing and amplitude are conserved.  
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A large class of dual-CDC genes encodes novel cell cycle proteins 
In the third sorting step, we categorized the 744 drCDC genes (Appendix Table 
A.1) as novel or not, which generated a list of 125 genes annotated in EupathDB as 
“hypothetical” and were designated here as drCDC unknowns (drCDC-UNK).  
Employing an expanded list of putative orthologs captured a larger number of drCDC-
UNK genes than is possible with other approaches to orthology assignment such as 
OrthoMCL, which use a more restricted protein length criterion.  For example, only 84 
(66%) of the 125 P. falciparum novel proteins identified here as drCDC-UNKs, would 
have been classified using OrthoMCL in step 1 (eupathdb.org, v.2.12).  We expected 
that drCDC-UNK gene lists would be enriched for phylum-specific proteins that could 
have roles in the apicoplast, invasion and unique cell division functions since these 
processes are specialized in the Apicomplexa.  The evolutionary specificity was 
confirmed as 109 of the drCDC-UNK were found only in genome sequence of 
Apicomplexa parasites, while only 16 drCDC-UNK genes had wider conservation 
including a few orthologs shared with human cells.  The drCDC-UNK genes conserved 
outside the Apicomplexa phylum are interesting and may represent undiscovered cell 
cycle factors present in the original eukaryote.  A correlation between evolutionary 
distribution and essentiality has been noted [71] and the recent discovery of a novel 
splicing factor in Toxoplasma that is widely conserved across the eukaryotes [72] also 
highlights these possibilities.   
Published half-life profiles for the P. falciparum drCDC-UNK mRNAs were 
analyzed with respect to the steady-state peak times [70].  Most of the mRNAs (89% or 
n=113) had the highest half-life at or within a few hours following the timeframe of the 
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maximum mRNA expression in the cell cycle (Fig. 2.3).  The most abundant category 
(n=36) was for mRNAs peaking in schizonts (31-44 h post infection), for which the 
longest half-life was in late schizonts (45-48 h post infection).  Thus, steady-state mRNA 
peak timing is likely a reasonable indicator for when transcriptional inputs yield their 
greatest influences on protein expression in the parasite cell cycle.  Analyzing relative 
abundance of the drCDC-UNK mRNAs in the context of timing of peak expression (Fig. 
2.4A, B) reveals that in T. gondii and P. falciparum novel drCDC-UNK mRNAs spanned 
all abundance classes and were expressed at all time points throughout the cell cycle.  
Interestingly, the cluster of drCDC-UNK mRNAs expressed in the second half of the P. 
falciparum merozoite cell cycle were all highly abundant transcripts (Fig. 2.4B) possibly 
reflecting the scaling difference between these two division processes (T. gondii division 
is 2x, while P. falciparum is ~10x) as was mentioned earlier. 
 
Apicomplexa drCDC-UNK proteins have conserved intrinsic disorder propensity 
To further understand drCDC-UNK proteins from T. gondii and P. falciparum, we 
analyzed their intrinsic disorder propensities for each orthologous pair in order to 
explore whether the disorder/order profiles were conserved over a long evolutionary 
time.  These modern parasites represent deep branches in the Apicomplexa lineage 
and have lost all chromosome syntenic structure (i.e. no three genes are in the same 
order) [57].  Since evolution typically conserves protein folding [71] and predisposition 
for functionally important intrinsic disorder [73,74,75,76], these features can aid in 
identifying and verifying orthologous relationships where primary amino acid sequence 
does not reveal ancestral linkage with significant confidence [71,73,74,75,76]. The 
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drCDC-UNK protein set comprises a range of predicted protein masses (8 to >1,000 
kDa) with wide variation in predicted disorder based on charge/hydrophobicity scores, 
which is a binary classifier of protein disorder at the whole protein scale.  In T. gondii, 76 
(60%) of the drCDC-UNK proteins were predicted to be disordered (Fig. 2.5A, left two 
quadrants, open circles), while in P. falciparum 54 (43%) are disordered (Fig. 2.5A, left 
two quadrants, closed squares). 
The overall molecule-level disorder propensity defined from average 
charge/hydrophobicity values for each protein does not reveal how evolutionary 
selection has operated to shape protein topology on a per amino acid scale.  We 
examined this question for each drCDC-UNK protein pair by analyzing per-residue 
disorder prediction.  Sequence distributions of the PONDR VSL2B scores (>0.5 
indicates disorder) were analyzed for each protein pair as previously described [77] and 
profiles of the predicted intrinsic disorder propensity were compared by best-fit criteria 
and independent of order/disorder for the drCDC-UNK proteins.  The pairwise matching 
of the VSL2B profiles revealed three broad categories of protein alignment (Fig. 2.5C): 
(i) highly conserved intrinsic order/disorder profiles (n=32, see all pairings in Appendix 
Fig. A.1-2), (ii) similar profiles with obvious tail(s) or domain(s)/loop(s) insertions or 
complex additions (n=78, see all in Fig. A.3-6) and (iii) minimal profile matches of both 
ordered and disordered proteins (n=15, see all in Fig. A.7).  Remarkably the drCDC-
UNK matched protein pairs include examples of proteins from both ends of the 
order/disorder spectrum with some fully ordered (5/32) and others nearly completely 
disordered (3/32) indicating that order/disorder itself is not the driving evolutionary 
characteristic (see Fig. A.1-2).  However, when domains have evolved that are unique 
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to either parasite species the addition is typically intrinsically disordered.  These 
additions occur at the N or C-terminus tail or display complex additions of various 
combinations of additions with some internal loops.  In the set of T. gondii drCDC-UNK 
proteins there were 14 N-terminal and 8 C-terminal additions.  Similar changes were 
observed in P. falciparum with 8 N-terminal and 7 C-terminal mostly disordered tails 
added.  Complex additions involving a combination of additions and loops were 
observed for both T. gondii and P. falciparum drCDC-UNK proteins (n=41).  The 
abundant class of protein topology profiles with loop/tail additions is represented by 
TGME49_025320 for T. gondii and PF11_0373 for P. falciparum where the P. 
falciparum protein extended the loop region (indicated by an arrow) in the N-terminus 
(Fig. 2.5C Loop/tail addition). An example of matching protein topology is the pair of 
proteins, T. gondii TGME49_026270 and P. falciparum PF10_0070 (Fig. 2.5C Topology 
match), whereas the disordered profiles of proteins T. gondii TGME49_091150 and P. 
falciparum PFL0360c poorly match (Fig. 2.5C Minimal match).  
  
Experimental validation of selected novel drCDC-UNK proteins. 
To explore the nature of drCDC-UNK proteins further, we selected a 
representative set of genes for epitope tagging by genetic knock-in in T. gondii.  The 
selection criteria was designed to include examples of 1) genes expressed from 
moderate to abundant mRNA levels (62-100 percentile), 2) genes with a range of 
cyclical amplitude representing different dynamic profiles, 3) genes with distributed 
timing of peak expression representing all cell cycle phases of T. gondii tachyzoite 
division, and finally 4) genes encoding proteins of different predicted mass from 140 to 
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4,000 amino acids (aa).  A total of 21 drCDC-UNK genes were selected (Table 2.1) 
along with one drCDC-UNK positive control (ISP1, gene ID TGME49_060820, for 
VSL2B graph see Fig. S2) [78].  Protein tagging in the gene locus was accomplished 
through the introduction of a triple copy of the hemaglutinin (HA) epitope into the 
predicted C-terminus in the T. gondii RH∆ku80 strain [79,80] and individual protein 
expression and localization was determined by immunofluorescence assay (IFA) using 
suitable co-markers.   
Epitope tagging was successful for 16 of 21 genes (75%) as determined by IFA 
(Fig. 2.6) and Western analysis (Fig. 2.7), which is similar to the published success rate 
in the RH∆ku80 strain [79].  A variety of localization patterns were observed with 
particular enrichment (5/16=31%) for proteins showing apical-specific distribution (Fig. 
2.6).  When combined with proteins found to be associated with budding the majority of 
the proteins tagged were localized to specialized structures of apicomplexan division 
and invasion (8/16=50%, see Fig. 2.6 left panel and Table 2.1).  Many of the mRNAs 
encoding these proteins reach peak expression in the S/M phase of the T. gondii 
tachyzoite cell cycle (Table 2.1 and Fig. 2.9), which is consistent with the timing of 
mRNAs encoding invasion and structural proteins in these parasites [58].  In general, 
Western analysis of the epitope tagged protein confirms the predicted protein mass 
(Fig. 2.7) with a few exceptions (see Fig. 2.8).  Thus, these results confirmed our 
original prediction that cell cycle timing in the S/M/C periods would be a valuable 
characteristic for identifying novel proteins involved in apicomplexan replication.  
The different fluorescent patterns of tagged drCDC-UNK proteins labeled many 
of the known sub compartments and novel structures within the T. gondii tachyzoite with 
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proteins concentrated in the very apical end, the apical cap, the region between the cap 
and nucleus, around the nucleus, in the nucleus and contained in membranes.  Five 
drCDC-UNK proteins were localized to invasion organelles including the apically located 
micronemes and rhoptries as well as dense granules.  The proteins encoded by genes 
TGME49_089100 and TGME49_094790 were co-localized with MIC2 indicating these 
proteins are new microneme factors (Fig. 2.6A, top two left panels). TGME49_094790 
also appears to partially co-localize with rhoptry bulb protein (ROP7) in the area 
posterior to the MIC2 co-localization. Additional independent experimentation will be 
required to validate that this factor is dual localized to microneme and rhoptry 
organelles. The mRNAs encoding these two putative microneme proteins displayed a 
cyclical profile with a peak in mitosis and cytokinesis that is characteristic of many other 
microneme mRNAs (Fig. 2.9) [58,81].  However, neither of these newly identified 
microneme proteins are predicted to have a signal peptide suggesting that they are not 
likely to be secreted and are more likely to be escorter proteins similar to MIC7, which 
also lacks a signal peptide [82].  The TGME49_089100 protein is predicted to have a 
Hook domain that is known to mediate attachment to microtubules and may aid in 
microneme translocation along the subpellicular microtubules from the Golgi to the 
apical end of the parasite [83].  TGME49_094790 partially co-localized with MIC2 and 
has an mRNA pattern that more closely matches the profile of MIC13 mRNA than MIC2 
(Fig. S11).  The recent finding demonstrating microneme proteins organize into distinct 
sub compartments may be reflected in these different mRNA patterns [84].  The 
proteins encoded by genes TGME49_089100 and TGME49_094790 are the 18th and 
19th proteins identified in the microneme organelle and therefore named MIC18 and 
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MIC19 respectively.  Two other drCDC-UNK proteins had distinctive concentrations that 
extended to the apical tip that was similar to rhoptry localization.  The TGME49_030350 
mRNA peaks in the S/M phase similar to other known rhoptry mRNAs (Fig. 2.9) [58] and 
the coding sequence is predicted to encompass an EF-hand domain and include a high 
number of strain-specific non-synonymous SNPs (n=47), which are also features shared 
with other rhoptry proteins [85,86].  During this study the TGME49_030350 gene was 
independently confirmed to be a new rhoptry neck protein, now designated RON11 and 
using anti-RON11 antibodies we validated that assignment by IFA analysis [87].  The 
protein encoded by the gene TGME49_041000 also displayed rhoptry localization.  The 
co-localization of this factor with rhoptry bulb protein, ROP7, indicated that it is likely a 
novel rhoptry bulb protein.  Like RON11 above, the mRNA encoding TGME49_041000 
peaks in the S/M phase (Fig. 2.9).  Interestingly, TGME49_041000 has 4 
transmembrane domains similar to TgDHHC7 (Asp-His-His-Cys) that localizes to the 
rhoptry and affects apical positioning of rhoptries [87,88].  TGME49_041000 is the 51st 
protein identified in the rhoptry organelle and is therefore named ROP51.  The fifth and 
last invasion organelle protein uncovered here is gene TGME49_025320, which 
encodes a protein with peak expression in S phase that partially localizes with the 
dense granule protein GRA7 (Fig. 2.6A).  This gene has a potential signal peptide (D-
score >0.5) and only has orthologs within Apicomplexa indicating it is a phylum specific 
invention consistent with the putative dense granule assignment.   Unlike most dense 
granule mRNAs [58], the TGME49_025320 mRNA pattern is dynamic and cyclical (Fig. 
2.9) indicating this factor is cell cycle regulated.  The partial co-localization with GRA7 
suggests this protein may have functions that are independent of this organelle or that 
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this protein does not tolerate C-terminal tagging and is mistargeted to some dense 
granules and other vesicles by default. 
Three proteins tagged in this study localized to specialized mitotic structures (Fig. 
2.6B).  Centrosome proteins show localization at the apical side of the nucleus in a 
structure that duplicates at the initiation of budding (Suvorova and White, unpublished 
and [89]).  The centrosome is composed of internal centriole cores and surrounding 
peri-centriolar matrix (PCM) that is the assembly site of a specialized fiber that mediates 
the connection of the centrosome to the developing daughter buds [90].  Protein 
TGME49_035130 is encoded by a S/M peak mRNA similar to inner membrane complex 
sub-compartment protein 1 (ISP1) and Sas-6-like (SAS6L) mRNAs (Fig. 2.9) and 
displayed PCM as well as apical cap localization.  This protein surrounds centrin1 
(Cen1), which is a marker of the distal end of the centriole (Fig. 2.6B). TGME49_035130 
is conserved only in apicomplexan parasites, which would be consistent with the low 
conservation of PCM proteins in other eukaryotes [91,92].  This protein also co-localizes 
with apical protein ISP1 (data not shown).  TGME49_064990 protein preferentially 
targeted to the daughter inner membrane complex (IMC) during parasite budding similar 
to IMC3 [93].  This protein had a tight cell cycle profile with peak expression in S/M (Fig. 
2.9), and similar to other IMC membrane proteins, TGME49_064990 is predicted to be 
palmitoylated.  Gene TGME49_005320 encodes the last factor we observed in parasite 
mitotic structures.  This factor localized to the basal complex and IMC structures.  This 
protein showed peak expression in the S/M phase of the cell cycle (Fig. 2.9).  
The next group of proteins we tagged included eight drCDC-UNK proteins that 
displayed distinct localization to conventional eukaryotic cell compartments (see Fig 
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2.6C).  This group included two cell cycle factors with potential functions across 
eukaryotic cells.  A highly conserved novel nuclear protein encoded by gene 
TGME49_028490 had peak expression at G1 and is predicted to be phosphorylated 
(ascore=100).  Co-localization of this protein with DAPI (Fig. 2.6C) and antibodies 
against the T. gondii proliferating cell nuclear antigen (PCNA) protein (data not shown) 
confirmed it was exclusively located in the parasite nucleus.   The gene, 
TGME49_036510, encoded a mitochondrial protein with a cyclical profile, which was 
confirmed by co-localization with the mitochondrial protein, F1β ATPase.  In P. 
falciparum, synthesis of mitochondrial proteins occurs when the mitochondria mature 
during the S/M phase (Table 2.1) of the cell cycle [53] and the relative cell cycle timing 
likely applies to the T. gondii tachyzoite [58].  The TGME49_036510 protein contains a 
predicted GAF-like domain present in a wide variety of proteins including cGMP 
phosphodiesterases that are important regulators of signal transduction and are 
potential therapeutic targets.  TGME49_005740 encodes for a protein that displays 
putative endoplasmic reticulum localization [81] due to its localization with DER1 and 
encodes for a highly conserved protein that contains a C-terminal transmembrane 
domain. The last three proteins of this group had extensive cytosolic distributions.  The 
TGME49_111880 mRNA displays peak expression in S phase (Table 2.1), and the 
encoded protein is predicted to be phosphorylated.  The protein encoded by gene 
TGME49_033810 displays punctate cytosolic localization consistent with vesicles and 
displays peak expression at S/M (Table 2.1).  The TGME49_033810 protein contains 
four predicted Sel1 domains that have been implicated in negative regulation of the 
notch developmental pathway in C. elegans.  We identified a protein with peak 
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expression at C/G1 phases (Table 2.1) encoded by TGME49_113860, which 
surprisingly localized to the cytosol.  The G1 image pattern for this factor was selected 
for comparisons with the two other cytosolic factors we discovered, however, this factor 
was found to increase dramatically in the newly formed daughter cytosol consistent with 
the profile of the encoded mRNA (data not shown). TGME49_113860 contains a 
predicted regulator of chromosome condensation (RCC1) repeat, suggesting this 
protein may have an interesting role in cell division. 
The final group of two proteins (Fig. 2.6C, bottom two panels) was found to 
associate with the plasmalemma or inner membrane structures.  Protein 
TGME49_052430 was concentrated in the parasite plasmalemma extending beyond the 
IMC and into the apical tip of the parasite.  This protein contains a predicted Bet v1-like 
domain that has been implicated in lipid binding and lipid transporter activity and peaks 
in S/M similar to known membrane proteins: IMC1 and Sag Related Sequence 12B 
(SRS12B) (Fig. 2.9).  TGME49_030160 encodes an interesting membrane protein that 
stains the complete parasite with a concentration in the apical end of the parasite and is 
absent in the developing daughters during endodyogeny.  This protein shows peak 
expression in G1 (Fig. 2.9) and contains a coil-coil domain that may aid in its membrane 
localization.  Independently from our studies, this protein was localized to the 
membrane after overexpression and fusion to GFP [94] corroborating our findings.  The 
localization of TGME49_030160 resembles another T. gondii protein, TgPhIL1 [95] that 
is thought to be required to help tether the inner membrane complex to the plasma 
membrane however, despite the similar localization pattern the mRNA patterns do not 
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match (data not shown) and the mRNA pattern for TGME49_030160 more closely 
resembles IMC12 and IMC13 (Fig. 2.9), which are known to peak in G1 as well.   
 
Building additional clues to function 
Biological interaction networks can be inferred using conserved protein 
interactions or interlogs [96,97], and while there is no global interactome data reported 
in T. gondii, there is a partial high-throughput yeast-two hybrid interactome in P. 
falciparum.  We used this P. falciparum network that represents ~25% of the total 
proteome [98] and includes a compilation of 2,849 interactions between 1,304 proteins 
[98] measured with an adapted yeast two-hybrid method to construct a P. falciparum 
interactome encompassing nine of the drCDC-UNK proteins (see Appendix Table A.2).  
This analysis revealed several interactions (Fig. 2.10 and Appendix Table A.2) that 
extend the information obtained by protein localization in T. gondii (Fig, 2.6). 
A large sub network (Fig. 2.10) comprising five of the drCDC P. falciparum 
proteins showed linkage to major groups of kinases (9) and cytoskeletal proteins (14).  
For three of the drCDC P. falciparum proteins the corresponding T. gondii orthologs 
were epitope tagged (Fig. 2.6 tagged proteins TGME49_005320, TGME49_089100, 
and TGME49_111880) and found to localize to the basal complex/internal membrane, 
micronemes, and cytosol, respectively, lending key biological information to these 
potential interactions.  The MAL7P1.125/TGME49_005320 ortholog pair is predicted to 
interact with five kinases including two calcium-dependent and two cyclic nucleotide 
kinases (Appendix Table A.2) that are thought to work closely together to control 
motility, invasion and egress [99,100] in P. falciparum.  This information together with 
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the localization of the T. gondii ortholog to the basal complex/internal membrane of the 
tachyzoite suggests a role for this factor in building the parasite invasion apparatus, and 
adds to the interests in these kinases as possible drug targets [101].  Protein PFI0175w 
(paired with TGME49_089100) was linked to several cytoskeletal proteins and the T. 
gondii protein ortholog localized to the micronemes (Fig. 2.6A).  As noted earlier, 
TGME49_089100 has the potential to interact with microtubules through a hook domain 
that is also conserved in the P. falciparum ortholog.   Another interaction of interest 
within the large sub network is the potential of PFB0145c (paired with 
TGME49_046190) to interact with the cytoskeletal components.  The predicted prefoldin 
domain in this factor is known to aid in the assembly of actin [102].  Also consistent with 
a role in invasion, is a piggyBac insertion mutant that disrupts P. falciparum PFB0145c 
leading to a severe growth defect in the intra-erythrocytic cycle of the merozoite [103].   
Two other smaller sub networks (Fig. 2.10 top right and left) were identified by 
this analysis.  The first involves a T. gondii protein encoded by TGME49_005740 for the 
corresponding drCDC P. falciparum ortholog (MAL8P1.105) that was found localized to 
the parasite endoplasmic reticulum (Fig. 2.6C).  It may be no coincidence that this is a 
major site of ribosome localization in cells and the network interactions shown here 
involve twenty-five translational factors.  Finally, the last protein subnetwork (Fig. 2.10 
top left) includes many transcription related factors and this could be related to the RNA 
methyltransferase domain in PF14_0307/TGME49_085950 and the possible nucleic 
acid binding site in the C-terminal end of the PF10_0054/TGME49_070960 protein pair. 
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Discussion 
Eukaryotic cell cycles are preserved in spatial and timing relationships [104] that 
are independent of chromosome evolution.  Lineages that are represented by P. 
falciparum and T. gondii are thought to have diverged several hundred million years ago 
[1] and, as a consequence, their chromosome structures have become very distinct.  
The nucleotide bias is substantially different and synteny from the apicomplexan 
common ancestor has been completely lost [57].  Despite this divergence, evidence 
presented here builds on discoveries of a dominant selection of gene expression timing 
[53,58] preserved to carryout the unique topology of daughter parasite assembly and 
replication.  Distinct sub-transcriptomes in the Apicomplexa deliver proteins in a “just-in 
time” assembly [53,58] and they also separate into the two halves of the cell cycle many 
apicomplexan specific inventions, such as building invasion organelles and internal 
daughter structures (S/M peak) from more ancient eukaryotic functions such as 
constructing transcription/translation and DNA replication machineries (G1 peak) [58].   
In 2002, we entered the genome era for Apicomplexa research with the complete 
sequencing of the P. falciparum genome [54,55,56] however, almost half of the genes 
discovered in these parasites have yet to be characterized and are still classified as 
hypothetical or unknown.  Many of these hypothetical genes could be essential for 
parasite growth and offer unique targets for therapeutic development if we understood 
their functions.  Large-scale studies of hypotheticals have been notoriously difficult to 
accomplish, and thus far, only one effort has launched a genome-wide gene knockout 
effort in the Apicomplexa that could capture the function of some of these genes [103].  
Short of expanding these high-through-put genetic approaches, the sorting strategies 
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based on co-expression used here have benefits in discovering important Apicomplexa 
proteins involved in building new parasites.  The strategy devised was an easily 
implemented decision tree analysis to identify novel proteins through relaxed orthology 
criteria, conserved mRNA peak timing and novel protein topology.  The modified criteria 
for orthology assignment identified nearly 600 additional protein pairs than found using 
conventional methods that do not adequately account for additions of intrinsically 
disordered tails or loops that lead to penalized scores in conventional algorithms.  Using 
cell cycle expression data to sort genes, we resolved genes that are uniquely cell cycle 
regulated in each parasite from those that form a core set of cycling mRNAs likely 
conserved across the parasite family.  Thus in P. falciparum, genes encoding cell cycle 
regulated surface and unique export proteins sorted into a CDC list that lacked 
conservation in T. gondii, while rhoptry proteins found in T. gondii and other coccidians 
fell into an opposite class.  The CDC genes specific to each parasite include a large 
number of novel proteins representing undiscovered molecular features necessary for 
completing the T. gondii and P. falciparum life cycles in each unique host cell 
environment.  These genes were not studied here, but are as worthy of serious 
investigation as the dual cell cycle regulated genes that were the focus of this study.   
The ~700 genes (9% in T. gondii and 12.8% HB3 P. falciparum) that were found 
to be dual cell cycle regulated and conserved in T. gondii and P. falciparum represent 
many of the core set of CDC genes in apicomplexan parasites.  This is a similar number 
of core CDC genes conserved in fungal and mammalian eukaryotic models (5-7%) [105] 
and the canonical CDC genes present in our lists overlaps these previous reports.  
Importantly, included in this set of core CDC genes are more than a hundred genes 
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(drCDC-UNK genes) classified as hypothetical in T. gondii and P. falciparum.  As a 
group these proteins have higher proportion of disordered domains and in T. gondii 
these proteins tended to be longer.  Given the lack of functional insight it is easy to 
assume these proteins are weakly conserved, perhaps even false positive cases of 
orthology assignment.  However, this study demonstrates these proteins have 
remarkable conserved topology and their expression at the mRNA level is well 
preserved in cell cycle timing.  The drCDC-UNK genes are also conserved in the levels 
of encoded mRNA abundance with the exception of the group of hypothetical CDC 
genes in P. falciparum that had peak expression during late nuclear reduplication and 
parasite budding (S/M timing, Fig. S2).  Here the uniform high abundance of expression 
of these novel CDC genes set them apart from their T. gondii counterparts.  We believe 
this indicates a dominant role for these proteins in organizing and building daughter 
parasites that have a 10-fold scaling difference between the replication of the merozoite 
of P. falciparum compared to the tachyzoite of T. gondii.  This theme again was borne 
out in the lack of regulatory proteins present in the hypothetical group of core CDC 
genes and the tagging of 16 of these genes in T. gondii that revealed newly discovered 
proteins of invasion organelles and membrane structures, which are all scalable building 
components of the infectious parasite.   The results of tagging hypothetical proteins also 
highlights the amount of biology we still must uncover in these parasites.     
Our results clearly demonstrated that screening hypothetical genes by mRNA 
timing, orthology and protein topology enhances our ability to find specific types of 
proteins such as novel invasion proteins based on co-expression.  The next steps in 
uncovering the function of the 125 drCDC-UNK proteins will be to use available genetic 
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models to define phenotypes and interactor studies to identify protein partners, which is 
beyond the scope of this initial study.  Currently, there is little global interactome data 
available and more interactome data is needed. As more interactome data becomes 
available for the Apicomplexa phylum it will be increasingly easier to predict protein 
function and help prioritize large lists of hypothetical proteins based on predicted 
functions for genome wide knockout strategies. 
 
Materials and Methods 
Cell culture 
Parasites were maintained as previously described [106] in primary human 
foreskin fibroblasts (HFF) kindly provided by Dr. David Roos.  The parasite strains 
RH∆ku80 and RH∆hxgprt∆ku80 were used for endogenous tagging of genes as 
previously described [79].  Stable transgenic parasite lines were selected in media 
containing 1 µM pyrimethamine. 
 
Sequence analysis and ortholog identification  
Gene/protein sequences of the ME49 and GT1 strains of T. gondii were obtained 
from www.toxodb.org, toxoDB V7.1, while gene/protein sequences of the HB3 strain of 
P. falciparum were retrieved from www.plasmodb.org, V8.0.  The predicted models for 
Toxoplasma and Plasmodium spp. genes are still being refined and therefore, it is 
possible there are differences between predicted protein size and the native proteins 
due to artifacts of incorrect calling of the translation start/stop sites or introns.  While 
imperfect, we used the current annotated protein sequences to analyze for the presence 
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of known domains, motifs and repeats using SMART (http://smart.embl-heidelberg.de). 
Gene expression data using spline curves, as previously described [58] for T. gondii 
and gene expression data from the DeRisi lab available on www.plasmodb.org [53] for 
the intraerythrocytic cycle of P. falciparum were used to determine mRNA expression 
and timing.  To determine orthologous pairs of proteins in T. gondii and P. falciparum 
we utilized all-versus-all BLASTP searches using the InParanoid script [107].  In 
particular, we accounted for all sequence alignments irrespective of any constraints of 
alignment length and score. Sequence pairs with mutually best scores were selected as 
central orthologous pairs. Homologous proteins of both species were clustered around 
these central pairs to form orthologous groups.  The quality of such clusters was further 
assessed by a standard bootstrap procedure.  Accounting for all pairs, we obtained a 
set of 2,781 orthologous protein pairs in P. falciparum and T. gondii (Appendix Table 
A.1).   
 
P. falciparum mRNA half-life analysis 
Cell cycle phases of peak mRNA abundance (expression data were obtained 
from [53]) and peak mRNA half-life [70] were manually compared for all 125 P. 
falciparum drCDC-UNK genes throughout the 48 h intra-erythrocytic life cycle. Where 
mRNA abundance and maximum half-life occurred in the same phase of the cell cycle 
the gene was scored a zero. An offset of one phase was scored a 1 when a gene’s 
abundance peaked in a cell-cycle phase before the half-life reached its maximum (e.g. 
abundance peak in ring phase, half-life peaks in trophozoite phase). In turn, an offset of 
one phase was scored as -1 when a gene’s abundance was maximal in a cell-cycle 
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phase after the half-life reached its peak (e.g. abundance peaks in trophozoite phase, 
half-life peaks in ring phase).  All mRNA abundance and half-life data was obtained 
from PlasmoDB. 
 
Protein intrinsic disorder predictions 
Two principally different approaches were used to identify the intrinsic disorder 
propensities in proteins. To these ends, we applied binary classifiers that classify whole 
proteins as either mostly disordered or mostly ordered and a disorder predictor that 
provides per-residue disorder propensity for a query protein. The two binary predictors 
of intrinsic disorder used were charge-hydropathy plot (CH-plot) [108,109] and 
cumulative distribution function analysis (CDF) [109]. These methods perform binary 
classification of whole proteins as either mostly disordered or mostly ordered [109].  
We also utilized the combined CH-CDF analysis, where the coordinates of each 
spot are calculated as a distance of the corresponding protein in the CH-plot (charge-
hydropathy plot) from the boundary (Y-coordinate) and an average distance of the 
respective cumulative distribution function (CDF) curve from the CDF boundary (X-
coordinate) [110,111]. The primary difference between CH and CDF binary predictors is 
that the CH-plot is a linear classifier that takes into account only two parameters of the 
particular sequence (charge and hydropathy), whereas CDF predictor was trained to 
distinguish order and disorder based on a significantly larger feature space. Therefore, 
CH-plot analysis is predisposed to discriminate proteins with substantial amount of 
extended disorder (random coils and pre-“molten globules”) from proteins with compact 
conformations (“molten globule”-like and rigid well-structured proteins). On the other 
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hand, CDF analysis may discriminate all disordered conformations, including molten 
globules and mixed proteins containing both disordered and ordered regions, from rigid 
well-folded proteins. Thus, the CH-CDF analysis enables discrimination of proteins with 
extended disorder from potential molten globules and mixed proteins.  
Positive and negative Y values in corresponding CH-CDF plot correspond to 
proteins predicted within CH-plot analysis to be intrinsically disordered and extended or 
compact, respectively. On the other hand, positive and negative X values are attributed 
to proteins predicted within the CDF analysis to be ordered or intrinsically disordered, 
respectively. Thus, the resultant quadrants of CDF-CH phase space correspond to the 
following expectations: Q1, proteins predicted to be disordered by CH-plots, but ordered 
by CDFs; Q2, ordered proteins; Q3, proteins predicted to be disordered by CDFs, but 
compact by CH-plots (i.e., putative molten globules or mixed proteins); Q4, proteins 
predicted to be disordered by both methods (i.e., proteins with extended disorder). This 
CH-CDF analysis was applied to the set of the 125 drCDC-UNK proteins in order to 
their overall order/disorder predispositions at the whole molecule level.   
PONDR VSL2B plots were analyzed to evaluate the disorder content in the 
protein sequences on the per-residue level as previously described [77]. PONDR 
VSL2B-based order/disorder (>0.5=disorder) scores per amino acid residue were used 
to create corresponding profiles and a best-fit method to align the T. gondii and P. 
falciparum proteins was applied to each ortholog pair.  
 
Endogenous epitope tagging of T. gondii proteins 
All designs for endogenously tagging of individual proteins in the genetic locus 
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employed predicted gene models that were verified by RNA-sequencing data in ToxoDB 
(www.toxodb.org). For endogenous tagging, the vector pLIC-HA3-DHFR was 
generously provided by Vern Carruthers [79].  Briefly, genomic fragments were 
amplified by PCR for each gene (for primers used see Dataset S3) using a design that 
fuses the C-terminal end of each coding region with a triple hemagglutinin tag (HA3) in 
the LIC-HA3-DHFR plasmid. A unique restriction site upstream of the predicted stop 
codon was identified to perform the linearization. pLIC-HA3-DHFR was linearized with 
PacI and subjected to T4 DNA polymerase (Novagen, LIC-qualified) for ligation 
independent cloning (LIC).  Sequenced constructs were electroporated into either 
RH∆ku80 or RH∆hxgprt∆ku80 parent strains using standard methods.  Transgenic 
strains were selected in media containing pyrimethamine (1 µM final).  Polyclonal 
isolates were screened to verify homologous recombination using a unique 5'-primer 
upstream of each genomic fragment used to tag the locus in combination with a 
common HA primer (see Appendix Table A.3) to confirm loss of the wild type locus.  To 
confirm endogenous tagging, western blotting was performed (Fig. 2.7) as previously 
described [112,113] using rat anti-HA antibodies (Roche) at a dilution of 1:500 and goat 
anti-rat IgG conjugated to HRP (Jackson ImmunoResearch Laboratories, Inc., West 
Grove, PA) at 1:1000.  For proteins that did not show a match in predicted protein size 
genomic DNA was harvested from purified parasites and analyzed by PCR to verify the 
correct gene locus was tagged. PCR products were amplified with the primers in 
Appendix Table A.3 using Taq DNA polymerase (New England Biolabs) and were 
analyzed after gel electrophoresis on a 0.8% agarose gel stained with SYBR safe DNA 
gel stain (Invitrogen). 
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Immunofluorescence assay and microscopy 
Immunofluorescence assays were performed as previously described [58].  
Briefly, infected HFF monolayers were fixed in 3.7% paraformaldehyde and 
permeabilized on 0.25% Triton TX-100.  After blocking in 1% PBS-BSA for at least 
30min, primary antibodies were added for one hour at room temperature.  Primary 
antibodies were prepared at the indicated dilutions: rat anti-HA (Roche) at 1:500, rabbit 
anti-HA (Abcam) at 1:1000, mouse anti-MIC2 (kindly provided by Dr. Jean Francois 
Dubremetz) at 1:2000, rat anti-RON11, mouse anti-ROP7 and mouse anti-GRA7 (all 
kindly provided by Dr. Peter Bradley) at 1:1000, rabbit anti-Cen1 [72] at 1:400, IMC1 
(kindly provided by Dr. Gary Ward) at 1:1000, and rabbit anti-GFP (Torrey Pines Biolabs 
Inc.) at 1:000 for mitochondrial plasmid (pF1β ATPase-GFP) and ER plasmid (pDer1-
RFP) in blocking buffer.  Alexa Fluor-conjugated secondary antibodies (Molecular 
Probes, Life Technologies) were used at 1:1000 dilutions in blocking buffer with the 
addition of DAPI (at 0.5 µg/mL) staining during the last 5 minutes of secondary antibody 
(Molecular Probes, Life Technologies) incubation.  The secondary antibody was 
removed and coverslips were washed 3X with 1X PBS pH 7.4 then mounted in 
Aquamount (Thermo Scientific).  Image acquisition was performed on a Zeiss Axiovert 
microscope equipped with 100x objective and images collected with a digital camera 
(SPOT, Dynamic Instruments Inc.) and processed in Adobe Photoshop CS v4.0 using 
linear adjustment for all channels in an intragroup fashion. 
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Figure 2.1: Identifying conserved Apicomplexa cell division cycling (CDC) genes 
of T. gondii and P. falciparum. [A.] The Venn diagram indicates the intersections 
between orthologous protein pairs and sets of cell cycle regulated mRNAs in T. gondii 
and P. falciparum asexual stages.  A total of 744 mRNAs encoding T. gondii and P. 
falciparum orthologs have cyclical profiles in replicating merozoites and tachyzoites.  
Other gene sets obtained from this analysis (see Appendix Table A.1) includes ortholog 
mRNAs exclusively cell cycle regulated in each species (354 for T. gondii and 1,153 for 
P. falciparum) and cyclical mRNAs that do not encode ortholog proteins (1,752 for T. 
gondii and 1,344 for P. falciparum).  The 530 orthologs that are not cell cycle regulated 
were excluded from this study.  [B.] Among the set of 744 orthologs that are dual cell 
cycle regulated (drCDC genes) are mRNAs encoding well-known eukaryotic proteins.  
For example, factors involved in transcription and translation machineries (e.g. RNA 
polymerase, ribosomal proteins, etc.) typically peak in G1, while mRNAs encoding 
cytoskeletal genes (e.g. actin, myosin, and tubulin) peak in the S phase and mitosis. 
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Figure 2.2: The timing of core drCDC genes defines clusters of co-regulated 
mRNAs. [A.] Cell cycle transcriptome data from T. gondii [58] and P. falciparum [53] 
asexual stages were analyzed, allowing the alignment of the cell cycles by the peak 
timing of canonical drCDC mRNAs as exemplified by DHFR-TS (dashed line).  In T. 
gondii, tachyzoite replication involves single S and mitotic [S/M] phases followed by 
parasite budding (cytokinesis=C).  In the P. falciparum merozoite repeated rounds of 
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chromosome replication and nuclear division produce multiple merozoites from a single 
infection.  Despite these scale differences in replication, adopting this procedure 
generates a basic partition of the cell cycles: Bin 1 encompasses mRNAs that peak in 
G1, while Bin 2 covers mRNAs with maximum expression in S phase, mitosis and 
cytokinesis.  Further sorting of G1 was apparent by the self-clustering of the peak timing 
of mRNAs encoding transcription and translation (early G1) from those mRNAs 
encoding known DNA replication factors (late G1): early G1 of T. gondii=4.6-6.5 h, P. 
falciparum=1-14 h; late G1 for T. gondii=6.6-8.75 h, P. falciparum=15-34h; and S/M/C of 
T. gondii=0-4.5 h, P. falciparum=35-48 h.  [B.] Pairwise expression timing of all 744 
drCDC mRNAs using the alignment scheme of [A.].  The G1/S transition (dashed line) 
and matched G1 timing is plotted in the lower left quadrant, while matched S/M/C timing 
corresponds to the upper right quadrant.  The relatively few mRNAs indicated in the 
upper left and lower right quadrants represent drCDC gene pairs with mismatched 
mRNA timing.  Color intensity (green: peak in G1, red: peak in S/M/C) indicates the 
increase in the number of genes showing similar timing in each cell cycle.  In the G1 
phase, two clusters correspond to the peak timing of mRNAs.  The cluster of paired 
mRNAs in circle 1 correspond to many general transcription/translation genes, while in 
circle 2 co-expressed mRNAs are enriched for DNA synthetic factors. [C.] Individual 
mRNA profiles for co-expressed mRNAs that peak in early G1, late G1 and S/M/C 
phases are displayed.   
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Figure 2.3: Correlation between peak mRNA abundance and peak mRNA half-life. 
Half-life mRNAs measurements and cell cycle assignments were retrieved [70] and the 
cell cycle phases of peak mRNA abundance [53] and peak mRNA half-life [70] were 
compared for all 125 drCDC-UNK genes in P. falciparum.  The P. falciparum drCDC-
UNK mRNAs that peak in the same phase of the cell cycle as their maximum mRNA 
half-life were assigned a score of zero. An offset of one phase (e.g. abundance peaks in 
ring, half-life peaks in trophozoite) was scored as 1, while the reverse relationship was 
scored -1.  For 89% of the P. falciparum drCDC-UNK genes the peak level and half-life 
fell within one phase of each other. 
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Figure 2.4: The peak expression of drCDC mRNAs encoding novel proteins is 
distributed throughout the parasite cell division cycles. The peak time of 
expression for 125 drCDC-UNK mRNAs (x-axis) in synchronized T. gondii tachyzoites 
[A.] and P. falciparum merozoites [B.] are shown.  Note that these mRNAs encompass 
a large range of expression levels (relative expression percentile, y-axis) from low to 
highly abundant.  The exception was the uniformly abundant drCDC-UNK mRNAs of P. 
falciparum merozoites with maximum levels in the S/M/C periods.  
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Figure 2.5: Novel drCDC-UNK proteins have highly conserved structural features. 
 [A.] CH-CDF analysis of the drCDC-UNK proteins. Here, the coordinates of each point 
were calculated as a distance of the corresponding protein in the CH-plot from the 
boundary (Y-coordinate) and an average distance of the respective CDF curve from the 
CDF boundary (X-coordinate). The four quadrants correspond to the following 
predictions: Q1 (upper right), proteins predicted to be disordered by CH-plots (positive 
values), but ordered by CDFs (negative values); Q2, ordered proteins; Q3, proteins 
predicted to be disordered by CDFs, but compact by CH-plots (i.e., putative molten 
globules or mixed proteins); Q4, proteins predicted to be disordered by both methods 
(i.e., proteins with extended disorder).  This plot shows that roughly half of the 125 
drCDC-UNK proteins are expected to be disordered as a whole with the degree of 
disorder slightly higher in T. gondii.  The ellipses encompass 80% of the data points for 
each species: P. falciparum=closed squares, T. gondii=open circles.  [B. and C.] The 
125 drCDC-UNK pairwise disorder/order alignments sorted into three general 
categories.  An example of an ortholog pair displaying loop/tail additions, compared to 
topologies that closely match versus a pair that minimally matched. Order/disorder plots 
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(VSL2B scores, >0.5=disordered) for T. gondii (blue) versus P. falciparum (red) proteins 
were aligned by best-fit methods.   Pairwise graphs for all 125 drCDC-UNK proteins are 
included in the Appendix Fig. A.1-7. 
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Figure 2.6: T. gondii drCDC-UNK proteins are enriched for invasion and mitotic 
proteins. Selected drCDC-UNK T. gondii genes representing a range of expression, 
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protein size, and cell cycle timing were epitope tagged (HA=green) by genetic knock-in 
(see Material and Methods).  Immunofluorescence analysis was performed on cloned 
transgenic strains to determine cellular localization of each drCDC-UNK protein. 
Representative images displayed here identified a variety of localizations. In all the 
image panels the drCDC-UNK protein tagged is shown in green.  [A.] Proteins localized 
to invasion organelles were detected with co-markers (red) for: microneme (MIC2), 
rhoptry neck (RON11), rhoptry bulb (ROP7), dense granules (GRA7), and nuclear DNA 
stain=DAPI (blue).  Direct interference contrast (DIC) images were included for the 
rhoptry and dense granule proteins.  [B.] Proteins localized to mitotic structures were 
stained with co-markers (red) for staining the centrosome (centrin1=Cen1), inner 
membrane complex (IMC1) and DAPI (blue) for the nucleus [C.] Proteins in other sub 
compartments were stained with co-markers: DAPI (blue) for the nucleus, co-markers 
(red) for mitochondria (F1β ATPase), ER (Der1), and membrane (IMC1).  The drCDC-
UNK gene IDs correspond to ToxoDB (http://www.toxodb.org/toxo/) assignment for the 
Type II ME49 strain and are indicated to the left of each image series omitting the 
common "TGME49_" pre-label.  Scale bar = 6 µm for each panel. 
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Figure 2.7: Western analysis of epitope tagged T. gondii drCDC-UNK proteins. 
Western blot analysis of protein extracts from T. gondii drCDC-UNK tagged strains in 
Fig. 2.6 were detected by anti-HA antibody to verify endogenous tagging.  Gene IDs 
correspond to ToxoDB (http://www.toxodb.org/toxo/) assignment for the Type II ME49 
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strain and are indicated above each western blot image omitting the common 
"TGME49_" pre-label.  The protein marker to the left of each western blot is shown in 
kDa.  Predicted protein sizes from ToxoDB are shown below each gene ID in 
parenthesis and include the additional 4.4 kDa for the triple HA tag.  Asterisks indicate 
the full-length protein detected by western blot and arrows indicate possible cleaved or 
degradation products.  The analysis showed that 12 out of 16 HA-tagged proteins 
migrated on Western blots with a mass close to the annotated protein size.  Three 
predicted membrane proteins (TGME49_005320, TGME49_052430 and 
TGME49_030160) showed anomalous protein sizes, while the protein encoded by 
TGME49_041000, could not be detected by western analysis.  PCR analysis to verify 
the correct gene knock-in of the 3xHA tag into the appropriate gene locus for these four 
exceptions are shown in Fig. 2.8. 
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Figure 2.8: PCR analysis of 3xHA knock-in into the genetic locus of 
TGME49_041000, TGME49_005320, TGME49_052430 and TGME49_030160. PCR 
analysis was used to verify tagging of the gene at the correct locus using primers from 
Appendix Table A.3 for the four drCDC-UNK proteins that failed western blot analysis 
(Fig. 2.7). For each of the four PCRs lane 1 shows the genomic DNA (gDNA) from the 
corresponding endogenously tagged strain amplified with a forward verification primer 
and a common reverse primer specific for the 3xHA cassette insertion.  Lane 2 shows 
the PCR results from parent strain (RH) gDNA with the forward verification primer and 
the common 3xHA reverse primer (negative control).  Lane 3 shows the PCR result 
confirming that parent strain gDNA contains the native gene locus; the forward 
verification primer was combined with a reverse primer binding to native gene sequence 
that is downstream of the gene knock-in site (present only in the parent gDNA).  
M=marker and the size of each PCR product is shown above the corresponding lane in 
base pairs (bp).  The analysis demonstrates that all four genes were tagged at the 
correct locus as evidence by the correct size PCR product for each tagged strain that is 
larger than the native DNA fragment produced from the native locus present in the 
parent gDNA. 
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Figure 2.9: Co-expression graphs for selected drCDC-UNK mRNAs. The mRNA 
expression [58] for ten T. gondii drCDC-UNK genes (blue line) endogenously tagged in 
Fig. 5 was compared to previously characterized T. gondii genes (green and red lines) 
that show a conserved timing of mRNA expression among genes that code for proteins 
with similar functions.  See Behnke et al. 2010 and ToxoDB for cell cycle data for all 
genes listed and gene IDs for the characterized genes (green and red lines) used to 
show conserved timing of mRNA peak expression.  Plots of mRNA expression profiles 
show mRNA expression levels (RMA value, y-axis) throughout the 8.75 h synchronized 
lifecycle of T. gondii tachyzoites (in hours, x-axis). Due to the method of synchrony that 
arrests T. gondii RHTK+ tachyzoites in late G1/early-S transition (thymidine block and 
release) [58,66], we partitioned the cell cycle into early G1=4.6-6.5 h, late G1=6.6-8.75 
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h, and S/M/C=0-4.5 h.  release) [58,66], we partitioned the cell cycle into early G1=4.6-
6.5 h, late G1=6.6-8.75 h, and S/M/C=0-4.5 h. 
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Figure 2.10: T. gondii and P. falciparum network analysis of drCDC-UNK proteins. 
From the 125 orthologous drCDC-UNK P. falciparum genes, 9 proteins (yellow squares) 
were identified in the yeast two-hybrid analysis to be involved in 3 sub networks. 
Specifically, we found 6 orthologs interacted with cytoskeletal components and cell 
cycle kinases (bottom left), while 2 ortholog pairs were linked to transcription factors 
(top left) or protein synthesis factors (top right).  Where the corresponding T. gondii 
ortholog was analyzed by IFA (Fig. 2.6) the T. gondii gene ID is indicated by bold font. 
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CHAPTER THREE: 
Characterization of a Novel Membrane Protein in Toxoplasma gondii and 
Plasmodium falciparum 
 
Introduction 
The cytoskeleton is unique in apicomplexans and includes an outer plasma 
membrane, inner membrane complex (IMC), microtubules, actin filaments and 
subpellicular network (SPN). Microtubules are extremely stable in apicomplexans unlike 
in other higher eukaryotes [89]. In the T. gondii tachyzoite stage there are 22 
subpellicular microtubules that spiral down the top 2/3 of the parasite and originate from 
the apical polar ring that serves as a microtubule-organizing center.  The microtubules 
provide support and act as a scaffold on which developing daughter cells are formed. It 
is hypothesized that microtubule-associated proteins (MAPs) connect the microtubules 
to the pellicle and contribute to the added stability [89].  Apicomplexans also contain 
atypical actin mainly present in the globular form as G-actin which makes up greater 
than 98% of the actin within the cell [114,115,116,117] and short transient filaments 
known as F-actin that have a role in parasite motility.  Actin is believed to play a role in 
invasion but not in early cell division [89,118].   
The IMC is made up of the alveolin proteins and the associated proteins that help 
form a meshwork.  Alveolin domains within IMC proteins contain EKIVEVP, EVVR, or 
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VPV repeats flanked by variable N and C-terminal regions [119].   The T. gondii IMC is 
a 14-member family (IMC2 does not contain an alveolin repeat) of intermediate filament-
like proteins that display different timings of expression and cellular localizations.  In P. 
falciparum, eight IMC members IMCa-h are currently identified [120,121]. The IMC is 
involved in providing support for the cell, forms the scaffold for daughter parasite 
assembly during cell division, and provides an anchor for the motility apparatus 
(glideosome).  Portions of the IMC membranes in T. gondii are insoluble in detergent 
extraction due to a high concentration of cholesterol [122].  
The components of the IMC are believed to have evolved early in the 
apicomplexan branch suggesting the core components of the IMC are conserved across 
the phylum [121].  However, Theileria lacks orthologs to several alveolins and T. gondii 
contains an expanded group of IMC proteins suggesting lineage specific requirements 
for their division/invasion methods [121].  The IMC is made up of 3 rows of fused plates 
surrounding the parasite and contains openings at the apical and basal ends in T. gondii 
[36,123,124].  In P. falciparum, the IMC is a single fused vesicle in all stages except 
gametocytes where they are composed of 9-15 plates [36,121].  The IMC has openings 
at the apical and posterior ends of the cell.   
Biogenesis of the IMC comes from the Golgi and involves clathrin-coated 
vesicles.  Evolutionarily the alveolin that make up the super phylum containing 
Apicomplexa all contain the Golgi derived flatted vesicles, however they have different 
functions in different members of the super phylum.  Alveolin are specialized for storage 
and regulatory activities in Ciliates [125] and act as armored plates in Dinoflagellates 
[89].  T. gondii contains a single Golgi containing stacked cisternae. In P. falciparum, 
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the Golgi is more highly reduced and contains only one cisternae [19].  The IMC sub 
compartment proteins (ISP) contain four family members that are not part of the IMC 
cytoskeleton meshwork as evident by their extraction with mild detergents.  Instead the 
ISPs are anchored in the alveoli membranes through myristoylation in the cytoplasm 
and palmitoylation (except for ISP4) at the developing IMC [78,126].  The reason for 
these sub compartments is currently unknown but because a knockout of ISP2 displays 
defects in budding leading to multiple daughters forming this indicates a role in cellular 
division.  
In addition to the ISPs additional proteins are also localized to specific areas of 
the parasite including the apical and basal regions.  The apical end of the parasites 
includes such proteins as ISP1, Centrin2, MORN1, IMC15, PhIL1, CAM1, CAM2, 
SAS6L, RNG1, RNG2 and the proteins we recently discovered including 
TGME49_035130 and TGME49_030160 (Chapter 2).  MORN1, Centrin2, and IMCs 5, 
8, 9, 13, and 15, and TGME49_005320 (Chapter 2) are present at the basal end of the 
parasite suggesting they play a role in building the basal end of the parasite and 
constricting the parasites during cytokinesis.  MORN1 localizes to the ends of the 
developing IMC, defines the basal complex, and is believed to be involved in cytokinesis 
[32].   
The SPN is located on the cytoplasmic face of the IMC and is composed of 8-10 
nm intermediate filament-like proteins [127].  It is believed the SPN aids in giving the 
IMC strength and support. The SPN has also been suggested to be involved in acting 
as linkers to maintain the relative position of organelles during gliding motility as long 
linkers appearing to be derived from the SPN have been observed to link with 
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organelles in Plasmodium sporozoites [128].  A physical link is needed to link the SPN 
to the IMC. It is predicted that this link is performed by 9 nm intramembranous particles 
(IMP). IMPs are seen in a double row overlaying microtubules [129] and a single row 
along the alveoli. No IMPs have conclusively been identified [36] although T. gondii IMC 
localizing protein 1 (TgILP1) and its ortholog in P. berghei glycine at position 2 (PbG2) 
is a potential candidate. TgILP1 is widely conserved across Apicomplexa, does not 
contain an alveoli domain, contains a coil-coil domain, contains multiple predicted 
palmitoylation sites, and does not appear to be part of a gene family [94]. PbG2 also 
localizes to the SPN without containing an alveoli domain and knocking out the gene 
leads to morphology defects of sporozoites and ookinetes [130] similar to IMC protein 
knockouts [120,131,132] and an abnormal arrangement of the subpellicular 
microtubules [130]. This protein also preferentially localized to daughter parasites in 
dividing parasites [94]. 
Glideosome components include an actomyosin motor complex, composed of 
type XIV myosin heavy chain (MyoA), myosin light chain (MLC1) in T. gondii or its P. 
falciparum ortholog myosin A tail domain-interacting protein (MTIP), essential light chain 
(ELC1) and the glideosome associated proteins GAP40, GAP45 and GAP50 [133] are 
anchored into the IMC.  During cell division, MyoA, MLC1/MTIP and GAP45 form a 
soluble complex in the cytoplasm. GAP45 phosphorylation is proposed to prevent the 
association of MyoA-MLC1-GAP45 complex with GAP50 until it reaches the IMC and in 
T. gondii, but not Plasmodium, GAP45 must then be dephosphorylated before the 
assembly of the motor complex can occur at the IMC.  GAP50 is a transmembrane 
protein inserted directly into the alveolin membrane that anchors the glideosome once 
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the soluble MyoA-MLC1-GAP45 complex associates with it.  GAP50 requires 
glycosylation at the amino-terminus in order to be targeted correctly and to interact with 
the other motor complex proteins.  The role of the 7-transmembrane protein GAP40 
remains unclear however, what is known is that it interacts with the components of the 
motor complex and is also present in early daughter cells at the same time as GAP50. 
GAP45 and MTIP phosphorylation is mediated by CDPK1 in Plasmodium falciparum 
however; a different CDPK enzyme in toxoplasma may phosphorylate GAP45 [41]. 
Although many membrane proteins have been characterized and considerable 
work has been accomplished there is still much yet to be discovered. Little is known 
about the lipid content of the alveolin membranes [36] and the mechanisms of 
membrane biogenesis and trafficking are still incompletely understood. No members of 
the IMPs have been identified yet and the purpose of the IMC sub compartments is also 
unclear. While CDPK1 has been shown to phosphorylate GAP45 in P. falciparum the 
kinase responsible for phosphorylating GAP45 in T. gondii is currently unknown. Recent 
data suggesting that motility is not coupled to invasion and RON5’s role in invasion 
[134] despite its localization to the host’s cytosolic face highlight the importance of 
continued research to elucidate the mechanisms involved in both motility and invasion.  
Understanding all the proteins involved in the composition, biogenesis and maintenance 
of the cytoskeleton and defining their functions will be important to better understanding 
the structure, cell division, and invasion mechanisms of these parasites. 
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Results/Discussion 
Identification of a novel membrane protein 
A novel membrane protein encoded by the gene TGME49_064990 was 
discovered by a decision tree analysis to prioritize unknown cell cycle Apicomplexa 
orthologs and experimentally validated by endogenous HA epitope tagging in T. gondii 
as was shown in Chapter 2.  TGME49_064990 encodes for a 29-kDa protein that 
localized to the IMC of T. gondii tachyzoites (Fig. 3.1 A and B).  Localization to the IMC 
was evident by costaining with IMC1 and absence from the apical tip and basal complex 
(Fig. 3.1 A and B) where IMCs are known to have openings unlike the plasma 
membrane that encloses the entire parasite.  Due to its localization, we named this 
protein IMC16.  Despite the IMC localization, IMC16 does not contain an alveolin 
domain (similar to IMC2).  Interestingly, IMC16 protein preferentially targeted to the 
daughter IMC during parasite budding of replicating cells and at that point was no longer 
visibly localized to the mother IMC of dividing parasites (Fig. 3.1 B and 3.2).  While this 
preferential localization pattern is similar to IMC3, 6, and 10 [93] uniquely IMC16 
appeared to be completely devoid from mother IMC in dividing parasites (Fig. 3.2).  The 
mRNA encoding IMC16 had a tight cell cycle profile with peak expression in the S/M 
phase of the cell cycle almost identical to the mRNAs encoding known IMC proteins 
IMC1 and IMC3 (Fig. 3.1 C).  IMC16 mRNA was also similar to other known proteins 
that preferentially target the daughter cells (Fig. 3.1 D) such as IMC10, ILP1, IMC3 and 
GAP50 however; the cell cycle pattern more closely resembled the IMC proteins.  
IMC16 localized to the newly developing IMC at the beginning of budding as is evident 
by the staining with ISP1 (Fig. 3.3), which is an early marker for daughter formation.  
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Since this localization appeared at the start of daughter formation (before IMC1 and 
similar to ISP1) it will be interesting to determine if IMC16 is the first protein known to 
localize to the IMC, which could hint at a possible function of recruiting other membrane 
proteins to the developing daughters.  Currently, IMC15 is thought to be the first IMC to 
localize to the developing daughters although it also displays basal localization, which is 
believed to play a role in cytokinesis.  Colocalization experiments with a transiently 
expressed IMC15-YFP plasmid made it difficult to determine the exact sequence of 
events and a lower expression level of IMC15 may make determining the exact 
sequence of events challenging however, additional experiments should be attempted 
to try to elucidate the precise timing.   
IMC proteins have multiple important roles in these parasites including providing 
structure, acting as a building block for developing daughters, and anchoring the motility 
complex.  Although many IMC and membrane proteins have been characterized, many 
proteins still remain unknown and the mechanisms for cell replication, building the 
glideosome and membrane biogenesis are still incompletely understood. All 
components of the parasite’s cytoskeleton need to be identified to develop a holistic 
picture of the ultrastructure and mechanisms involved.  The identification of IMC16 
points to the importance of identifying additional unknown proteins that could represent 
important biology.   
IMC16 is evolutionarily conserved in Plasmodium (with relaxed orthology 
assignment as described in Chapter 2), Eimeria and Neospora and is not a part of an 
identified gene family in any of these species.  The gene encoding this novel membrane 
protein is located on chromosome IX in T. gondii and its P. falciparum ortholog is 
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located on chromosome XIV. The T. gondii and P. falciparum genes each contain four 
exons.  The predicted protein sequence contains 259 aa in T. gondii and the protein is 
predicted to have a molecular weight of 29 kDa. The predicted protein sequence 
contains 359 aa in P. falciparum and the protein is predicted to have a molecular weight 
of 42 kDa.  Western blot analysis of the HA epitope tagged protein confirmed the 
predicted molecular weight of approximately 29 kDa in T. gondii parasites (Fig. 3.4) and 
confirmed the epitope tagging of the protein.  Protein sequence alignments (Fig. 3.5 A) 
of the T. gondii and P. falciparum proteins show approximately 45% identity to each 
other and order/disorder plots (VSL2B scores, >0.5=disordered) of TgIMC16 versus 
PfIMC16 displayed an overall conserved protein topology with additions including a T. 
gondii specific N-terminal tail and P. falciparum C-terminal tails (Fig. 3.5 B). 
To elucidate whether the localization and cell cycle timing was conserved in other 
Apicomplexa as predicted by orthology assignments, we raised antiserum against the P. 
falciparum ortholog (PF14_0333, designated PfIMC16).  PF14_0333 rabbit polyclonal 
antibody was used to determine localization in P. falciparum NF54 parasites.  The 
protein was shown to localize to the membrane in P. falciparum (Fig. 3.6 A) similarly to 
T. gondii IMC16 (TgIMC16), although the exact membrane compartment is yet to be 
determined.  PfIMC16 displayed peak protein expression in schizonts and the mRNA 
expression verified this timing (Fig. 3.6 B) and coincided with the S/M expression seen 
in TgIMC16 (Fig. 3.1) when the T. gondii and P. falciparum cell cycles were aligned as 
described in Chapter 2.  Additional microscopy experiments are needed to determine 
the exact localization of PfIMC16.  
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IMC16 solubility 
TgIMC16 and PfIMC16 are not predicted to be myristoylated or palmitoylated 
however, the predicted protein sequence for both proteins contains a glycine at position 
2.  Myristoylation on a glycine at position two modifications are evident in ISP proteins 
(except ISP4, which is only palmitoylated) [78] and PbG2 [130] predicted to be an IMP 
protein.  No IMPs have conclusively been identified [36] although T. gondii ILP1 and its 
ortholog in P. berghei (PbG2) are potential candidates.  Similar to ILP1, PfIMC16 
contains a coil-coil domain [94].  Since no IMP proteins have conclusively been 
identified it is difficult to determine if IMC16 is in fact an IMP protein or is a member of 
the SPN.  Additional post translational modifications are predicted including the 
predicted phosphorylation of both TgIMC16 and PfIMC16.  The TgIMC16 predicted 
phosphorylation sites include (threonine 131 and serines at position 133, 154, 156, and 
201) however, the strongest evidence is for phosphorylation at positions 156 and 201.  
Additional work is needed to confirm and determine the functionality of these predicted 
post translational modifications.   
To determine how IMC16 localized to the membrane without an alveolin domain, 
transmembrane domain or signal peptide we decided to determine its solubility by 
detergent extraction to further characterize this protein.  Detergent extract analysis and 
western blot indicated that TgIMC16 was partially soluble in 0.5% NP-40 detergent used 
to detect membrane-bound proteins (Fig 3.7).  This further supports the analysis that 
this protein is not an alveolin containing IMC such as IMC1, which was insoluble in NP-
40 but associates or partially inserts itself into the IMC membrane.  ISP proteins are 
known to attach to the IMC by myristoylation and/or palmitoylation [78,126] however, 
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they were completely soluble in NP-40 [78,126] suggesting that IMC16 would need 
additional protein structural aspects, modifications or binding partners to localize to the 
IMC since it was only partially soluble in NP-40.  The partially soluble nature of the 
protein is an interesting observation and solubility could be due to the protein being 
soluble in developing daughters and insoluble in the mother IMC, involve protein 
structure or protein interactions and/or involve post translational modifications.   
 
Clues to function 
To gain clues to the function of IMC16 we decided to analyze potential protein-
protein interactions.  We used immunoprecipitation and liquid chromatography coupled 
to mass spectrometry to identify potential protein interactions for TgIMC16 and found 
nine potential interactions (Table 3.1) absent from negative controls and with the same 
peak of protein expression indicating they would be assembled within the cell at the 
same time since protein assembly appears to be “just in time” [53,58]. These nine 
proteins included IMC2a, cyclin dependent kinase 1 (CDPK1), two microneme proteins, 
two rhoptry pseudokinases and three hypothetical proteins.  The top protein interaction 
candidate was IMC2a based on its localization to the IMC despite not having an alveolin 
domain like IMC16.  Interestingly, TgIMC16 is predicted to be phosphorylated and was 
predicted to interact with both a kinase (CDPK1) and phosphatase (IMC2a).  
Additionally, If the predicted interactions with the three hypothetical proteins prove to be 
verified it will be interesting to determine their localization and could lead to the possible 
identification of additional membrane proteins.  Additional work will be needed to 
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determine protein interactions for the soluble fraction of TgIMC16 that was omitted in 
the original experiment and to validate these potential protein interactions listed here.  
Knockout attempts to determine essentiality and potential function have begun. A 
traditional three-fragment knockout approach using the gateway system where the gene 
of interest was replaced by double-homologous recombination with the DHFR 
selectable marker was attempted.  PCR analysis of gDNA from the knockout and parent 
strain (negative control) indicated that the gene was replaced with the selectable marker 
in the polyclonal population (data not shown). Additional work is currently underway to 
determine if individual clones contain the knockout.  Any knockout clones confirmed by 
PCR will additionally be confirmed by Southern blot.  This protein may have a potential 
role as a marker for daughter parasites to differentiate the building of the newly forming 
daughter parasites from the deconstruction and recycling of the mother parasite.  This 
protein may also serve as an early membrane protein that acts as a scaffold and 
recruits additional membrane proteins to the newly developing daughter membrane.  
We predict this protein will be required for daughter formation however; it is possible 
that redundancy of membrane proteins may render this protein non-essential or 
essential in another life cycle stage.  In the case of possible redundancies, multi-gene 
knockouts might be required to better define IMC16’s function.  
Additional work is needed to elucidate the function of this protein in developing 
daughter formation and in mother parasites and to confirm the interacting partners 
predicted by the protein interaction work and find additional protein interactions for the 
soluble portion of this protein.  IMC16 could be a potential novel therapeutic target 
based on its potential role in cell division, membrane localization and conservation only 
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within the Apicomplexa phylum however, additional work is needed to evaluate these 
possibilities.    
 
Materials and Methods 
Sequence retrieval and analysis 
Sequences were collected from ToxoDB (www.toxoDB.org) [135] and PlasmoDB 
(www.plasmoDB.org) [136]. Orthologs were detected using orthoMCL [137] and for P. 
falciparum we utilized all-versus-all BLASTP searches using the InParanoid script [107].  
In particular, we accounted for all sequence alignments irrespective of any constraints 
of alignment length and score. Sequence pairs with mutually best scores were selected 
as central orthologous pairs. Homologous proteins of both species were clustered 
around these central pairs to form orthologous groups.  The quality of such clusters was 
further assessed by a standard bootstrap procedure. Multiple sequence alignments 
were performed and color-coded using ClustalW2 [138,139]. Palmitoylation sites were 
predicted using CSS-Palm 3.0 with a high threshold [112] and myristoylation sites were 
predicted by NMT Myristoylation Predictor 
(http://mendel.imp.ac.at/myristate/SUPLpredictor.htm). Coiled-coils were predicted with 
the program COILS [140]. For genes of interest, the mRNA expression profiles 
throughout tachyzoite development in T. gondii [58] and in P. falciparum [53] were 
analyzed and graphed using Excel or pulled from www.plasmodb.org.  
 
 
 
	   80	  
Cell culture and parasite strains 
Parasites were maintained as previously described [106] in primary human 
foreskin fibroblasts (HFF) kindly provided by Dr. David Roos.  The parasite strains 
RH∆ku80 and RH∆hxgprt∆ku80 were used for endogenous tagging of genes as 
previously described [79].  Stable transgenic parasite lines were selected in media 
containing 1 µM pyrimethamine. For IMC16 knockout constructs the 5’ and 3’ UTR of 
the IMC16 locus were PCR amplified from type I gDNA and used to create three 
fragment Gateway (Invitrogen) entry clones.  The 5’ UTR was cloned into the 
pDONRP4-P1r plasmid and the 3’UTR was cloned into the pDONRB2r-B3 plasmid by 
the BP recombination reaction.  After isolation of the entry clones, pDONRP4-P1R-
IMC16 and pDONRP2r-P3-IMC16 were combined in a LR recombination reaction with 
p221-DHFR to create the pDEST-IMC16-DHFR knockout plasmid.  The final plasmid 
was introduced into the RH∆hxgprt∆ku80 strain and transgenic parasites were selected 
using 1 µM pyrimethamine. 
 
Endogenous epitope tagging 
For endogenous tagging in the genetic locus, the vector pLIC-HA3-DHFR was 
generously provided by Vern Carruthers [79].  Briefly, genomic fragments were 
amplified by PCR for each gene (for primers used see Appendix) using a design that 
fuses the C-terminal end of each coding region with a triple hemagglutinin tag (HA3) in 
the LIC-HA3-DHFR plasmid. A unique restriction site upstream of the predicted stop 
codon was identified to perform the linearization. pLIC-HA3-DHFR was linearized with 
PacI and subjected to T4 DNA polymerase (Novagen, LIC-qualified) for ligation 
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independent cloning (LIC).  Sequenced constructs were electroporated into either 
RH∆ku80 or RH∆hxgprt∆ku80 parent strains using standard methods.  Transgenic 
strains were selected in media containing pyrimethamine (1 µM final).  Polyclonal 
isolates were screened to verify homologous recombination using a unique 5'-primer 
upstream of each genomic fragment used to tag the locus in combination with a 
common HA primer (see Appendix Table 1) to confirm loss of the wild type locus.   
 
Western blot analysis 
To confirm endogenous tagging, western blotting was performed as previously 
described [112,113] using rat anti-HA antibodies (Roche) at a dilution of 1:500 and goat 
anti-rat IgG conjugated to HRP (Jackson ImmunoResearch Laboratories, Inc., West 
Grove, PA) at 1:1000.  Genomic DNA was harvested from purified parasites and 
analyzed by PCR to verify the correct gene locus was tagged. PCR products were 
amplified with the primers in Appendix 3 using Taq DNA polymerase (New England 
Biolabs) and were analyzed after gel electrophoresis on a 0.8% agarose gel stained 
with SYBR safe DNA gel stain (Invitrogen). 
 
Immunofluorescence assays and microscopy 
Immunofluorescence assays were performed as previously described [58].  
Briefly, infected HFF monolayers were fixed in 3.7% paraformaldehyde and 
permeabilized on 0.25% Triton TX-100.  After blocking in 1% PBS-BSA for at least 30 
min, primary antibodies were added for one hour at room temperature.  Primary 
antibodies were prepared at the indicated dilutions: rat anti-HA (Roche) at 1:500, rabbit 
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anti-HA (Abcam) at 1:1000, mouse anti-ISP1 (kindly provided by Dr. Peter Bradley) at 
1:2000, IMC1 (kindly provided by Dr. Gary Ward) at 1:1000 in blocking buffer.  Alexa 
Fluor-conjugated secondary antibodies (Molecular Probes, Life Technologies) were 
used at 1:1000 dilutions in blocking buffer with the addition of DAPI (at 0.5 µg/mL) 
staining during the last 5 minutes of secondary antibody (Molecular Probes, Life 
Technologies) incubation.  The secondary antibody was removed and coverslips were 
washed 3X with 1X PBS pH 7.4 then mounted in Aquamount (Thermo Scientific).  
Image acquisition was performed on a Zeiss Axiovert microscope equipped with 100x 
objective and images collected with a digital camera (SPOT, Dynamic Instruments Inc.) 
and processed in Adobe Photoshop CS v4.0 using linear adjustment for all channels in 
an intragroup fashion. 
 
Protein intrinsic disorder predictions 
PONDR VSL2B plots were analyzed to evaluate the disorder content in the 
protein sequences on the per-residue level as previously described [77]. PONDR 
VSL2B-based order/disorder (>0.5=disorder) scores per amino acid residue were used 
to create corresponding profiles and a best-fit method to align the T. gondii and P. 
falciparum proteins was applied to each ortholog pair. 
 
Antibody production  
PF14_0333 coding sequence encoding the first 112 aa of the protein was 
assembled from synthetic oligonucleotides (GeneArt) and cloned into pMAT-T using Sfil 
cloning sites and then into His pET-21a (Novagen) that introduced a C-terminal His tag 
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to the protein. Recombinant PF14_0333-His was expressed in BL21 E. coli (Invitrogen), 
purified on Gluthatione-agarose beads (Sigma-Aldrich), and used to immunize rabbits.  
 
Detergent extraction analysis 
For detergent extraction experiments, 3x107 freshly lysed parasites were washed 
in 1xPBS, pelleted and lysed in 1 mL TBS (50 mM Tris-HCl [pH 7.4], 150 mM NaCl) 
containing 0.5% NP-40 and complete protease inhibitors (Roche) for 15 min at 4 degree 
C and then centrifuged for 15 min at 14,000 x g. Equivalent amounts of total, 
supernatant and pellet fractions were separated on a 15% gel, transferred to 
nitrocellulose and blotted using anti-IMC1 and anti-HA (Roche). 
 
Cell lysis and immunoprecipitation 
For proteomics studies, parasites were grown at 37° C for 48 hours. Infected 
monolayers of HFF cells were washed once with PBS and collected by centrifugation at 
4° C for 10 min at 700xg. Cells resuspended in cold PBS were passed sequentially 
through 20/23/25-guage needles to release parasites from host cells and 
parasitophosphorous vacuoles. Parasites were pelleted (4° C for 15 min at 700xg) and 
counted. Whole cell lysates were obtained by lysing 2x109 parasites for 60 min at 4° C 
in the lysis buffer (0.1% [v/v] Nonidet P-40, 10 mM HEPES pH 7.4, 150 mM KCl, with 
protease inhibitors), followed by five cycles of snap freezing in the liquid nitrogen bath 
and slow thawing in ice-water bath. Lysates were clarified by centrifugation at 12,000xg 
for 30 minutes at 4° C.  Protein extracts were rotated overnight at 4° C. 
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Liquid chromatography coupled to mass spectrometry 
Proteins from a coomassie-stained gel slice were reduced and alkylated with 
TCEP and iodoacetamide prior to trypsin digest (10 ng/µl in 25 mM ammonium 
bicarbonate, 0.1% Protease-Max (Promega)) for 1 hour at 50° C. Nanospray LC-MS/MS 
was performed on a LTQ linear ion trap mass spectrometer (LTQ, Thermo, San Jose, 
CA) interfaced with a Rapid Separation LC 3000 system (Dionex Corporation, 
Sunnyvale, CA). Samples were run sequentially on Acclaim PepMap C18 Nanotrap 
column (5 µm, 100 Å,/100 µm i.d.×2 cm) followed by Acclaim PepMap RSLC C18 
column (2 µm, 100  Å, 75 µm i.d. ×25 cm) (Dionex Corp). Peptides eluted with gradient 
mobile phase A (2% Acetonitrile/water +0.1% formic acid) and mobile phase B (80% 
acetonitrile/water +0.1% formic acid) were assessed for MS/MS analysis. Raw LC-
MS/MS data was collected using Proteome Discoverer 1.2 (Thermo Scientific). Created 
mgf files were used to search the Toxo_Human Combined database using in-house 
Mascot Protein Search engine (Matrix Science). Final list was generated by Scaffold 
3.5.1 (Proteome Software) with following filters: 99% minimum protein probability, 
minimum number peptides of 2 and 95% peptide probability. 
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Figure 3.1: TGME49_064990 localization and cell cycle timing.  A. 
Immunofluorescence analysis (IFA) was performed on endogenously epitope tagged 
(HA=green) parasites by genetic knock-in (see Material and Methods). Costaining with 
the inner membrane complex (IMC=red) and Dapi=nuclear stain (blue) determine an 
IMC localization.  B. IFA analysis throughout the cell cycle of endogenously epitope 
tagged (HA=green) parasites shows cellular localization with peak protein expression in 
S phase and in budding and shows preferential staining for developing daughter IMC 
(IMC1=red) in both early and late budding. C. mRNA co-expression graph for 
TGME49_064990 (blue) and other known IMC mRNAs. See Behnke et al. 2010 and 
ToxoDB for cell cycle data for all genes listed and gene IDs for the characterized genes 
(green and red lines) used to show conserved timing of mRNA peak expression with 
known IMC genes.  D. mRNA co-expression graph for TGME49_064990 (blue) and 
other known membrane proteins that preferentially target the developing daughter IMC. 
Plots of mRNA expression profiles show mRNA expression levels (RMA value, y-axis) 
throughout the 8.75 h synchronized lifecycle of T. gondii tachyzoites (in hours, x-axis). 
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Due to the method of synchrony that arrests T. gondii RHTK+ tachyzoites in late 
G1/early-S transition (thymidine block and release) [58,66], we partitioned the cell cycle 
into early G1=4.6-6.5 h, late G1=6.6-8.75 h, and S/M/C=0-4.5 h. 
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Figure 3.2: TGME49_064990 preferentially targets daughter membranes in 
dividing parasites and mother membranes in non-dividing parasites.  IFA of T. 
gondii parasites shows HA tagged TGME49_064990 (green) localizes to the daughter 
IMC (red) of dividing parasites and mother parasites in non-dividing parasites as is 
illustrated in the IFA above and the schematic of the IMC during budding shown below. 
Interestingly TGME49_064990 is devoid from the mother IMC in dividing parasites 
unlike IMC1 as shown in the above panel. 
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Figure 3.3: TGME49_064990 (IMC16) localizes to early daughters. IFA and 
microscopy of endogenously epitope tagged IMC16 parasites (green) shows localization 
to daughter membranes early in budding (top panel) as evident by the ISP1 (red) 
comarker, which is one of the earliest markers for daughter formation and localizes at 
the apical tip of the newly forming daughter parasites and above the nucleus shown by 
the nuclear stain Dapi (blue) where daughter membrane scaffolds are formed.  IMC16 
appears to grow in length as the daughters develop in mid budding (bottom panel). 
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Figure 3.4: Western blot analysis confirming endogenous tagging and the 
predicted protein size. Western blot analysis of protein extract from T. gondii IMC16 
(TGME49_064990) tagged strain was detected by anti-HA antibody to verify 
endogenous tagging.  The protein marker to the left of each western blot is shown in 
kDa.  The 259 aa protein in T. gondii is predicted to have a molecular weight of 29 kDa.  
The analysis showed that IMC16 HA-tagged proteins migrated with a mass close to the 
annotated protein size and is absent from the parent strain RH∆ku80.   
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Figure 3.5: Primary and secondary protein alignment shows conservation 
between orthologs.  [A.] Alignment of the T. gondii IMC16 (TgIMC16) and P. 
falciparum PF14_0333 (PfIMC16) proteins shows 45% identity (red=alignment). The 
259 aa protein in T. gondii is predicted to have a molecular weight of 29 kDa and 359 aa 
protein is predicted to have a molecular weight of 42 kDa in P. falciparum. [B.] 
Order/disorder plots (VSL2B scores, >0.5=disordered) of TgIMC16 (blue) versus 
PfIMC16 (red) proteins that display an overall conserved protein topology with additions 
including a T. gondii specific N-terminal tail and P. falciparum C-terminal tails.  
Order/disorder curves for drCDC-UNK protein pairs were aligned by best-fit methods, 
and independent of order/disorder. 
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Figure 3.6: Localization and timing of PF14_0333 (PfIMC16) by native antibody in 
NF54 parasites.  [A.] IFA of three representative images for each cell cycle stage in P. 
falciparum parasites using native antibody to PfIMC16 (green) shown with nuclear 
staining by Dapi marker (blue) display PfIMC16 protein localization throughout the cell 
cycle with peak expression seen in schizonts of P. falciparum parasites.  [B.] The 
mRNA expression value (y-axis) over the cell cycle (x-axis, h) shows the mRNA curve 
for PfIMC16 shows peak expression in schizonts and coincides with the S/M expression 
seen in TgIMC16 (Fig. 3.1) when the T. gondii and P. falciparum cell cycles are aligned 
as described in Chapter 2. Data obtained from www.plasmodb.org. 
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Figure 3.7: Detergent extraction indicates TgIMC16 is partially soluble.  Detergent 
extraction of T. gondii IMC16 (top panel) and IMC1 control (bottom panel) in different 
salt and detergent conditions (1xTBS, NACl, NP-40 and SDS) indicate that IMC16 is 
partially soluble (S=soluble fraction) in NP-40 and IMC1 is insoluble in NP-40 as evident 
by the localization to the pelleted fraction (P=pelleted fraction). This indicates that 
IMC16 is associated with membranes and is not a part of the alveolin membrane like 
IMC1.   
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Table 3.1: Table of the top hits for potential protein interactions of TgIMC16.  
Immunoprecipitation and liquid chromatography coupled to mass spectrometry (LC/MS-
MS) was used to detect possible protein-protein interactions for endogenously HA 
epitope tagged IMC16 protein (see Materials and methods for details). The final list of 
potential protein interactions was generated with the following filters: minimum number 
of peptides of at least 2, same cell cycle peak. 
 
Protein 
Name 
Gene ID 
(TGME49_*) 
Cell 
Cycle 
Peak 
Peak 
mRNA 
(%) 
Exclusive 
Unique 
Peptide 
Count 
Exclusive 
Unique 
Spectrum 
Count 
Total 
Spectrum 
Count 
Percentage 
of Total 
Spectra 
(%) 
IMC2a 228170 S/M/C 92 3 3 3 0.18 
MIC10 250710 S/M/C 100 2 3 3 0.17 
M2AP 214940 S/M/C 100 2 2 2 0.12 
Hypothetical 240060 S/M/C 97 2 2 2 0.11 
Hypothetical 263850 S/M/C 96 2 2 2 0.11 
CDPK1 301440 S/M 93 2 2 2 0.10 
Hypothetical 211030 S 97 2 2 2 0.09 
ROP26 211260 S/M 98 2 2 2 0.08 
ROP8 215775 S/M 89 2 2 2 0.08 
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CHAPTER FOUR: 
Summary and future directions 
 
Note to Reader  
Portions of this chapter, in part or in entirety, have been previously published in: 
Butler CL, Lucas O, Wuchty S, Xue B, Uversky VN, et al. (2014) Identifying Novel Cell 
Cycle Proteins in Apicomplexa Parasites through Co-Expression Decision Analysis. 
PLoS ONE 9(5): e97625. doi:10.1371/journal.pone.0097625 and are used with 
permission from indicated publishers. 
 
Summary 
Transcriptome data published by the DeRisi lab and our lab have shown that 
Plasmodium falciparum (P. falciparum) and Toxoplasma gondii (T. gondii) gene 
expression occurs in a “wave like” progression where peak expression of mRNA 
typically occurs once per cell cycle and proteins are made in a “just in time” assembly 
where they are made in the time and quantity that is needed [53,58] despite the fact that 
the nucleotide bias is substantially different and synteny from the apicomplexan 
common ancestor has been completely lost [57].  Distinct sub-transcriptomes in the 
Apicomplexa separate the cell cycle into two halves where many apicomplexan specific 
inventions, such as building invasion organelles and internal daughter structures (S/M 
peak) are distinct from more ancient eukaryotic functions such as constructing 
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transcription/translation and DNA replication machineries (G1 peak) [58].  Our 
bioinformatics approach to identify important novel structural and invasion proteins by a 
decision tree analysis in two clinically significant apicomplexan parasites (P. falciparum 
and T. gondii) led to the identification of 744 dual cell division cycle (CDC) regulated 
orthologs that represent many of the core set of CDC genes in apicomplexan parasites.  
Of these 744 orthologous genes, 125 had unknown functions in T. gondii and P. 
falciparum.  These unknown CDC proteins have a higher proportion of disordered 
domains and these proteins tend to be longer in T. gondii.  Given the lack of functional 
insight it is easy to assume these proteins are weakly conserved, perhaps even false 
positive cases of orthology assignment.  However, this study demonstrates these 
proteins have remarkable conserved topology and their expression at the mRNA level is 
well preserved in cell cycle timing.  The dual regulated cell division cycling unknown 
(drCDC-UNK) genes are also conserved in the levels of encoded mRNA abundance 
with the exception of the group of hypothetical CDC genes in P. falciparum that had 
peak expression during late nuclear reduplication and parasite budding (S/M timing, Fig. 
2.4).  Here the uniform high abundance of expression of these novel CDC genes set 
them apart from their T. gondii counterparts.  We believe this indicates a dominant role 
for these proteins in organizing and building daughter parasites that have a 10-fold 
scaling difference between the replication of the merozoite of P. falciparum compared to 
the tachyzoite of T. gondii.  This theme again was borne out in the lack of regulatory 
proteins present in the hypothetical group of core CDC genes and the tagging of 16 of 
these genes in T. gondii that revealed newly discovered proteins of invasion organelles 
and membrane structures, which are all scalable building components of the infectious 
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parasite.  Many of these hypothetical genes could be essential for parasite growth and 
offer unique targets for therapeutic development if we understood their functions.  Short 
of performing high-through-put genetic knockout approaches, the sorting strategies 
based on co-expression used here have benefits in discovering important Apicomplexa 
proteins involved in building new parasites.  The results of tagging hypothetical proteins 
also highlights the amount of biology we still must uncover in these parasites.  Our 
results clearly demonstrated that screening hypothetical genes by mRNA timing, 
orthology and protein topology enhances our ability to find specific types of proteins 
such as novel invasion proteins based on co-expression. 
Membrane proteins have multiple important roles in these parasites including 
providing structure, acting as a building block for developing daughters, and anchoring 
the motility complex.  Although many proteins have been characterized, many proteins 
still remain unknown and the mechanisms for cell replication, building the glideosome 
and membrane biogenesis are still incompletely understood. Additional components of 
the parasite’s cytoskeleton need to be identified to develop a holistic picture of the 
ultrastructure and mechanisms involved in the assembly and function of the 
cytoskeleton.  Among the sixteen novel proteins we discovered, one particularly 
interesting membrane protein we named inner membrane complex protein 16 (IMC16) 
was further characterized.  The identification of this interesting new membrane protein 
points to importance of identifying additional unknown proteins.  IMC16 preferentially 
targets to the daughter IMC in dividing parasites and appears to completely disappear 
from the mother IMC in dividing parasites.  This localization pattern suggests that this 
protein may have a potential role as a marker for daughter parasites to differentiate the 
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deconstruction and recycling of the mother parasite from the building of the newly 
forming daughter parasites.  This protein may also serve as an early membrane protein 
that acts as a scaffold and recruits additional membrane proteins to the newly 
developing daughter membrane. Interestingly, IMC16 localizes to the IMC without an 
alveolin domain, transmembrane domain or signal peptide.  This protein may require 
post-translational modification to anchor it into the IMC or may be a component of the 
subpellicular network (SPN) or intramembranous particle (IMP).  If it were in fact an IMP 
protein it would be the first IMP protein identified.  Protein interaction studies suggest 
that IMC16 interacts with both a kinase (CDPK1) and phosphatase (IMC2a) suggesting 
this protein might act like GAP45 and be phosphorylated in the cytoplasm and 
dephosphorylated to associate with the IMC.  
 
Future Directions 
Further studies of unknown proteins 
While identification of cell cycle orthologs and novel membrane and invasion 
proteins has provided insight to the novel Apicomplexa specific proteins yet to be 
discovered, additional research is needed to further analyze the different sets of 
proteins we identified in our decision tree analysis in Chapter 2.  The modified criteria 
for orthology assignment identified nearly 600 additional protein pairs than found using 
conventional methods that do not adequately account for additions of intrinsically 
disordered tails or loops that lead to penalized scores in conventional algorithms.  
Future directions should include further analysis of the additional orthologs identified to 
determine how many of the additional orthologs identified are in fact true orthologs and 
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if additional criteria are useful when determining orthology assignments.  Using cell 
cycle expression data to sort genes, we resolved genes that are uniquely cell cycle 
regulated in each parasite from those that form a core set of cycling mRNAs likely 
conserved across the parasite family.  Thus in P. falciparum, genes encoding cell cycle 
regulated surface and unique export proteins sorted into a cell cycle list that lacked 
conservation in T. gondii, while rhoptry proteins specific to T. gondii and other 
coccidians fell into an opposite class.  The cell cycle genes specific to each parasite 
include a large number of novel proteins representing undiscovered molecular features 
necessary for completing the T. gondii and P. falciparum life cycles in each unique host 
cell environment.  These genes were not studied here, but are as worthy of serious 
investigation as the dual cell cycle regulated genes that were the focus of this study.  
Additionally the highly conserved genes with orthologs in yeast and humans are also 
worthy of being investigated as the potential exists that a highly conserved protein is 
more likely to be essential for basic cell growth and division.  Additional studies should 
look into the different lists of genes identified (species specific, cyclical or not, and 
highly conserved or not) and employ a similar strategy to prioritize genes for 
characterization in order to increase the throughput of the discovery of unknown 
proteins. As additional proteins are identified further network analysis should be 
performed to continue to build clues to their function and add to the overall knowledge 
of potential protein interactions. The next steps in uncovering the function of the 125 
unknown dual regulated cell division cycling (drCDC-UNK) proteins and the other 
proteins from the other lists identified in Chapter 2 will be to use available genetic 
models to define phenotypes and interactor studies to identify protein partners, which is 
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beyond the scope of this initial study.  Currently, there is little global interactome data 
available and more interactome data is needed. As more interactome data becomes 
available for the Apicomplexa phylum it will be increasingly easier to predict protein 
function and help prioritize large lists of hypothetical proteins based on predicted 
functions for genome wide knockout strategies. 
 
Further Studies of IMC16 
Additional work is needed to further characterize IMC16, elucidate the function of 
this protein in developing daughter formation by genetic knockout and to confirm the 
interacting partners predicted by the proteomic experiment in order to build additional 
clues to potential functions and mechanisms. Future characterization experiments 
should include creating doubly tagged strains with IMC16 and other known membrane 
proteins such as IMC3, IMC15, Rab11b, ISP1, MORN1, etc. to determine the exact 
timing and localization of IMC16 in relation to other proteins important in early daughter 
formation. Additional live imaging experiments with dual tagged strains could also prove 
useful to pinpoint exact timing in relation to sequence of events and could be useful to 
determine if the protein is cytoplasmic and then recruited to the membrane.  
Fluorescence recovery after photobleaching (FRAP) experiments would help determine 
if IMC16 is made de novo and determine localization in mother and daughter parasites. 
Cre/LoxP (Fig. 4.1) and CRISPR/CAS9 knockout systems should be utilized to 
determine essentiality of IMC16. Given these results if IMC16 proves not to be essential 
in the tachyzoite stage, testing essentiality in additional life cycle stages and in 
combination with different membrane proteins to tease out redundancies should be 
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performed. However, if IMC16 is essential as we predict a phenotype would need to be 
characterized by additional assays to test growth rates, viability, morphology, invasion, 
etc.   
Additional solubility experiments including detergent extraction experiments with 
deoxycholic acid (DOC) will aid in further determining IMC16’s relationship with the 
membrane. Examining the ultrastructure by DOC extraction followed by freeze fracture 
and scanning electron microscopy would also be useful to determine if IMC16 is 
localized to the SPN or IMP.  The proteomic results for IMC16 should be verified by co-
immunoprecipitation experiments and additional proteomics studies should include 
repeating the immunoprecipitation and mass spectrometry experiment with separate 
soluble and insoluble fractions of the protein to determine if the soluble and insoluble 
fractions are involved in different protein interactions to give additional clues to its 
function and mechanisms of assembly.   
Determining phosphorylation and dephosphorylation by site directed 
mutagenesis of the five predicted sites of phosphorylation will also be interesting 
experiments to test the theory that IMC16 is phosphorylated by CDPK1 in the cytoplasm 
and dephosporylated by IMC2a at the IMC in order for IMC16 to associate with the IMC. 
Although IMC16 is not predicted to be myristoylated or palmitoylated, characterizing the 
predicted glycine at position 2, which is a conserved residue among other membrane 
proteins, will also be interesting to determine if this residue is important in membrane 
localization and verify IMC16 is not myristoylated to aid in anchoring it to the IMC.  
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Figure 4.1: Schematic representation of the Cre/LoxP knockout technique.  The 
cytoskeleton is comprised of an outer plasma membrane, the underlying inner 
membrane complex (IMC) and microtubules. LoxP sites will be added to flank the gene 
of interest using a modified LIC cassette that I described earlier that contains a loxP 
downstream of the selection marker.  The first LoxP site is located downstream and the 
second upstream of the gene of interest.  The resulting plasmid will be electroporated 
into a T. gondii strain containing diCre and produce an endogenously tagged gene 
flanked by LoxP sites.  Adding 50 nM Rapamycine will allow for the dimerization of the 
two Cre moieties and diCre will excise Gene-HA3-DHFR to create the knockout.   
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Figure A.1: Topology matches for drCDC-UNK proteins (1-15 out of 32 profiles). 
Order/disorder plots (VSL2B scores, >0.5=disordered) of T. gondii (blue) versus P. 
falciparum (red) proteins that display matching topology protein pairs. Topology profiles 
for the first fifteen (1-15 out of 32 profiles) drCDC-UNK protein pairs with matching 
topology are shown.  Order/disorder curves for drCDC-UNK protein pairs were aligned 
by best-fit methods, independent of order/disorder, and ordered by increasing protein 
length. Note that the set of matching orthologs includes examples of proteins that are 
nearly fully ordered (<0.5 score) as well as those that are nearly completely disordered 
(>0.5). 
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Figure A.2: Topology matches for drCDC-UNK proteins (16-32 of 32 profiles). 
Order/disorder plots (VSL2B scores, >0.5=disordered) of T. gondii (blue) versus P. 
falciparum (red) proteins that display matching topology protein pairs. Topology profiles 
for the next seventeen (16-32 out of 32 profiles) drCDC-UNK protein pairs with 
matching topology are shown.  Order/disorder curves for drCDC-UNK protein pairs were 
aligned by best-fit methods, independent of order/disorder, and ordered by increasing 
protein length.  The x-axis for longer proteins was extended to better display the protein 
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secondary structure.  Note that the set of matching orthologs includes examples of 
proteins that are nearly fully ordered (<0.5 score) as well as those that are nearly 
completely disordered (>0.5). 
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Figure A.3: Topology additions of N-terminal domains for drCDC-UNK proteins. 
Order/disorder plots (VSL2B scores, >0.5=disordered) of T. gondii (blue) versus P. 
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falciparum (red) proteins that display additions of loops or tails for the protein pairs.  
Order/disorder curves for drCDC-UNK protein pairs were aligned by best-fit methods, 
independent of order/disorder, and ordered by increasing protein length. The x-axis for 
longer proteins was extended to better display the protein secondary structure.  
Topology profiles of drCDC-UNK proteins with N-terminal domain additions in either 
species in most cases the domain addition was highly disordered.  
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Figure A.4: Topology additions of C-terminal tails for drCDC-UNK proteins.  
Order/disorder plots (VSL2B scores, >0.5=disordered) of T. gondii (blue) versus P. 
falciparum (red) proteins that display additions of loops or tails for the protein pairs.  
Order/disorder curves for drCDC-UNK protein pairs were aligned by best-fit methods, 
independent of order/disorder, and ordered by increasing protein length. The x-axis for 
longer proteins was extended to better display the protein secondary structure.  Unique 
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C-terminal additions were observed for 15 drCDC-UNK pairs. Similar to N-terminal 
additions, the C-terminal extension was species specific and disordered.   
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Figure A.5: Topology additions of complex additions of tails and loops in drCDC-
UNK proteins (1-21 of 41 profiles). Order/disorder plots (VSL2B scores, 
>0.5=disordered) of T. gondii (blue) versus P. falciparum (red) proteins that display 
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complex additions were observed in 41 drCDC-UNK pairs and included combinations of 
N and C-terminal tails or loops.  The first 21 profiles of complex additions are shown 
here.  Order/disorder curves for drCDC-UNK protein pairs were aligned by best-fit 
methods, independent of order/disorder, and ordered by increasing protein length.  
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Figure A.6: Topology additions of complex additions of tails and loops in drCDC-
UNK proteins (22-41 of 41 profiles). Order/disorder plots (VSL2B scores, 
>0.5=disordered) of T. gondii (blue) versus P. falciparum (red) proteins that display 
additions of loops or tails for complex additions were observed in 41 drCDC-UNK pairs 
and included combinations of N and C-terminal tails or loops.  The next 20 profiles of 
complex additions are shown here.  Order/disorder curves for drCDC-UNK protein pairs 
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were aligned by best-fit methods, independent of order/disorder, and ordered by 
increasing protein length. The x-axis for longer proteins was extended to better display 
the protein secondary structure.  
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Figure A.7: Minimal topology matches for drCDC-UNK proteins.  
Order/disorder plots (VSL2B scores, >0.5=disordered) of 15 T. gondii (blue) versus P. 
falciparum (red) proteins that display minimal topology matched protein pairs.  
Order/disorder curves for drCDC-UNK protein pairs were aligned by best-fit methods, 
independent of order/disorder, and ordered by increasing protein length.  The x-axis for 
longer proteins was extended to better display the protein secondary structure. 
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Table A.1: Decision tree analysis datasets used to identify conserved 
Apicomplexa CDC genes. 
All datasets used in the decision tree analysis described in Fig. 1A to identify the 744 
drCDC genes and the 125 drCDC-UNK genes.  
 
744#dual#regulated#cell#division#cycling#(drCDC)#genes#identified#by#decision#tree#analysis#described#in#Fig.#1A
125 unknown drCDC (drCDC-UNK) genes highlighted in yellow obtained from the 744 list with conserved timing
T. gondii (Tg) G1=4.6-8.75 h, S/M/C=0-4.5 and 8.75-12 h (transciptome data gathered for 1.5 cell cycles in Behnke et al. 2010)
P. falciparum (Pf) G1=1-34 h, S/M/C=35-48 h
744 drCDC 
orthologs, Tg 
genes 
Tg mRNA 
peak (h) Tg Gene list anotation
744 drCDC 
orthologs, Pf 
genes 
Pf#mRNA#
peak#(h) Pf Gene list anotation
TGME49_000320 12.00 hypoxanthine-xanthine-guanine phosphoribosyl transferase PF10_0121 18 hypoxanthine-guanine phosphoribosyltransferase (HGPRT)
TGME49_000330 3.46 hypothetical protein, conserved MAL13P1.188 38 conserved Plasmodium protein, unknown function
TGME49_000370 6.10 protein farnesyltranstransferase beta subunit, putative PF11_0483 12 farnesyltransferase beta subunit, putative
TGME49_000400 3.25 protein phosphatase 2A, putative PF13_0302 29 phosphatase 2A regulatory subunit-related protein, putative
TGME49_001220 1.22 hypothetical protein PFE0895c 36 zinc finger protein, putative
TGME49_001680 5.90 eukaryotic translation initiation factor 3 subunit 10, putative PFL0625c 12 eukaryotic translation initiation factor 3 subunit 10, putative
TGME49_001830 6.31 hypothetical protein, conserved PF11_0248 29 mitochondrial ribosomal protein L37, putative
TGME49_002040 1.63 hypothetical protein, conserved PF10_0312 35 conserved Plasmodium protein, unknown function
TGME49_002130 8.34 hypothetical protein PF13_0120 37 conserved Plasmodium protein, unknown function
TGME49_002180 6.31 hypothetical protein, conserved PFC0571c 30 conserved Plasmodium protein, unknown function
TGME49_002230 5.29 histone deactylase, putative PF14_0690 5 histone deacetylase, putative
TGME49_002290 6.92 hypothetical protein, conserved PFI0845w 37 conserved Plasmodium membrane protein, unknown function
TGME49_002310 12.00 glycoprotease family domain-containing protein PF10_0299 11 glycoprotease, putative
TGME49_002350 5.69 hypothetical protein PF14_0212 36 mitochondrial ribosomal protein L21 precursor, putative
TGME49_002360 6.10 hypothetical protein PFL2305w 11 conserved Plasmodium protein, unknown function
TGME49_002370 7.73 TCP-1/cpn60 family chaperonin, putative PFC0900w 18 T-complex protein 1 epsilon subunit, putative
TGME49_002460 0.61 diacylglycerol kinase, putative PF14_0681 37 diacylglycerol kinase, putative
TGME49_002500 3.05 hypothetical protein MAL13P1.130 38 glideosome associated protein with multiple membrane spans 1 (GAPM1)
TGME49_002530 6.71 aspartyl-tRNA synthetase, putative PFA0145c 18 aspartyl-tRNA synthetase
TGME49_002570 6.92 ribophorin I, putative PFC0490w 23 conserved Plasmodium protein, unknown function
TGME49_002750 4.88 exosome complex exonuclease, putative MAL13P1.204 11 exosome complex component RRP42, putative (RRP42)
TGME49_002790 5.69 dihydrouridine synthase domain-containing protein PF14_0086 18 tRNA-dihydrouridine synthase, putative
TGME49_002800 6.71 cytochrome c oxidase assembly protein COX11, putative PF14_0721 27 cytochrome c oxidase assembly protein, putative
TGME49_003010 2.85 Aurora kinase MAL13P1.278 39 serine/threonine protein kinase, putative (ARK3)
TGME49_003160 3.46 hypothetical protein, conserved PF14_0149 42 conserved Plasmodium protein, unknown function
TGME49_003170 8.14 replication factor-A C terminal domain-containing protein PFI0235w 28 replication protein A1, small fragment
TGME49_003380 5.69 DnaJ domain-containing protein PFL0815w 12 DNA-binding chaperone, putative
TGME49_003390 3.46 CRAL/TRIO domain-containing protein PFI1015w 42 conserved Plasmodium protein, unknown function
TGME49_003620 6.51 hypothetical protein PF13_0068 27 mitochondrial ribosomal protein S35 precursor, putative
TGME49_003940 6.31 ABC1 domain-containing protein PF08_0098 25 ABC1 family, putative (ABCK1)
TGME49_004050 12.00 subtilase family serine protease, putative PFE0370c 42 subtilisin-like protease 1 (SUB1)
TGME49_004280 0.81 CMGC kinase, Dyrk family PF14_0408 38 serine/threonine protein kinase (SRPK2)
TGME49_004370 7.12 hypothetical protein PF14_0671 30 conserved protein, unknown function
TGME49_004400 7.32 ATP synthase alpha chain, putative PFB0795w 30 ATP synthase F1, alpha subunit
TGME49_004410 3.05 endonuclease/exonuclease/phosphatase domain-containing protein PF13_0336 34 DNase I-like protein, putative
TGME49_005010 5.49 splicing factor 3B subunit 1, putative PFC0375c 11 splicing factor 3B subunit 1, putative (SF3B1)
TGME49_005200 4.07 hypothetical protein PF11_0168 37 rhoptry neck protein 4 (RON4)
TGME49_005240 6.51 cleft lip and palate associated transmembrane protein 1, putative PF11_0384 10 conserved Plasmodium membrane protein, unknown function
TGME49_005280 3.25 hypothetical protein MAL7P1.34 1 conserved Plasmodium membrane protein, unknown function
TGME49_005320 11.19 hypothetical protein MAL7P1.125 41 conserved Plasmodium protein, unknown function
TGME49_005440 7.32 TCP-1/cpn60 family chaperonin, putative PFL1425w 17 T-complex protein 1, gamma subunit, putative
TGME49_005460 2.03 AN1-like Zinc finger-containing protein PFE0200c 42 AN1-like zinc finger family protein
TGME49_005470 7.32 elongation factor 2, putative PF14_0486 13 elongation factor 2
TGME49_005490 2.85 integral membrane protein, putative MAL8P1.13 37 folate transporter 1 (FT1)
TGME49_005510 5.90 nucleolar protein NOP5, putative PF10_0085 11 small subunit rRNA processing protein, putative
TGME49_005670 1.83 SF-assemblin, putative PF14_0311 36 SF-assemblin, putative
TGME49_005740 7.53 hypothetical protein MAL8P1.105 11 conserved protein, unknown function
TGME49_006430 7.73 formin FRM1 (FRM1) PFE1545c 37 formin 1, putative
TGME49_006480 6.71 hypothetical protein, conserved PFB0600c 26 conserved Plasmodium protein, unknown function
TGME49_006490 7.73 metacaspase 1 precursor, putative PF13_0289 9 metacaspase 1 (MCA1)
TGME49_006690 3.05 hypothetical protein, conserved PFD1110w 38 glideosome associated protein with multiple membrane spans 2 (GAPM2)
TGME49_006710 2.44 hypothetical protein, conserved PF11_0383 38 conserved Plasmodium protein, unknown function
TGME49_007060 7.73 ribonucleotide-diphosphate reductase, small subunit, putative PF14_0053 31 ribonucleotide reductase small subunit (RNR)
TGME49_007180 6.92 indole-3-glycerol phosphate synthase domain containing protein MAL13P1.319 30 indole-3-glycerol-phosphate synthase, putative
TGME49_007590 3.46 T-cell activation protein phosphatase 2C, putative PF07_0019 40 conserved Plasmodium protein, unknown function
TGME49_007640 6.51 isoleucine-tRNA synthetase, putative PF13_0179 12 isoleucine-tRNA ligase, putative
TGME49_007720 5.49 hypothetical protein PF14_0214 11 conserved Plasmodium protein, unknown function
TGME49_007800 7.12 hypothetical protein PFL2045w 29 conserved protein, unknown function
TGME49_007900 12.00 transcription factor IIIB subunit, putative PF14_0469 1 transcription factor IIIb subunit, putative
TGME49_007990 5.29 ftsJ-like methyltransferase domain-containing protein PF13_0286 11 large subunit rRNA methyltransferase, putative
TGME49_008490 4.88 hypothetical protein PF14_0292 11 large ribosomal subunit associated GTPase, putative
TGME49_008540 5.29 ATP-dependent RNA helicase, putative MAL8P1.19 11 ATP-dependent RNA helicase DBP10, putative (DBP10)
TGME49_009030 3.05 actin PFL2215w 40 actin I (ACT1)
TGME49_009140 8.34 anti-silencing protein 1, putative PFL1180w 34 chromatin assembly protein (ASF1), putative
TGME49_009160 1.63 glycylpeptide N-tetradecanoyltransferase, putative PF14_0127 6 N-myristoyltransferase (NMT)
TGME49_009200 9.97 hypothetical protein, conserved PFL1025c 37 conserved Plasmodium protein, unknown function
TGME49_009430 5.90 U3 small nucleolar ribonucleoprotein protein IMP3, putative PF14_0584 8 mitochondrial ribosomal protein S4/S9 precursor, putative
TGME49_009550 6.92 hypothetical protein MAL13P1.78 21 conserved Plasmodium protein, unknown function
TGME49_009710 6.92 50S ribosomal protein L28, putative PFE0145w 42 organelle ribosomal protein L28 precursor, putative
TGME49_009970 8.14 gamma-tubulin complex component 4, putative PF14_0414 26 conserved Plasmodium protein, unknown function
TGME49_010360 5.49 DEAD/DEAH box helicase, putative PFE1390w 5 RNA helicase 1
TGME49_010830 5.49 RIO1 family domain-containing protein PFL1490w 3 atypical protein kinase, RIO family, putative
TGME49_010960 7.73 replication factor C subunit, putative PFL2005w 29 replication factor C subunit 4, putative
TGME49_011400 5.29 helicase, putative PFD0245c 11 ATP-dependent RNA helicase, putative
TGME49_011410 6.92 hypothetical protein, conserved PFI0365w 9 translation initiation factor SUI1, putative
TGME49_011600 3.86 hypothetical protein PFL0840c 39 conserved Plasmodium protein, unknown function
TGME49_011690 10.17 ATP-dependent helicase, putative MAL7P1.12 16 erythrocyte membrane-associated antigen
TGME49_011710 6.71 TB2/DP1, HVA22 domain-containing protein MAL13P1.288 9 conserved Plasmodium protein, unknown function
TGME49_011730 8.14 SET domain-containing protein PFD0190w 37 SET domain protein, putative (SET8)
TGME49_011900 6.92 hypothetical protein PF14_0509 19 RAP protein, putative
TGME49_012130 1.02 patatin-like phospholipase domain-containing protein PFI1180w 1 patatin-like phospholipase, putative
TGME49_012190 8.75 RNA recognition motif domain containing protein PF11_0402 47 conserved Plasmodium protein, unknown function
TGME49_012270 12.00 hypothetical protein PF14_0325 40 conserved Plasmodium membrane protein, unknown function
TGME49_012760 6.31 hypothetical protein PF14_0592 29 conserved Plasmodium protein, unknown function
TGME49_012950 1.02 ADP-ribosylation factor domain-containing protein PF14_0399 22 ADP-ribosylation factor, putative
TGME49_013000 7.73 activator 1 36 kDa, putative PF14_0601 29 replication factor C3 (RFC3)
TGME49_013650 5.08 conserved hypothetical ATP binding domain-containing protein PF13_0261 10 nucleolar preribosomal associated cytoplasmic ATPase, putative
TGME49_013740 5.29 methyltransferase domain containing protein PFD0460c 11 conserved Plasmodium protein, unknown function
TGME49_013800 3.05 protein phosphatase 2B regulatory subunit PF14_0492 36 protein phosphatase 2b regulatory subunit, putative
TGME49_013970 6.10 NOL1/NOP2/sun family domain-containing protein PFL1475w 22 sun-family protein, putative
TGME49_014150 5.90 mitochondrial import inner membrane translocase subunit, putative PF13_0300 18 mitochondrial inner membrane translocase, putative
TGME49_014170 5.69 hypothetical protein PF14_0403 17 protein prenyltransferase alpha subunit, putative
TGME49_014180 3.25 EPN3 protein PFL2195w 44 clathrin coat assembly protein AP180, putative
TGME49_014210 5.29 centromere/microtubule binding protein, putative PF14_0174 11 pseudouridine synthase, putative
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TGME49_014320 6.31 facilitative glucose transporter, putative PFB0210c 9 hexose transporter (HT)
TGME49_014350 6.92 GTP-binding protein, putative MAL7P1.122 11 GTP binding protein, putative
TGME49_014560 8.14 hypothetical protein MAL13P1.103 30 conserved Plasmodium protein, unknown function
TGME49_014780 7.73 bis(5'-nucleosyl)-tetraphosphatase (asymmetrical), putative PFE1035c 11 BIS(5'-nucleosyl)-tetraphosphatase (diadenosine tetraphosphatase), putative
TGME49_014790 6.31 mitochondrial glycoprotein domain-containing protein PF14_0329 21 conserved protein, unknown function
TGME49_014820 5.49 DNA repair enzyme, putative PF14_0513 12 RNA binding protein, putative
TGME49_014850 7.53 1-deoxy-D-xylulose 5-phosphate reductoisomerase, putative PF14_0641 31 1-deoxy-D-xylulose 5-phosphate reductoisomerase (DOXR)
TGME49_014970 8.34 DNA replication licensing factor, putative PF14_0177 31 minchromosome maintenance (MCM) complex subunit (MCM2)
TGME49_015060 1.02 carbamoyl phosphate synthetase II PFD0810w 28 small GTP-binding protein sar1 (SAR1)
TGME49_015210 3.86 hypothetical protein PF14_0703 43 conserved Plasmodium protein, unknown function
TGME49_015260 5.49 carbamoylphosphate synthetase PF13_0044 17 carbamoyl phosphate synthetase (cpsSII)
TGME49_015370 5.29 hypothetical protein PF08_0101 25 conserved Plasmodium protein, unknown function
TGME49_015390 6.31 Tim10/DDP family zinc finger containing protein PFL0430w 17 tim10 homologue, putative
TGME49_015510 5.49 S-adenosyl-methyltransferase mraW, putative PFL1775c 29 s-adenosyl-methyltransferase, putative
TGME49_015560 5.49 protein arginine N-methyltransferase, putative PF13_0323 11 arginine methyltransferase 5, putative (PRMT5)
TGME49_015570 10.17 hypothetical4protein PF07_0126 9 transcription factor with AP2 domain(s) (ApiAP2)
TGME49_015700 12.00 phosphatidylinositol 3-kinase, putative PFE0765w 31 phosphatidylinositol 3-kinase (PI3K)
TGME49_015740 5.49 hypothetical protein, conserved PF11_0471 11 nucleolar preribosomal assembly protein, putative
TGME49_015990 8.14 helicase, putative MAL13P1.134 28 DEAD box helicase, putative
TGME49_016000 3.25 alveolin domain containing intermediate filament IMC3 (ALV3) PFL1030w 47 membrane skeletal protein, putative (ALV3)
TGME49_016080 3.46 apical complex lysine methyltransferase PF11_0160 37 SET domain protein, putative (SET7)
TGME49_016210 5.49 hypothetical protein PFL0405w 13 conserved Plasmodium protein, unknown function
TGME49_016390 5.29 RNA methyltransferase, putative PFE1275c 25 RNA methyltransferase, putative
TGME49_016410 6.31 hypothetical protein, conserved PF14_0176 28 conserved Plasmodium protein, unknown function
TGME49_016730 8.14 DNA replication licensing factor, putative PFE1345c 34 minchromosome maintenance (MCM) complex subunit, putative (MCM3)
TGME49_016820 4.47 transmembrane domian-containing protein PFB0275w 42 metabolite/drug transporter, putative
TGME49_016870 5.08 excision repair protein rad15, putative PFI1650w 23 DNA excision-repair helicase, putative
TGME49_016950 5.69 pre-mRNA splicing factor RNA helicase, putative PF08_0042 9 ATP-dependent RNA helicase prh1, putative
TGME49_016970 3.46 hypothetical protein, conserved PFL2460w 42 coronin
TGME49_017460 12.00 glutaminyl-tRNA synthetase, putative PF13_0170 11 glutaminyl-tRNA synthetase, putative
TGME49_017560 12.00 DNA-directed RNA polymerase II, 8.2 kDa polypeptide, putative PF07_0027 9 DNA-directed RNA polymerase 2 8.2 kDa polypeptide, putative
TGME49_017580 6.10 DNA-directed RNA polymerases III, 39 kDa polypeptide, putative PF14_0207 17 DNA-directed RNA polymerase III subunit C, putative
TGME49_017820 6.71 proteasome PCI domain-containing protein PFD0880w 11 golgi organization and biogenesis factor, putative
TGME49_017870 2.85 zinc finger DHHC domain-containing protein PF11_0167 48 conserved Plasmodium membrane protein, unknown function
TGME49_017880 5.08 KH domain-containing protein PF14_0151 21 RNA-binding protein Nova-1, putative
TGME49_017890 6.92 peroxiredoxin PF14_0368 11 thioredoxin peroxidase 1 (Trx-Px1)
TGME49_017910 7.73 DNA polymerase alpha catalytic subunit PFD0590c 30 DNA polymerase alpha
TGME49_018250 6.51 immunoglobulin-binding protein, putative PF07_0102 24 immunoglobulin-binding protein 1-related, putative
TGME49_018360 1.63 zinc finger (CCCH type) protein, putative PF13_0314 39 zinc finger protein, putative
TGME49_018570 5.69 hypothetical protein PFD0905w 42 conserved Plasmodium protein, unknown function
TGME49_018610 5.08 UPF0202 family protein PF10_0200 11 ribosomal processing ATPase, putative
TGME49_018840 7.53 mismatch repair protein, putative PF14_0051 25 DNA mismatch repair protein, putative
TGME49_018850 1.42 ribosomal protein S9, putative PF14_0132 29 40S ribosomal protein S9A, putative
TGME49_019070 3.46 cAMP-dependent protein kinase regulatory subunit, putative PF14_0173 39 cyclic nucleotide-binding protein, putative, pseudogene (cNBP)
TGME49_019080 7.93 hypothetical protein PF14_0365 9 conserved Plasmodium protein, unknown function
TGME49_019140 6.71 EF-1 guanine nucleotide exchange domain-containing protein PFC0870w 11 elongation factor 1 (EF-1), putative
TGME49_019150 5.49 krr1 family, zinc finger-containing protein PF08_0026 5 conserved protein, unknown function
TGME49_019190 12.00 nuclear movement domain-containing protein PFI1325w 34 CS domain protein, putative
TGME49_019200 5.49 DEAD/DEAH box RNA helicase, putative PFL2475w 1 DEAD/DEAH box ATP-dependent RNA helicase, putative
TGME49_019260 5.90 cation-transporting ATPase, putative PFE0805w 22 cation-transporting ATPase 1 (ATPase1)
TGME49_019310 6.92 heat shock protein, putative PF07_0033 15 heat shock protein 70 (HSP70-z)
TGME49_019320 3.05 acid phosphatase, putative PFI0880c 36 glideosome-associated protein 50,secreted acid phosphatase (GAP50)
TGME49_019520 5.49 arginine N-methyltransferase 1 PF14_0242 16 arginine methyltransferase 1 (PRMT1)
TGME49_019540 7.53 alanyl-tRNA synthetase, putative PF13_0354 12 alanyl-tRNA synthetase,Alanine--tRNA ligase (AlaRS)
TGME49_019630 12.00 NADPH-cytochrome p450 reductase, putative PFI1140w 11 flavodoxin-like protein
TGME49_019870 8.34 DNA replication licensing factor, putative PF13_0291 34 minchromosome maintenance (MCM) complex subunit (MCM6)
TGME49_020100 5.90 phosphoribosylpyrophosphate synthetase, putative PF13_0143 21 phosphoribosylpyrophosphate synthetase
TGME49_020270 3.46 hypothetical protein, conserved PF13_0226 30 conserved Plasmodium protein, unknown function
TGME49_020350 7.73 lysyl-tRNA synthetase, putative PF14_0166 21 lysine-tRNA ligase, putative
TGME49_020490 5.29 hypothetical protein PF14_0661 11 small subunit rRNA processing KH domain protein, putative
TGME49_020600 8.14 hypothetical protein, conserved PF11_0310 16 transporter, putative
TGME49_020860 7.12 DEAD/DEAH box helicase, putative PF14_0563 6 ATP-dependent RNA helicase DBP5 (DBP5)
TGME49_021320 8.14 acetyl-CoA carboxylase ACC1 (ACC1) PF14_0664 31 biotin carboxylase subunit of acetyl CoA carboxylase, putative (ACC1)
TGME49_021330 7.93 DNA gyrase subunit A, putative PFL1120c 26 DNA gyrase subunit A (GyrA)
TGME49_021410 8.14 actin-like protein ALP4 (ALP4) MAL7P1.153 28 actin-like protein, putative
TGME49_021440 8.14 RPGR, putative PF14_0404 16 TRAP-like protein,sporozoite-specific transmembrane protein S6 (TREP)
TGME49_022000 5.69 ribosome biogenesis protein Brix, putative PF07_0122 11 BRIX protein, putative
TGME49_022040 5.90 Ran-interacting Mog1 protein MAL13P1.232 20 mog1 homolog, putative
TGME49_022100 9.97 hypothetical protein PF13_0116 10 rhoptry protein 2, putative (PRP2)
TGME49_022210 1.02 SPFH domain / Band 7 family domain-containing protein PFC0800w 20 band 7-related protein
TGME49_022230 4.47 hypothetical protein PFE0245c 12 conserved Plasmodium membrane protein, unknown function
TGME49_022670 9.97 hypothetical protein PF11_0420 32 conserved Plasmodium protein, unknown function
TGME49_022860 6.92 eukaryotic translation initiation factor 3 subunit 9, putative PFE0885w 11 eukaryotic translation initiation factor, putative
TGME49_023000 9.56 dynein light chain, putative PFL0660w 28 dynein light chain 1, putative
TGME49_023040 6.31 hypothetical protein, conserved PF11_0440 30 conserved Plasmodium protein, unknown function
TGME49_023130 5.49 hypothetical protein PF11_0316 10 conserved Plasmodium protein, unknown function
TGME49_023140 6.71 multisynthetase complex auxiliary component p43, putative PF14_0401 11 tRNA binding protein, putative
TGME49_023390 5.29 sec63 domain-containing DEAD/DEAH box helicase, putative PFD1060w 12 pre-mRNA-splicing helicase BRR2, putative (BRR2)
TGME49_023570 3.86 zinc finger (C2H2 type) protein, putative PF14_0707 6 conserved Plasmodium protein, unknown function
TGME49_023710 6.31 N-terminal acetyltransferase complex subunit NARG1, putative PFL2120w 42 conserved Plasmodium protein, unknown function
TGME49_023790 9.97 hypothetical protein, conserved PF11_0300 37 conserved Plasmodium protein, unknown function
TGME49_023940 3.46 hypothetical protein PFL1090w 42 glideosome-associated protein 45 (GAP45)
TGME49_024340 2.85 hypothetical protein PFB0810w 30 conserved Plasmodium protein, unknown function
TGME49_024530 3.66 inner membrane complex associated protein 4 PF10_0039 42 membrane skeletal protein IMC1-related (ALV5)
TGME49_024590 5.08 hypothetical protein PF11_0469 16 conserved Plasmodium protein, unknown function
TGME49_024850 6.51 polyadenylate-binding protein, putative PFL1170w 48 polyadenylate-binding protein, putative (PABP)
TGME49_024860 5.90 exosome complex exonuclease, putative PFD0515w 10 exosome complex component RRP4, putative (RRP4)
TGME49_024880 3.46 kinesin motor domain-containing protein PF07_0104 42 kinesin-like protein, putative
TGME49_024950 4.88 CAM kinase, CDPK family TgTOXPK2 PF13_0211 44 calcium dependent protein kinase 5 (CDPK5)
TGME49_025050 7.32 adenosylhomocysteinase, putative PFE1050w 30 S-adenosyl-L-homocysteine hydrolase (SAHH)
TGME49_025250 6.10 ribosomal protein L14p/L2 domain containing protein PFE0960w 33 mitochondrial ribosomal protein L14 precursor, putative
TGME49_025320 2.03 hypothetical protein, conserved PF11_0373 37 conserved Plasmodium protein, unknown function
TGME49_025580 7.32 26S Proteasome non-ATPase regulatory subunit 9, putative PFC0785c 25 proteasome regulatory protein, putative
TGME49_025800 7.32 ABC transporter, putative PF14_0133 30 FeS assembly ATPase SufC (SufC)
TGME49_025930 6.10 triosephosphate isomerase, putative PF14_0378 23 triosephosphate isomerase (TIM)
TGME49_026000 7.12 ATP synthase, putative PF11_0485 30 mitochondrial ATP synthase delta subunit, putative
TGME49_026280 6.31 ribosomal protein L28, putative PF14_0539 25 mitochondrial ribosomal protein L28 precursor, putative
TGME49_026340 2.64 hypothetical protein, conserved PF10_0189 37 conserved Plasmodium protein, unknown function
TGME49_026480 6.71 DNA topoisomerase III alpha, putative PF13_0251 29 DNA topoisomerase III, putative
TGME49_026550 6.71 hypothetical protein, conserved PFI0195c 11 GTPase activator, putative
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TGME49_026560 12.00 zinc finger (CCCH type) protein, putative PF14_0416 25 zinc finger protein, putative
TGME49_026740 3.66 zinc finger (C3HC4 RING finger) protein, putative PF10_0276 33 zinc finger, C3HC4 type, putative
TGME49_027140 4.07 hypothetical protein MAL13P1.138 23 conserved Plasmodium protein, unknown function
TGME49_027260 5.49 RIO1 family domain-containing protein PFD0975w 11 RIO-like serine/threonine kinase, putative (RIO2)
TGME49_027420 7.12 lytB domain-containing protein PFA0225w 48 4-hydroxy-3-methylbut-2-enyl diphosphate reductase (LytB)
TGME49_027660 5.29 DNA methyltransferase 2, putative MAL7P1.151 DNA (cytosine-5)-methyltransferase, putative (DNMT2)
TGME49_027670 5.08 hypothetical protein PF10_0188 36 conserved Plasmodium membrane protein, unknown function
TGME49_027800 3.46 hypothetical protein, conserved PF10_0244 1 formin 2, putative
TGME49_027830 6.10 mitochondrial import inner membrane translocase TIM44, putative PF11_0265 20 mitochondrial inner membrane translocase subunit tim44, putative
TGME49_027950 4.47 zinc metalloprotease 2, putative PF13_0322 30 falcilysin (FLN)
TGME49_027970 7.32 DNA-binding protein HU, putative PFI0230c 34 bacterial histone-like protein (HU)
TGME49_028180 6.92 cytochrome C oxidase assembly factor COX15, putative PF14_0331 29 cytochrome c oxidase assembly protein, putative
TGME49_028190 6.71 eukaryotic translation initiation factor 3 subunit 5, putative PFI0895c 9 eukaryotic translation initiation factor 3 subunit 5, putative
TGME49_028250 8.34 elongation factor Tu GTP binding domain-containing protein PF13_0069 24 translation initiation factor IF-2, putative
TGME49_028490 6.31 hypothetical protein, conserved PF13_0136 11 conserved Plasmodium protein, unknown function
TGME49_029000 3.25 kelch repeat-containing protein PFL0650c 44 conserved Plasmodium protein, unknown function
TGME49_029180 5.29 importin beta-3 subunit, putative PFE1195w 11 karyopherin beta (KASbeta)
TGME49_029290 5.29 kelch motif domain-containing protein PF10_0219 10 kelch protein, putative
TGME49_029420 1.42 cytochrome c, putative MAL13P1.55 12 cytochrome c2 precursor, putative
TGME49_029480 1.22 membrane-associated calcum-binding protein, related PF11_0098 32 endoplasmic reticulum-resident calcium binding protein (ERC)
TGME49_029650 3.46 josephin protein PFL1295w 34 conserved Plasmodium protein, unknown function
TGME49_029710 3.46 OTU-like cysteine protease domain-containing protein PF10_0308 40 OTU-like cysteine protease, putative
TGME49_030050 5.29 ribosomal protein L3p, putative PFL2180w 26 mitochondrial ribosomal protein L3 precursor, putative
TGME49_030060 7.32 acetyltransferase domain-containing protein PF13_0131 28 acetyltransferase, GNAT family, putative
TGME49_030160 12.00 hypothetical protein PF13_0058 42 conserved Plasmodium protein, unknown function
TGME49_030170 4.27 hypothetical protein, conserved PF14_0531 31 conserved Plasmodium protein, unknown function
TGME49_030220 0.61 hypothetical protein PFE0100w 12 conserved Plasmodium protein, unknown function
TGME49_030340 3.46 high molecular mass nuclear antigen, putative MAL13P1.102 41 conserved Plasmodium protein, unknown function
TGME49_030350 9.97 hypothetical protein, conserved PF14_0607 38 conserved Plasmodium membrane protein, unknown function
TGME49_030450 5.69 GMP synthase, putative PF10_0123 11 GMP synthetase (GMPS)
TGME49_030480 2.03 hypothetical protein PFC0486c 8 conserved Plasmodium protein, unknown function
TGME49_030520 6.71 cyclophilin, putative PFC0975c 23 peptidyl-prolyl cis-trans isomerase (CYP19A)
TGME49_030690 4.07 hypothetical protein PFC0150w 37 hypothetical5protein,5conserved
TGME49_031040 5.29 exosome complex exonuclease, putative PF14_0256 11 exosome complex exonuclease rrp41, putative
TGME49_031120 6.51 ribosomal protein S11, putative PF14_0519 22 mitochondrial ribosomal protein S11 precursor, putative
TGME49_031150 5.90 hypothetical protein PF14_0161 28 conserved protein, unknown function
TGME49_031170 7.93 chromosome condensation protein, putative PFE0450w 30 chromosome condensation protein, putative
TGME49_031210 3.05 EH protein, putative PFC0190c 9 EH (Eps15 homology) protein (PAST1)
TGME49_031430 8.34 oligosaccharyl transferase STT3, putative PF11_0173 37 oligosaccharyl transferase STT3 subunit, putative
TGME49_031630 3.25 membrane skeletal protein IMC1, putative PFC0185w 41 membrane skeletal protein IMC1-related (ALV2)
TGME49_031790 1.42 hypothetical protein PF07_0108 30 conserved Plasmodium protein, unknown function
TGME49_031910 5.49 ATP synthase gama chain, putative PF13_0061 27 ATP synthase subunit gamma, mitochondrial
TGME49_032080 3.46 hypothetical protein, conserved PFE1120w 39 conserved Plasmodium protein, unknown function
TGME49_032120 3.66 hypothetical protein, conserved PFL2410w 45 conserved Plasmodium membrane protein, unknown function
TGME49_032150 2.64 hypothetical protein, conserved MAL7P1.87 37 conserved Plasmodium protein, unknown function
TGME49_032380 5.08 WD-40 repeat protein, putative PF14_0456 15 U3 snoRNA-associated small subunit rRNA processing protein, putative
TGME49_032390 5.29 RNA 3' terminal phosphate cyclase, putative PF14_0677 17 RNA 3'-terminal phosphate cyclase-like protein, putative
TGME49_032520 5.69 brix domain-containing protein PF10_0278 11 nucleolar preribosomal assembly protein, putative
TGME49_032650 3.66 hypothetical protein, conserved PFE0995c 12 conserved protein, unknown function
TGME49_032750 5.49 hypothetical protein PF14_0115 24 conserved Plasmodium protein, unknown function
TGME49_032760 12.00 protein phosphatase inhibitor IPP2 (IPP2) PFC0886w 34 conserved Plasmodium protein, unknown function
TGME49_032820 5.69 tim10/DDP zinc finger domain-containing protein PF13_0358 23 mitochondrial import inner membrane translocase, putative
TGME49_033100 6.51 prohibitin, putative PF10_0144 21 prohibitin, putative
TGME49_033130 6.92 adenosine transporter, putative PF13_0252 20 nucleoside transporter 1 (NT1)
TGME49_033140 8.14 deoxyuridine 5'-triphosphate nucleotidohydrolase, putative PF11_0282 28 deoxyuridine 5'-triphosphate nucleotidohydrolase (dUTPase)
TGME49_033260 5.69 GTP-binding protein, putative MAL13P1.294 11 GTP binding protein, putative
TGME49_033400 5.90 UPF0101 protein CGI-137, putative PFA0530c 12 adenylate kinase, putative
TGME49_033410 5.29 WD domain, G-beta repeat-containing protein PFD0455w 48 40S ribosomal processing protein, putative
TGME49_033520 8.34 ATP-dependent RNA helicase, putative PFI0860c 9 pre-mRNA-splicing factor ATP-dependent RNA helicase PRP43, putative (PRP43)
TGME49_033540 8.34 integral membrane transporter PFB0465c 30 monocarboxylate transporter, putative
TGME49_033720 5.90 RNA polymerase, putative PFL0665c 11 RNA polymerase subunit 8c, putative
TGME49_033810 3.05 hypothetical protein PFB0190c 37 conserved Plasmodium protein, unknown function
TGME49_033830 6.92 hypothetical protein, conserved PFL2355w 11 conserved Plasmodium protein, unknown function
TGME49_034190 7.53 serine hydroxymethyltransferase 2, putative PFL1720w 34 serine hydroxymethyltransferase (SHMT)
TGME49_034350 12.00 hypothetical protein PF11_0441 37 conserved Plasmodium protein, unknown function
TGME49_034500 6.71 phenylalanyl tRNA synthetase isoform, putative PFA0480w 10 phenylalanyl-tRNA synthetase, putative
TGME49_034970 8.14 Tyrosine kinase-like (TKL) protein PF11_0488 29 serine/threonine protein kinase, putative
TGME49_035130 10.17 hypothetical protein PFB0475c 42 conserved Plasmodium protein, unknown function
TGME49_035450 2.64 ubiquitin-conjugating enzyme, putative PF13_0301 38 ubiquitin conjugating enzyme, putative
TGME49_035470 3.46 myosin A, putative PF13_0233 42 myosin A (MyoA)
TGME49_035540 5.90 translation initiation factor 2 beta, putative PF10_0103 11 eukaryotic translation initiation factor 2 beta subunit, putative
TGME49_035610 5.69 ATPase, AAA family domain-containing protein PF14_0126 20 AAA family ATPase, putative
TGME49_035620 5.90 deoxyhypusine synthase, putative PF14_0125 11 deoxyhypusine synthase
TGME49_035890 5.69 hypothetical protein PFC0380w 11 dual specificity phosphatase (YVH1)
TGME49_035970 6.10 eukaryotic translation initiation factor 2 gamma subunit, putative PF14_0104 10 eukaryotic translation initiation factor 2 gamma subunit, putative
TGME49_035980 5.29 IBR domain-containing protein PFC0175w 24 IBR domain protein, putative
TGME49_036070 3.66 pyrroline-5-carboxylate reductase, putative MAL13P1.284 18 pyrroline carboxylate reductase
TGME49_036510 3.25 hypothetical protein PF11_0467 31 conserved Plasmodium protein, unknown function
TGME49_036580 5.69 Prp31-15.5k-U4 Snrna Complex family protein PF11_0250 11 splicing factor, putative
TGME49_037000 7.32 hypothetical protein, conserved PF11_0287 42 CRAL/TRIO domain-containing protein, putative
TGME49_037020 5.49 exonuclease domain-containing protein PF13_0208 15 exoribonuclease, putative
TGME49_037110 8.14 replication factor C small subunit, putative PFB0840w 29 replication factor C, subunit 2, putative
TGME49_037220 8.14 DNA replication licensing factor, putative PF07_0023 32 minchromosome maintenance (MCM) complex subunit, putative (MCM7)
TGME49_037250 0.81 hypothetical protein PF13_0082 31 cop-coated vesicle membrane protein p24 precursor, putative
TGME49_037280 4.07 TLD domain-containing protein PF14_0647 38 rab GTPase activator, putative
TGME49_037460 6.51 hypothetical protein PF14_0498 27 DER1-like protein (Der1-1)
TGME49_037470 7.73 aminomethyltransferase, mitochondrial, putative PF13_0345 22 glycine cleavage T protein, putative (GCVT)
TGME49_038170 3.05 hypothetical protein PF10_0037 39 conserved Plasmodium protein, unknown function
TGME49_038240 5.49 bystin, putative PF11_0105 7 U3/U14 snoRNA-associated small subunit rRNA processing protein, putative
TGME49_038940 7.93 GDP mannose 4,6-dehydratase, putative PF08_0077 40 GDP-mannose 4,6-dehydratase, putative
TGME49_038950 8.34 fatty acyl-CoA desaturase, putative PFE0555w 34 stearoyl-CoA delta 9 desaturase, putative
TGME49_039250 6.10 diacylglycerol kinase, putative PFI1485c 39 diacylglycerol kinase, putative (DGK1)
TGME49_039310 6.31 ribose 5-phosphate isomerase, putative PFE0730c 11 ribose 5-phosphate epimerase, putative
TGME49_039420 12.00 protein kinase PF11_0060 41 calcium/calmodulin-dependent protein kinase, putative
TGME49_039750 0.81 hypothetical protein PFC0435w 34 parasite-infected erythrocyte surface protein (PIESP1)
TGME49_039790 5.49 pescadillo family protein PF11_0090 12 pescadillo-like protein (PES)
TGME49_039800 3.25 hypothetical protein PFD0860w 36 conserved Plasmodium protein, unknown function
TGME49_040210 7.93 phosphate transporter, putative MAL13P1.206 42 sodium-dependent phosphate transporter (PiT)
TGME49_040250 3.25 macro domain-containing protein PF14_0466 24 Appr-1-p processing domain protein
TGME49_040380 9.56 hypothetical protein PF13_0079 37 conserved Plasmodium protein, unknown function
TGME49_040450 6.31 maf-like protein, putative PFI0310w 9 Maf-like protein, putative
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TGME49_040590 5.90 DNA-directed RNA polymerases I, II, and III subunit RPABC1, putative PF13_0341 11 DNA-directed RNA polymerase 2, putative
TGME49_040600 7.93 TCP-1/cpn60 chaperonin family protein, putative PFL1545c 16 60 kDa chaperonin (CPN60)
TGME49_040630 1.83 ULK kinase PF14_0476 1 serine/threonine protein kinase, putative
TGME49_040670 4.88 ferredoxin, putative PFL0705c 11 adrenodoxin-type ferredoxin, putative
TGME49_040890 6.10 phosphofructokinase, putative PFI0755c 11 6-phosphofructokinase (PFK9)
TGME49_041000 9.97 hypothetical protein PF14_0572 38 conserved Plasmodium membrane protein, unknown function
TGME49_042460 5.08 mitochondrial carrier domain-containing protein PFL2000w 11 mitochondrial carrier protein, putative
TGME49_042680 5.90 ribosomal protein RPL24e (RPL24E) PFE0300c 11 60S ribosomal subunit protein L24-2, putative
TGME49_042730 6.10 guanylate kinase, putative PFI1420w 18 guanylate kinase (GK)
TGME49_042800 5.69 TGF-beta-inducible nuclear protein 1, putative MAL7P1.24 13 large ribosomal subunit processing protein, putative
TGME49_043240 5.08 G-protein beta-subunit, putative PFE1310c 10 nucleolar Jumonji domain interacting protein, putative
TGME49_043510 6.71 OTU-like cysteine protease domain-containing protein PF11_0428 20 conserved Plasmodium protein, unknown function
TGME49_043530 6.10 PPR repeat-containing protein PFL1605w 24 pentatricopeptide repeat protein, putative
TGME49_043590 6.31 endonuclease/exonuclease/phosphatase domain-containing protein PFC0850c 23 endonuclease/exonuclease/phosphatase family protein, putative
TGME49_043710 7.53 TCP-1/cpn60 family chaperonin, putative PFC0285c 12 T-complex protein beta subunit, putative
TGME49_043730 2.85 p36 protein MAL7P1.114 30 P36-like protein homologue, putative
TGME49_043920 8.14 DNA replication licensing factor, putative PFL0580w 33 minchromosome maintenance (MCM) complex subunit, putative (MCM5)
TGME49_043930 12.00 hypothetical protein PF08_0008 42 GPI-anchored micronemal antigen (GAMA)
TGME49_043950 7.12 prohibitin, putative PF08_0006 20 prohibitin, putative
TGME49_044000 5.08 DEAD/DEAH box helicase, putative PF14_0183 44 signal recognition particle RNA
TGME49_044310 5.90 developmentally regulated GTP-binding protein 1, putative PFE1215c 7 cytosolic preribosomal GTP-binding protein, putative
TGME49_044420 5.69 hypothetical protein PFA0475c 11 conserved protein, unknown function
TGME49_044880 5.29 DNA-directed RNA polymerase I largest subunit, putative PFE0465c 12 RNA polymerase I (RNAPI)
TGME49_045570 7.73 origin recognition complex subunit 2, putative MAL7P1.21 36 origin recognition complex subunit 2, putative (ORC2)
TGME49_046060 5.49 DNA-dependent RNA polymerase, putative PF11_0264 20 DNA-dependent RNA polymerase
TGME49_046190 2.24 hypothetical protein, conserved PFB0145c 44 conserved Plasmodium protein, unknown function
TGME49_046550 3.46 eukaryotic aspartyl protease, putative PF14_0281 38 plasmepsin IX
TGME49_046770 7.93 hypothetical protein PF11_0091 39 transcription factor with AP2 domain(s) (ApiAP2)
TGME49_046920 6.51 glutathione reductase, putative PF14_0192 22 glutathione reductase (GR)
TGME49_047320 12.00 hypothetical protein PFE0955w 21 conserved Plasmodium protein, unknown function
TGME49_047370 2.03 hypothetical protein PF13_0078 37 conserved Plasmodium membrane protein, unknown function
TGME49_047470 5.49 nucleolar protein 5A, putative PF11_0191 12 box C/D snoRNP rRNA 2'-O-methylation factor, putative
TGME49_047550 6.10 heat shock protein 60 PF10_0153 21 heat shock protein 60 (HSP60)
TGME49_047670 5.90 ribulose-phosphate 3-epimerase PFL0960w 31 D-ribulose-5-phosphate 3-epimerase, putative
TGME49_048200 5.90 dimethyladenosine transferase, putative PF14_0156 11 small subunit rRNA dimethylase, putative
TGME49_048310 1.02 SNF7 protein, putative PFL2090c 36 endosome sorting protein (SNF7 homologue), putative
TGME49_048670 2.85 H+-translocating inorganic pyrophosphatase TVP, putative PF14_0541 8 V-type H( )-translocating pyrophosphatase, putative
TGME49_048850 6.31 methionine aminopeptidase, putative PF10_0150 11 methionine aminopeptidase 1b, putative (MetAP1b)
TGME49_048950 1.02 mitochondrial carrier domain-containing protein PF13_0359 27 mitochondrial carrier protein, putative
TGME49_048960 6.10 hypothetical protein PF10_0274 12 methyltransferase, putative
TGME49_049010 5.69 hypothetical protein PFI0815c 6 methyltransferase, putative
TGME49_049030 11.80 endonuclease/exonuclease/phosphatase domain-containing protein PFL1870c 36 sphingomyelin phosphodiesterase, putative
TGME49_049180 7.73 bifunctional dihydrofolate reductase / thymidylate synthase PFD0830w 34 bifunctional dihydrofolate reductase-thymidylate synthase (DHFR-TS)
TGME49_049270 8.54 thioredoxin, putative PF11_0352 32 protein disulfide isomerase (PDI-11)
TGME49_049320 5.49 NADPH-dependent oxidoreductase, putative PF14_0478 9 DNA polymerase delta interacting protein, putative
TGME49_049380 1.02 zinc finger DHHC domain-containing protein PF11_0217 34 zinc finger, DHHC-type, putative
TGME49_049480 3.05 TPR domain-containing protein PF14_0196 41 tetratricopeptide repeat family protein, putative
TGME49_049650 6.51 apolipoprotein A-I binding protein, putative PF14_0570 25 pyridoxal 5'-phosphate synthase, putative
TGME49_049690 6.92 hypothetical protein PFA0405w 26 conserved Plasmodium protein, unknown function
TGME49_049850 2.85 hypothetical protein, conserved PFE0785c 37 glideosome-associated protein 40, putative (GAP40)
TGME49_049910 5.69
mitochondria-associated granulocyte macrophage CSF signaling 
molecule, putative PFE0670w 12 mitochondrial matrix protein, putative
TGME49_049920 6.10 diphthine synthase, putative PF10_0087 11 diphthine synthase
TGME49_049950 5.49 MAK16 protein, putative PFB0175c 11 nucleolar preribosomal assembly protein, putative
TGME49_049970 5.69 hypothetical protein PFD0705c 37 conserved protein, unknown function
TGME49_050010 8.34 hypothetical protein, conserved PFL0730w 18 conserved Plasmodium protein, unknown function
TGME49_050340 1.83 caltractin, putative PF14_0443 37 centrin-2 (CEN2)
TGME49_050770 6.92 eukaryotic translation initiation factor 4A PF14_0655 13 eukaryotic initiation factor 4A (eIF4A)
TGME49_050870 4.47 zinc finger DHHC domain-containing protein PFE1415w 40 cell cycle regulator with zn-finger domain, putative
TGME49_050890 6.10 3'-5' exonuclease domain-containing protein PFA0290w 26 DNA binding protein, putative
TGME49_051480 5.29 ATP-dependent RNA helicase, putative MAL7P1.113 11 DEAD/DEAH box ATP-dependent RNA helicase, putative
TGME49_051500 6.71 eukaryotic translation initiation factor 3 subunit 3, putative PF14_0191 12 conserved Plasmodium protein, unknown function
TGME49_051600 5.49 RNA processing factor, putative PFI1070c 10 nucleolar preribosomal assembly protein, putative
TGME49_051680 6.92 translationally-controlled tumor protein, putative PFE0545c 11 translationally controlled tumor protein homolog, putative
TGME49_051760 6.31 subunit of proteaseome activator complex, putative PFI0370c 11 subunit of proteaseome activator complex, putative
TGME49_051840 5.29 hypothetical protein PF08_0082 37 conserved Plasmodium protein, unknown function
TGME49_051850 4.07 serine/threonine protein phosphatase 5, putative PF14_0224 40 serine/threonine protein phosphatase (PP7)
TGME49_052220 5.69 Hsc70/Hsp90-organizing protein, putative PF14_0324 20 Hsp70/Hsp90 organizing protein (HOP)
TGME49_052290 7.32 importin alpha, putative PF08_0087 21 karyopherin alpha (KARalpha)
TGME49_052320 6.10 nuclear DNA-binding protein, putative PF14_0432 3 conserved Plasmodium protein, unknown function
TGME49_052420 4.88 hypothetical protein, conserved PF08_0092 48 histone-arginine methyltransferase, putative (CARM1)
TGME49_052430 3.46 hypothetical protein, conserved PFI0540w 42 conserved Plasmodium protein, unknown function
TGME49_052490 1.63 vacuolar protein sorting 29, putative PF14_0064 32 phosphatase, putative
TGME49_053290 7.73 valyl-tRNA synthetase, putative PF14_0589 11 valine-tRNA ligase, putative
TGME49_053320 5.69 hypothetical protein, conserved PF08_0029 22 conserved Plasmodium protein, unknown function
TGME49_053430 12.00 asparagine synthetase, putative PFC0395w 10 asparagine synthetase, putative
TGME49_053780 6.51 GTP cyclohydrolase I, putative PFL1155w 25 GTP cyclohydrolase I (GTP-CH)
TGME49_053890 12.00 peptidase M16 inactive domain-containing protein PF14_0382 21 stromal-processing peptidase, putative (SPP)
TGME49_053900 6.71 delta-aminolevulinic acid dehydratase, putative PF14_0381 22 delta-aminolevulinic acid dehydratase (ALAD)
TGME49_053950 5.69 XAP5 protein, putative PFE1530c 12 XAP-5 DNA binding protein, putative
TGME49_054260 5.69 hypothetical protein PFL0090c 27 cytochrome c oxidase assembly protein, putative
TGME49_054510 5.49 hypothetical protein, conserved PF11_0439 11 conserved protein, unknown function
TGME49_054580 7.73 UDP-galactose transporter protein, putative PF11_0141 33 UDP-galactose transporter, putative
TGME49_054730 5.29 hypothetical protein, conserved MAL7P1.28 12 rRNA/tRNA ribonuclease MRP/P subunit, putative
TGME49_054770 6.10 serine/threonine protein phosphatase, putative PF14_0660 42 protein phosphatase, putative
TGME49_054930 1.42 hypothetical protein, conserved PF14_0440 45 conserved Plasmodium membrane protein, unknown function
TGME49_055250 5.90 NOL1/NOP2/sun family domain-containing protein PF07_0015 14 tRNA m5C-methyltransferase, putative
TGME49_055260 12.00 apical membrane antigen 1, putative PF11_0344 42 apical membrane antigen 1 (AMA1)
TGME49_055320 5.90 hypothetical protein, conserved MAL13P1.341 11 ribosome biogenesis protein MRT4, putative
TGME49_055330 6.31 hypothetical protein MAL7P1.14 11 conserved Plasmodium protein, unknown function
TGME49_056990 6.51 glycyl-tRNA synthetase, putative PF14_0198 12 glycyl-tRNA synthetase,glycine--tRNA ligase (GlyRS)
TGME49_057070 3.66 major ampullate spidroin 2 PF08_0083 45 conserved Plasmodium protein, unknown function
TGME49_057110 6.71 hypothetical protein PF14_0396 25 conserved Plasmodium protein, unknown function
TGME49_057470 3.25 myosin IJ heavy chain, putative PFL1435c 40 myosin D (MyoD)
TGME49_057680 3.46 myosin light chain TgMLC1 PFL2225w 43 myosin light chain 1,myosin A tail domain interacting protein (MTIP)
TGME49_057710 7.93 actin-like family protein ARP6, putative PF07_0077 11 actin-like protein, putative
TGME49_057740 8.14 UMP-CMP kinase PFA0555c 36 UMP-CMP kinase, putative
TGME49_057770 7.93 SET domain-containing protein MAL13P1.122 1 SET domain protein, putative (SET2)
TGME49_057800 5.29 hypothetical protein, conserved PFL1585c 20 nucleotidyltransferase, putative
TGME49_058030 8.14 DNA polymerase delta catalytic subunit, putative PF10_0165 29 DNA polymerase delta catalytic subunit
TGME49_058210 5.08 DNA-directed RNA polymerase II RPB2 PFB0715w 11 DNA-directed RNA polymerase II second largest subunit, putative
	   128	  
 
 
 
 
TGME49_058410 3.66 hypothetical protein PFA0440w 42 photosensitized INA-labeled protein 1, PhIL1, putative
TGME49_058560 5.90 hypothetical protein MAL8P1.55 27 conserved Plasmodium protein, unknown function
TGME49_058680 3.66 TATA-box binding protein, putative PFE0305w 6 transcription initiation factor TFiid, TATA-binding protein (TBP)
TGME49_058700 2.85 hypothetical protein PFI0785c 39 sugar transporter, putative
TGME49_058780 2.24 OTU family cysteine protease PFI1135c 24 OTU-like cysteine protease, putative
TGME49_059220 5.49 ATP-dependent nucleolar RNA helicase, putative PFL2010c 11 DEAD/DEAH box ATP-dependent RNA helicase, putative
TGME49_059250 7.53 ATP-dependent DNA helicase, putative PFI0910w 24 DNA helicase, putative
TGME49_059260 7.93 cell division protein, putative PFL1925w 26 cell division protein FtsH, putative
TGME49_059550 8.14 hydroxymethyldihydropterin pyrophosphokinase-dihydropteroate synthase PF08_0095 22 dihydropteroate synthetase (DHPS)
TGME49_059570 6.51 tRNA-specific adenosine deaminase, putative PF13_0259 10 cytidine and deoxycytidylate deaminase, putative
TGME49_059670 3.46 von Willebrand factor type A domain-containing protein PFC0640w 1 circumsporozoite- and TRAP-related protein (CTRP)
TGME49_059690 6.10 orotidine-monophosphate-decarboxylase, putative PF10_0225 11 orotidine monophosphate decarboxylase (OMPDC)
TGME49_059720 1.02 hypothetical protein, conserved PF11_0054 29 conserved Plasmodium protein, unknown function
TGME49_060160 4.88 hypothetical protein PF10_0197 11 methyltransferase, putative
TGME49_060180 8.34 hypothetical protein, conserved PFA0370w 29 conserved Plasmodium protein, unknown function
TGME49_060320 5.69 hypothetical protein, conserved PF13_0219 11 conserved Plasmodium protein, unknown function
TGME49_060440 6.31 46 kDa FK506-binding nuclear protein, putative MAL8P1.95 17 conserved Plasmodium protein, unknown function
TGME49_060500 2.03 hypothetical protein, conserved PF14_0091 40 conserved Plasmodium membrane protein, unknown function
TGME49_060550 3.86 acetlytransferase, GNAT family domain containing protein PF08_0102 11 asparagine-rich antigen Pfa55-14 (pfa55-14)
TGME49_060610 5.69 hypothetical protein PFE1115c 11 S-adenosylmethionine-dependent methyltransferase, putative
TGME49_060820 2.03 hypothetical protein PF10_0107 30 conserved protein, unknown function
TGME49_060990 6.31 hypothetical protein PFL0710w 24 conserved Plasmodium protein, unknown function
TGME49_061050 5.29 mitotic control protein dis3, putative MAL13P1.289 12 mitotic control protein dis3 homologue, putative (RRP44)
TGME49_061060 5.08 putative diphthamide synthesis domain-containing protein PF14_0136 6 diphthamide synthesis protein, putative
TGME49_061070 7.93 hypothetical protein PFE0410w 21 triose phosphate transporter (oTPT)
TGME49_061440 3.86 armadillo/beta-catenin-like repeat-containing protein PFD0720w 42 conserved ARM repeats protein, unknown function
TGME49_061460 8.14 structure specific recognition protein I, putative PF14_0393 25 FACT complex subunit SSRP1, putative (FACT-S)
TGME49_061480 7.53 phosphatidylserine synthase, putative MAL13P1.335 11 phosphatidylserine synthase I, putative
TGME49_061540 5.69 DNA-directed RNA polymerases I and III subunit RPAC2, putative PF14_0150 11 DNA-directed RNA polymerase I/III subunit, putative
TGME49_061600 6.71 X-prolyl aminopeptidase, putative PF14_0517 18 aminopeptidase P (APP)
TGME49_061610 7.73 hypothetical protein PF14_0470 11 DNA replication related protein, putative
TGME49_061680 8.14 hypothetical protein PFE0155w 34 conserved Plasmodium protein, unknown function
TGME49_061950 7.73 ATP synthase beta chain, putative PFL1725w 30 ATP synthase subunit beta, mitochondrial
TGME49_062040 6.10 eukaryotic translation initiation factor 3 subunit 11, putative PFC0441c 9 SAC3/GNAP family-related protein, putative
TGME49_062150 3.05 kelch motif domain-containing protein PF13_0238 48 kelch protein, putative
TGME49_062380 6.51 elongation factor Tu, putative MAL13P1.164 29 elongation factor Tu, putative
TGME49_062430 8.34 4-hydroxy-3-methylbut-2-en-1-yl diphosphate synthase, putative PF10_0221 29 4-hydroxy-3-methylbut-2-en-1-yl diphosphate synthase (GcpE)
TGME49_062480 3.46 dynein light chain roadblock-type 2, putative PF10_0195 1 kinesin, putative
TGME49_062490 3.66 hypothetical protein MAL8P1.138 32 alpha/beta hydrolase, putative
TGME49_062620 7.12 Gbp1p protein, putative PF10_0068 11 RNA binding protein, putative
TGME49_062860 3.46 ADP-ribosylation factor domain-containing protein PF10_0337 36 ADP-ribosylation factor, putative
TGME49_062910 7.53 NADH-cytochrome B5 reductase, putative PF13_0353 33 NADH-cytochrome b5 reductase, putative
TGME49_063420 6.71 ubiquitin carboxyl-terminal hydrolase, putative PFE0835w 8 ubiquitin carboxyl-terminal hydrolase 2, putative
TGME49_063500 0.81 vacuolar protein sorting 26, putative PFL2415w 30 Hbeta58/Vps26 protein homolog, putative
TGME49_063530 6.31 chaperonin CPN10, mitochondrial, putative PFL0740c 21 10 kDa chaperonin (CPN10)
TGME49_063670 5.69 ribosomal RNA methyltransferase, putative PFI0415c 6 ribosomal RNA methyltransferase, putative
TGME49_064020 12.00 hypothetical protein PF11_0254 12 conserved Plasmodium protein, unknown function
TGME49_064080 8.14 acyl carrier protein PFB0385w 34 acyl carrier protein (ACP)
TGME49_064130 5.90 hypothetical protein PFL2235w 12 conserved Plasmodium protein, unknown function
TGME49_064640 10.78 bromodomain domain-containing protein PFL0635c 48 bromodomain protein, putative
TGME49_064710 6.31 hypothetical protein PFE0275w 25 conserved Plasmodium protein, unknown function
TGME49_064760 0.81 Oxysterol-binding protein PF11_0327 19 oxysterol-binding protein-related protein 2
TGME49_064780 7.53 UDP-N-acetylhexosamine pyrophosphorylase, putative MAL13P1.218 25 UDP-N-acetylglucosamine pyrophosphorylase, putative
TGME49_064990 3.25 hypothetical protein, conserved PF14_0333 37 conserved Plasmodium protein, unknown function
TGME49_065110 5.69 hypothetical protein PF14_0494 11 small subunit rRNA processing factor, putative
TGME49_065220 6.10 co-chaperone GrpE, putative PF11_0258 19 co-chaperone GrpE, putative
TGME49_065250 5.08 alpha-1 type II collagen, putative PF11_0111 6 asparagine-rich antigen
TGME49_065320 3.46 hypothetical protein PFE0750c 12 RNA recognition motif, putative
TGME49_065420 2.03 hypothetical protein PFI0705w 36 conserved Plasmodium protein, unknown function
TGME49_065790 3.66 hypothetical protein, conserved PF10_0295 41 conserved Plasmodium protein, unknown function
TGME49_066090 3.46 hypothetical protein PF14_0682 1 conserved Plasmodium membrane protein, unknown function
TGME49_066120 2.44 glutathione/thioredoxin peroxidase, putative PFL0595c 34 glutathione peroxidase (Trx-G1)
TGME49_066400 12.00 hypothetical protein PF13_0352 11 conserved Plasmodium protein, unknown function
TGME49_066420 9.97 hypothetical protein PF11_0528 37 conserved Plasmodium protein, unknown function
TGME49_066630 3.25 hypothetical protein, conserved PF07_0096 11 conserved Plasmodium protein, unknown function
TGME49_066730 7.12 leucyl-tRNA synthetase, putative PF08_0011 23 leucine-tRNA ligase, putative
TGME49_066800 5.90 integral membrane protein, putative PFL1140w 28 integral membrane protein, putative
TGME49_066880 5.08 dihydrouridine synthase domain-containing protein PFI0920c 7 dihydrouridine synthase, putative
TGME49_066930 5.08 hypothetical protein PF13_0279 29 transcription initiation factor TFIIH, putative
TGME49_067390 5.90 DNA-directed RNA polymerases I and III subunit RPAC1, putative PF11_0445 11 DNA-directed RNA polymerase I, putative
TGME49_067480 5.29 N2,N2-dimethylguanosine tRNA methyltransferase, putative PF13_0109 10 N2,N2-dimethylguanosine tRNA methyltransferase, putative
TGME49_068010 0.00 protein kinase, PfEST homolog MAL7P1.91 28 exported serine/threonine protein kinase (EST)
TGME49_068210 3.25 AGC kinase PF11_0227 34 serine/threonine protein kinase, putative
TGME49_068290 5.90 RNA helicase, putative PF13_0037 20 DEAD box helicase, putative
TGME49_068590 3.86 rhomboid-like protease 4 PFE0340c 37 rhomboid protease ROM4 (ROM4)
TGME49_068600 7.73 DNA polymerase alpha subunit, putative PF14_0602 26 DNA polymerase alpha subunit, putative
TGME49_068630 5.90 uncharacterized ACR, YagE family COG1723 domain-containing protein MAL8P1.63 18 conserved protein, unknown function
TGME49_068640 5.69 WD domain, G-beta repeat-containing protein PF07_0092 11 nucleolar rRNA processing protein, putative
TGME49_068690 6.31 hypothetical protein PF13_0265 37 conserved Plasmodium protein, unknown function
TGME49_068710 5.49 elongation factor Tu GTP-binding domain-containing protein MAL13P1.243 10 elongation factor Tu, putative
TGME49_068840 5.49 mRNA (2'-O-methyladenosine-N(6)-)-methyltransferase, putative PFL1715w 11 mRNA methyltransferase, putative
TGME49_068850 7.53 enolase 2 PF10_0155 21 enolase (ENO)
TGME49_068910 6.71 mitochondrial inner membrane protease, putative PF13_0118 24 type I signal peptidase (SPB)
TGME49_069140 0.81 transport protein particle component Bet3 domain-containing protein PF14_0358 4 41-2 protein antigen precursor,transport protein particle (TRAPP) component, Bet3
TGME49_069310 2.03 D13, putative PF14_0652 42 zinc finger protein, putative (D13)
TGME49_069330 9.97 hypothetical protein PFE0650c 37 conserved Plasmodium protein, unknown function
TGME49_069410 6.10 hypothetical protein PFL2265c 11 conserved Plasmodium protein, unknown function
TGME49_069650 7.73 hypothetical protein PF14_0717 27 trailer hitch homolog, putative (CITH)
TGME49_069730 9.97 protein kinase PF11_0464 37 serine/threonine protein kinase, putative
TGME49_069770 5.69 WD-repeat membrane protein, putative PF13_0309 11 U3 snoRNA-associated small subunit rRNA processing protein, putative
TGME49_069800 5.49 glutamine-dependent NAD(+) synthetase protein, putative PFI1310w 29 NAD synthase, putative
TGME49_070310 1.02 hypothetical protein, conserved PFL0415w 23 mitochondrial ACP precursor, putative
TGME49_070510 8.14 asparaginyl-tRNA synthetase, putative PFB0525w 24 asparagine-tRNA ligase, putative
TGME49_070650 5.90 deoxyribose-phosphate aldolase PF10_0210 11 deoxyribose-phosphate aldolase, putative
TGME49_070760 7.53 hypothetical protein PF13_0137 12 conserved Plasmodium protein, unknown function
TGME49_070860 3.46 adenylate cyclase, putative MAL8P1.150 38 adenylyl cyclase beta, putative (ACbeta)
TGME49_070880 5.08 RNA binding motif-containing protein PFD0775c 31 RNA binding protein, putative
TGME49_070960 5.69 hypothetical protein PF10_0054 16 conserved protein, unknown function
TGME49_071100 5.29 hypothetical protein PFL0355c 5 small subunit rRNA processing factor, putative
TGME49_071280 5.90 60S ribosome subunit biogenesis protein NIP7, putative PF14_0635 11 large ribosomal subunit assembling protein, putative
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TGME49_071300 6.31 DNA-directed RNA polymerase II subunit RPB7, putative PF10_0269 11 DNA-directed RNA polymerase II, putative
TGME49_071350 5.90 folylpolyglutamate synthase, putative PF13_0140 30 dihydrofolate synthase/folylpolyglutamate synthase (DHFS-FPGS)
TGME49_071780 1.42 hypothetical protein PF11_0158 36 conserved Plasmodium protein, unknown function
TGME49_071810 7.93 inhibitor-1 of protein phosphatase type 2A PF14_0257 25 conserved protein, unknown function
TGME49_071970 2.85 hypothetical protein PF14_0065 38 glideosome associated protein with multiple membrane spans 3 (GAPM3)
TGME49_072010 5.69 nucleolar protein family A, putative PF13_0051 10 small nucleolar ribonucleoprotein, putative
TGME49_072210 0.41 hypothetical protein MAL13P1.255 26 N6-adenine-specific methylase, putative
TGME49_072270 5.08 radical SAM domain-containing protein PFE1240w 18 tRNA-YW synthesizing protein, putative
TGME49_072290 7.93 pyruvate dehydrogenase complex subunit PD-HE1Beta (PDHE1B) PF14_0441 28 pyruvate dehydrogenase E1 beta subunit (pdhB)
TGME49_072490 5.49 protoporphyrinogen oxidase, putative PF10_0275 14 protoporphyrinogen oxidase
TGME49_072610 3.05 hypothetical protein PFL2220w 7 conserved Plasmodium protein, unknown function
TGME49_072710 4.68 hypothetical4protein PFD0985w 43 transcription factor with AP2 domain(s) (ApiAP2)
TGME49_072740 5.49 DNA-directed RNA polymerase III subunit, putative PFL0330c 11 DNA-directed RNA polymerase III subunit, putative
TGME49_072770 11.59 hypothetical protein PFB0655c 12 conserved Plasmodium protein, unknown function
TGME49_072910 7.93 TCP-1/cpn60 family chaperonin, putative MAL13P1.283 13 TCP-1/cpn60 chaperonin family, putative
TGME49_073520 6.71 proteasome PCI domain-containing protein PFE1405c 6 eukaryotic translation initiation factor 3, subunit 6, putative
TGME49_073960 6.51 10 kDa chaperonin, putative PF13_0180 22 20 kDa chaperonin (CPN20)
TGME49_074160 1.22 hypothetical protein PF14_0472 37 conserved Plasmodium protein, unknown function
TGME49_074190 6.31 eukaryotic initiation factor 2B epsilon subunit, putative PFL0675c 47 conserved Plasmodium protein, unknown function
TGME49_075670 9.97 hypothetical protein, conserved MAL13P1.260 42 alveolin, putative (ALV6)
TGME49_075690 7.93 chaperone clpB 1 protein, putative PF08_0063 23 ClpB protein, putative (ClpB1)
TGME49_075830 5.29 3'-5' exonuclease domain-containing protein MAL13P1.311 28 exonuclease, putative
TGME49_076110 8.75 cytochrome b5 family heme/steroid binding domain-containing protein PFL1555w 28 cytochrome b5, putative
TGME49_076130 9.97 cathepsin C2 (TgCPC2) PFD0230c 39 dipeptidyl peptidase 3 (DPAP3)
TGME49_076930 5.69 hypothetical protein PF07_0127 42 conserved Plasmodium protein, unknown function
TGME49_077090 5.08 mitochondrial carrier domain-containing protein PFI0255c 6 mitochondrial carrier protein, putative
TGME49_077560 8.14 hypothetical protein PF11_0233 37 conserved Plasmodium protein, unknown function
TGME49_077870 12.00 hypothetical protein, conserved PFE1410c 1 conserved Plasmodium protein, unknown function
TGME49_077890 2.24 hypothetical protein, conserved PFA0220w 45 ubiquitin carboxyl-terminal hydrolase, putative
TGME49_077970 2.03 dolichol-phosphate mannosyltransferase, putative PF11_0427 29 dolichol phosphate mannose synthase (DPM1)
TGME49_078050 8.54 proteasome subunit alpha type 1, putative PF14_0716 31 proteosome subunit alpha type 1, putative
TGME49_078170 6.51 hypothetical protein MAL8P1.56 34 conserved Plasmodium membrane protein, unknown function
TGME49_078530 6.10 multiprotein bridging factor type 1, putative PF11_0293 11 multiprotein bridging factor type 1, putative
TGME49_078550 5.29 elongation factor Tu GTP-binding domain-containing protein PF08_0018 23 translation initiation factor IF-2, putative
TGME49_078900 5.69 protein kinase, BUD32 homolog MAL7P1.26 18 O-sialoglycoprotein endopeptidase, putative
TGME49_078930 2.85 Tubulin-tyrosine ligase family protein PFE0700c 1 tubulin-tyrosine ligase, putative (TTL)
TGME49_078970 1.22 ICE-like protease (caspase) p20 domain-containing protein PF14_0160 33 metacaspase-like protein (MCA3)
TGME49_079330 5.69 ATP-dependent RNA helicase, putative PFB0860c 11 DEAD/DEAH box ATP-dependent RNA helicase, putative
TGME49_079390 6.31 proliferation-associated protein 2G4, putative PF14_0261 11 proliferation-associated protein 2g4, putative
TGME49_080370 12.00 KH domain containing protein MAL13P1.295 22 conserved Plasmodium protein, unknown function
TGME49_080560 7.73 selenophosphate synthetase, putative PFI0505c 25 selenide water dikinase, putative
TGME49_080700 3.66 lysine decarboxylase, putative PFD0285c 18 lysine decarboxylase, putative
TGME49_080770 9.76 regulator of chromosome condensation domain-containing protein PFI0975c 37 regulator of chromosome condensation, putative
TGME49_081430 1.42 protein kinase, PfPK7 homolog PFB0605w 25 protein kinase 7 (PK7)
TGME49_081550 12.00 hypothetical protein, conserved PFI0625c 10 tRNA 1-methyladenosine methyltransferase subunit, putative
TGME49_083710 8.14 longevity-assurance (LAG1) domain-containing protein PFE0405c 30 longevity-assurance (LAG1) domain protein, putative
TGME49_083830 6.92 soluble inorganic pyrophosphatase PFC0710w 30 inorganic pyrophosphatase, putative
TGME49_083880 5.49 RNA binding motif-containing protein PF10_0194 11 large subunit rRNA processing RRM protein, putative
TGME49_084010 7.93 5'-3' exonuclease, N-terminal resolvase family domain-containing protein PFB0180w 22 5'-3' exonuclease, N-terminal resolvase-like domain, putative
TGME49_084540 7.53 ATP synthase subunit O, putative MAL13P1.47 24 mitochondrial ATP synthase delta subunit, putative (OSCP)
TGME49_084580 5.08 ribose-phosphate pyrophosphokinase, putative PF13_0157 10 ribose-phosphate pyrophosphokinase, putative
TGME49_085240 2.24 trans-2,3-enoyl-CoA reductase, putative PF11_0370 35 3-oxo-5-alpha-steroid 4-dehydrogenase, putative
TGME49_085670 1.63 hypothetical protein PF13_0260 35 conserved Plasmodium membrane protein, unknown function
TGME49_085720 5.90 XPA-binding protein, putative PFL0075w 11 XPA binding protein 1, putative
TGME49_085800 12.00 hypothetical protein, conserved PFB0435c 36 transporter, putative
TGME49_085840 7.53 hypothetical protein PF14_0673 20 RAP protein, putative
TGME49_085950 5.08 hypothetical protein PF14_0307 11 conserved protein, unknown function
TGME49_085970 5.69 hypothetical protein, conserved MAL7P1.66 28 mitochondrial ribosomal protein S5 precursor, putative
TGME49_086210 7.53 serine/threonine protein phosphatase, putative PFI1360c 34 serine/threonine protein phosphatase, putative
TGME49_086610 6.92 30S ribosomal protein S14, putative PF11_0386 33 apicoplast ribosomal protein S14p/S29e precursor, putative
TGME49_086620 5.29 30S ribosomal protein S1, putative MAL8P1.101 30 RNA binding protein, putative
TGME49_086630 8.14 redoxin domain-containing protein MAL7P1.159 27 1-cys peroxiredoxin (AOP)
TGME49_086640 6.31 GTPase PF14_0339 45 GTPase, putative
TGME49_086750 8.75 MA3 domain protein PF14_0546 11 conserved Plasmodium protein, unknown function
TGME49_087270 7.32 hypothetical protein PFL0600w 28 peripheral plastid protein 1, putative (PPP1)
TGME49_087500 7.73 TCP-1/cpn60 family chaperonin, putative PFB0635w 17 T-complex protein 1, putative
TGME49_088360 7.12 tryptophanyl-tRNA synthetase, putative PF13_0205 12 tryptophan--tRNA ligase, putative
TGME49_088530 5.49 NOL1/NOP2/sun family domain-containing protein PF11_0305 11 RNA methyltransferase, putative
TGME49_088680 5.49 endonuclease V, putative PF13_0176 34 apurinic/apyrimidinic endonuclease Apn1, putative (APN1)
TGME49_088700 8.75 chromosome segregation protein smc1, putative PF11_0317 28 structural maintenance of chromosome protein, putative
TGME49_088910 7.12 hypothetical protein, conserved MAL13P1.257 9 conserved Plasmodium protein, unknown function
TGME49_088990 6.31 hypothetical protein, conserved PF13_0054 24 conserved Plasmodium protein, unknown function
TGME49_089070 8.14 P-Type cation-transporting ATPase, putative PFE0195w 26 cation transporting P-ATPase (ATPase3)
TGME49_089100 3.46 hypothetical protein, conserved PFI0175w 42 conserved Plasmodium protein, unknown function
TGME49_089550 5.29 hypothetical protein, conserved PFL1820w 11 rRNA processing WD-repeat protein, putative
TGME49_089620 4.27 cathepsin C PF11_0174 15 cathepsin C, homolog,dipeptidyl peptidase 1 (DPAP1)
TGME49_089640 6.10 hypothetical protein PFC0095c 21 conserved Plasmodium protein, unknown function
TGME49_089650 12.00 phosphoenolpyruvate carboxykinase PF13_0234 19 phosphoenolpyruvate carboxykinase (PEPCK)
TGME49_089670 5.90 DNA cross-link repair protein, putative PF14_0711 23 DNA repair metallo-beta-lactamase protein, putative
TGME49_089830 6.10 eukaryotic translation initiation factor 3 delta subunit, putative MAL7P1.81 11 eukaryotic translation initiation factor 3 37.28 kDa subunit, putative
TGME49_089880 3.46 hypothetical protein MAL7P1.29 46 conserved Plasmodium membrane protein, unknown function
TGME49_089900 5.90 N-acetyltransferase 5, putative PFA0465c 11 N-acetyltransferase, putative
TGME49_089910 3.25 hypothetical protein PFL0260c 37 conserved Plasmodium protein, unknown function
TGME49_090040 7.53 macrophage migration inhibitory factor, putative PFL1420w 29 macrophage migration inhibitory factor (MIF)
TGME49_090170 2.44 protein serine/threonine phosphatase, putative / sortilin PF14_0630 35 protein serine/threonine phosphatase
TGME49_090260 6.31 hypothetical protein, conserved MAL13P1.159 27 thioredoxin, putative
TGME49_090290 1.02 ubiquitin-activating enzyme E1 family protein PFL1245w 31 ubiquitin-activating enzyme e1, putative (Uba1)
TGME49_090340 5.69 PBS lyase HEAT-like repeat domain-containing protein PF13_0013 1 deoxyhypusine hydroxylase (DOHH)
TGME49_090640 7.93 DNA mismatch repair protein, putative PFE0270c 30 DNA repair protein, putative
TGME49_090670 7.93 cytosol aminopeptidase PF14_0439 11 M17 leucyl aminopeptidase (LAP)
TGME49_090730 8.54 hypothetical protein, conserved PFC0581w 35 co-chaperone p23 (P23)
TGME49_090870 0.20 patched family domain-containing protein, conserved PFA0375c 45 lipid/sterol:H symporter
TGME49_090920 5.08 2OG-Fe(II) oxygenase family protein MAL8P1.8 36 prolyl 4-hydroxylase alpha subunit 1, putative
TGME49_091020 0.81 IQ calmodulin-binding motif domain-containing protein PFL0975w 35 Cell cycle associated protein, putative
TGME49_091080 6.10 TATA-box binding protein, putative PF14_0267 19 transcription initiation TFIID-like, putative
TGME49_091150 6.92 hypothetical protein PFL0360c 27 conserved Plasmodium protein, unknown function
TGME49_091800 3.05 ADP-ribosylation factor-like protein 1, putative PFI1005w 42 ADP-ribosylation factor, putative
TGME49_091820 6.31 regulator of nonsense transcripts UPF1, putative PF10_0057 30 regulator of nonsense transcripts, putative
TGME49_091870 3.46 hypothetical protein MAL7P1.95 1 conserved Plasmodium protein, unknown function
TGME49_091930 5.49 nucleolar phosphoprotein nucleolin, putative PF11_0083 35 nucleic acid binding protein, putative
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TGME49_092010 6.31 transcription initiation factor IIB, putative PFA0525w 42 transcription initiation factor TFIIB, putative
TGME49_092140 8.75 NEK kinase PFL1370w 32 NIMA related kinase 1 (NEK1)
TGME49_092920 6.31 heat shock protein 90, putative PF11_0188 19 heat shock protein 90, putative
TGME49_093060 1.63 SPRY domain-containing protein PF10_0140 29 conserved protein, unknown function
TGME49_093190 4.27 endonuclease/exonuclease/phosphatase family protein PF11_0122 33 endonuclease/exonuclease/phosphatase family protein, putative
TGME49_093240 2.64 hypothetical protein PF11_0276 19 steryl ester hydrolase, putative
TGME49_093660 6.31 hypothetical protein PF14_0535 23 SNARE protein, putative (SYN3)
TGME49_093690 3.25 profilin family protein PFI1565w 40 profilin, putative (PFN)
TGME49_093720 3.46 hypothetical protein, conserved PFD0915w 29 conserved Plasmodium protein, unknown function
TGME49_093900 3.66 hypothetical protein PFB0570w 42 secreted protein altered thrombospondin repeat protein (SPATR)
TGME49_094010 6.10 yrdC domain protein PFL0175c 10 conserved Plasmodium protein, unknown function
TGME49_094310 6.51 hypothetical protein PFE0600c 22 conserved Plasmodium protein, unknown function
TGME49_094350 7.32 DEAD/DEAH box helicase, putative PFI0165c 12 DEAD/DEAH box helicase, putative
TGME49_094430 5.29 hypothetical protein, conserved PF07_0067 11 large ribosomal subunit assembling factor, putative
TGME49_094620 6.71 eukaryotic translation initiation factor 3 subunit 8, putative PFL0310c 12 eukaryotic translation initiation factor 3 subunit 8, putative
TGME49_094640 8.34 ribonucleoside-diphosphate reductase, large subunit, putative PF14_0352 34 ribonucleoside-diphosphate reductase, large subunit
TGME49_094790 2.64 hypothetical protein PFD0955w 38 apical merozoite protein (Pf34)
TGME49_095010 5.90 ATP-dependent RNA helicase, putative PF13_0177 9 DEAD/DEAH box ATP-dependent RNA helicase, putative
TGME49_095350 6.51 nucleoside diphosphate kinase, putative PF13_0349 28 nucleoside diphosphate kinase (NDK)
TGME49_095680 5.08 periodic tryptophan protein PWP2, putative PF08_0130 12 rRNA processing WD-repeat protein, putative
TGME49_095730 6.10 TPR domain-containing protein PF11_0101 12 conserved Plasmodium protein, unknown function
TGME49_095990 7.93 ubiquitin-conjugating enzyme E2, putative MAL13P1.227 34 ubiquitin conjugating enzyme (UBC)
TGME49_097110 7.73 kinesin motor domain containing protein PFC0770c 29 kinesin-like protein, putative
TGME49_097170 6.92 ribosomal protein L17, putative PF14_0289 27 mitochondrial ribosomal protein L17-2 precursor, putative
TGME49_097420 8.54 beta-tubulin cofactor D, putative PF14_0668 22 conserved Plasmodium protein, unknown function
TGME49_097530 4.88 DNA-directed RNA polymerase I subunit RPA2, putative PF11_0358 11 DNA-directed RNA polymerase 1, subunit 2, putative
TGME49_097800 8.34 structural maintenance of chromosomes protein, putative MAL13P1.96 30 chromosome segregation protein, putative
TGME49_097930 6.92 HesB-like domain containing protein PFE1135w 31 iron-sulfur assembly protein, putative (SufA)
TGME49_097960 9.97 hypothetical protein, conserved PFB0680w 38 rhoptry neck protein 6 (RON6)
TGME49_098010 1.83 hypothetical protein PFI0410c 39 conserved Plasmodium protein, unknown function
TGME49_099070 6.71 pyruvate kinase, putative PF10_0363 21 pyruvate kinase 2 (PyKII)
TGME49_099210 6.10 CTP synthase, putative PF14_0100 11 cytidine triphosphate synthetase
TGME49_100040 2.03 ubiquitin-conjugating enzyme E2, putative PF10_0330 35 ubiquitin conjugating enzyme, putative
TGME49_100100 3.05 rhoptry neck protein 2 PF14_0495 39 rhoptry neck protein 2 (RON2)
TGME49_100200 1.63 histone H2A PFC0920w 39 histone H2A variant, putative (H2A.Z)
TGME49_100260 7.73 threonyl-tRNA synthetase family protein PF11_0270 14 threonyl-tRNA synthetase,Threonine--tRNA ligase (ThrRS)
TGME49_100380 7.73 endoplasmic reticulum oxidoreductin, putative PF11_0251 33 endoplasmic reticulum oxidoreductin, putative
TGME49_101390 5.49 ribosome biogenesis protein BOP1, putative PF14_0055 11 large subunit rRNA processing protein, putative
TGME49_101440 3.66 CAM kinase, CDPK family TgCDPK1 PF07_0072 41 calcium dependent protein kinase 4 (CDPK4)
TGME49_104460 1.83 zinc finger, C3HC4 type (RING finger) domain-containing protein PF14_0215 35 ubiquitin ligase, putative (HRD1)
TGME49_104680 1.42 DNA-damage inducible protein, putative PF14_0090 37 DNA-damage inducible protein, putative
TGME49_104710 5.90 eukaryotic peptide chain release factor subunit, putative PFB0550w 11 peptide chain release factor subunit 1, putative
TGME49_105320 6.10 mRNA capping enzyme, putative PF14_0144 38 RNA guanylyltransferase (Pgt1)
TGME49_105460 5.90 methionine aminopeptidase, type II, putative PF14_0327 6 methionine aminopeptidase 2 (MetAP2)
TGME49_105470 12.00 hypothetical protein PFL0420w 34 amino acid transporter, putative
TGME49_105480 5.29 elongator complex protein 3, putative PFL1345c 14 histone S-adenosyl methyltransferase, putative
TGME49_105490 5.90 programmed cell death protein, putative PFE0515w 11 conserved Plasmodium protein, unknown function
TGME49_105750 5.69 nucleolar GTP-binding protein NOG2, putative PF14_0221 11 GTPase, putative
TGME49_105860 4.27 CAM kinase, CDPK family TgCDPK1_2 (TGTPK4) PFB0815w 40 calcium dependent protein kinase 1 (CDPK1)
TGME49_106290 5.49 DNA-directed RNA polymerase III largest subunit, putative PF13_0150 12 DNA-directed RNA polymerase 3 largest subunit
TGME49_106350 3.05 hypothetical protein PF13_0173 40 conserved Plasmodium protein, unknown function
TGME49_106380 6.51 U1 small nuclear ribonucleoprotein, putative PF08_0084 22 RNA-binding protein (U1 snRNP-like), putative
TGME49_106520 4.88 tRNA pseudouridine synthase B, putative PF10_0175 24 tRNA pseudouridine synthase, putative
TGME49_106630 5.69 tRNA (adenine-N(1)-)-methyltransferase catalytic subunit, putative PF13_0087 12 1-methyladenosine tRNA methyltransferase subunit, putative
TGME49_106650 6.92 hypothetical protein PF13_0246 34 conserved Plasmodium protein, unknown function
TGME49_106930 8.75 proteasome subunit beta type 7, putative PF13_0156 38 proteasome subunit beta type 7 precursor, putative
TGME49_106960 7.12 phenylalanyl-tRNA synthetase beta chain, putative PF11_0051 12 phenylalanyl-tRNA synthetase beta chain, putative
TGME49_106980 1.83 hypothetical protein PF10_0297 10 conserved Plasmodium protein, unknown function
TGME49_107020 2.44 hypothetical protein, conserved PFC0370w 40 conserved Plasmodium protein, unknown function
TGME49_107030 5.90 purine nucleoside phosphorylase PFE0660c 22 purine nucleoside phosphorylase (PNP)
TGME49_107650 6.51 uracil-DNA glycosylase, putative PF14_0148 29 uracil-DNA glycosylase, putative
TGME49_107800 2.03 ectonucleoside triphosphate diphosphohydrolase, putative PF14_0297 22 apyrase, putative
TGME49_108060 1.83 hypothetical protein PF13_0299 36 conserved Plasmodium protein, unknown function
TGME49_108580 5.49 lon protease, putative PF14_0147 19 ATP-dependent protease, putative
TGME49_108920 5.69 U2 small nuclear ribonucleoprotein auxiliary factor U2AF PF07_0066 12 RNA binding protein, putative
TGME49_109120 6.92 60s ribosomal protein L4, putative PFE0350c 11 60S ribosomal protein L4, putative
TGME49_109180 4.27 hypothetical protein PF11_0379 39 conserved Plasmodium protein, unknown function
TGME49_109240 5.08 CorA family Mg2+ transporter protein MAL13P1.23 42 CorA-like Mg2 transporter protein, putative
TGME49_109380 7.93 nuf2 family domain-containing protein PFC0720w 36 conserved Plasmodium protein, unknown function
TGME49_109400 7.32 chromosome segregation protein, putative PFE1255w 37 conserved Plasmodium protein, unknown function
TGME49_109850 3.46 hypothetical protein PFB0845w 35 conserved Plasmodium membrane protein, unknown function
TGME49_109990 4.07 hypothetical protein, conserved PF10_0112 23 conserved Plasmodium membrane protein, unknown function
TGME49_110070 1.02 methyltransferase, putative PF14_0526 26 conserved Plasmodium protein, unknown function
TGME49_110100 8.14 sushi domain-containing protein / SCR repeat-containing protein PFL0540w 33 GPI mannosyltransferase I (PIG-M)
TGME49_110380 6.10 U3 small nucleolar ribonucleoprotein protein, putative PF08_0055 9 U3 small nucleolar ribonucleoprotein protein, putative
TGME49_110410 5.90 WD-repeat proein, putative PFE1270c 13 conserved Plasmodium protein, unknown function
TGME49_110440 1.63 phosphatidylinositol-4-phosphate 5-kinase, putative PF10_0306 39 MORN repeat-containing protein 1 (MORN1)
TGME49_110450 3.25 myosin heavy chain, putative PFL1930w 29 conserved Plasmodium protein, unknown function
TGME49_110710 5.29 hypothetical protein PF10_0267 21 mitochondrial ribosomal protein S22 precursor, putative
TGME49_110770 6.71 hypothetical protein, conserved PFE1450c 27 conserved Plasmodium protein, unknown function
TGME49_110950 5.49 hypothetical5protein PF14_0633 10 transcription factor with AP2 domain(s) (ApiAP2)
TGME49_111030 5.49 hypothetical protein MAL13P1.293 14 conserved Plasmodium protein, unknown function
TGME49_111240 6.51 DnaJ domain-containing protein PF14_0359 11 HSP40, subfamily A, putative
TGME49_111310 3.46 serine/threonine protein phosphatase, putative PF08_0129 39 serine/threonine protein phosphatase, putative
TGME49_111430 5.90 fibrillarin, putative PF14_0068 11 fibrillarin, putative (NOP1)
TGME49_111500 7.12 ubiquitin-activating enzyme, putative PFL1790w 26 ubiquitin-activating enzyme, putative (Uba2)
TGME49_111800 2.24 endonuclease/exonuclease/phosphatase domain-containing protein MAL13P1.112 24 conserved Plasmodium protein, unknown function
TGME49_111870 12.00 WD repeat protein, putative PF08_0065 11 nucleolar preribosomal assembly protein, putative
TGME49_111880 1.42 hypothetical protein MAL13P1.152 37 conserved Plasmodium protein, unknown function
TGME49_112110 8.34 nucleoredoxin, putative PF14_0186 24 conserved Plasmodium protein, unknown function
TGME49_112220 5.69 mitochondrial import inner membrane translocase subunit TIM17, putative PF14_0328 20 mitochondrial import inner membrane translocase subunit tim17, putative
TGME49_112250 6.10 DNA-directed RNA polymerase III subunit, putative PFB0290c 11 transcription factor, putative
TGME49_112400 5.69 hypothetical protein MAL13P1.36 11 PNAS-3 related protein, putative
TGME49_112410 5.69 hypothetical protein PF10_0215 9 conserved Plasmodium protein, unknown function
TGME49_112530 6.10 splicing factor protein, putative MAL13P1.120 12 splicing factor, putative
TGME49_112630 3.86 hypothetical protein MAL13P1.308 40 conserved Plasmodium protein, unknown function
TGME49_113010 7.93 ATP-dependent RNA helicase, putative PFC0915w 28 ATP-dependent RNA helicase, putative (DOZI)
TGME49_113030 3.46 hypothetical protein PF11_0146 35 conserved Plasmodium membrane protein, unknown function
TGME49_113130 5.29 hypothetical protein PF11_0341 3 conserved membrane protein, unknown function
TGME49_113200 8.34 hypothetical protein PF11_0243 35 leucine-rich repeat protein (LRR11)
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TGME49_113240 5.08 DEAD/DEAH box helicase, putative PFL1310c 22 DNA helicase 60 (DH60)
TGME49_113280 5.29 WD-40 repeat protein, putative PFL0470w 42 conserved Plasmodium protein, unknown function
TGME49_113290 3.66 phosphatidylinositol-4-phosphate 5-kinase, putative PF14_0586 41 conserved Plasmodium protein, unknown function
TGME49_113380 3.46 hypothetical protein, conserved PFI1455c 1 conserved Plasmodium protein, unknown function
TGME49_113600 3.46 hypothetical protein MAL8P1.91 47 phospholipase DDHD1, putative
TGME49_113830 5.08 ribosome biogenesis protein BMS1, putative PFA0330w 12 small ribosomal subunit assembling AARP2 protein (AARP2)
TGME49_113860 3.66 hypothetical protein, conserved PFD0900w 42 regulator of chromosome condensation, putative
TGME49_113930 12.00 hypothetical protein, conserved MAL7P1.27 9 chloroquine resistance transporter (CRT)
TGME49_113980 5.49 ribosome biogenesis protein nep1, putative PF08_0041 9 ribosome biogenesis protein nep1 homologue, putative
TGME49_114500 4.88 subtilisin-like protease TgSUB2 PF11_0381 43 subtilisin-like protease 2 (SUB2)
TGME49_114710 6.31 mitochondrial carrier domain-containing protein PFA0415c 47 mitochondrial carrier protein, putative
TGME49_114770 5.49 tRNA (guanine-N1)-methyltransferase PF11_0198 17 tRNA m(1)G methyltransferase, putative
TGME49_114790 6.10 small nuclear ribonucleoprotein E/G, putative MAL8P1.48 10 small nuclear ribonucleoprotein G, putative (SNRPG)
TGME49_115130 1.42 protein-L-isoaspartate O-methyltransferase, putative PF14_0309 30 protein-L-isoaspartate O-methyltransferase beta-aspartate methyltransferase, putative
TGME49_115170 7.32 soluble liver antigen/liver pancreas antigen domain-containing protein PFL0255c 20 UGA suppressor tRNA-associated antigenic protein, putative
TGME49_115300 1.83 hypothetical protein PFE0415w 37 transcription factor IIb, putative
TGME49_115310 5.49 hypothetical protein MAL7P1.33 22 conserved Plasmodium protein, unknown function
TGME49_115530 7.93 hypothetical protein PF14_0229 12 conserved Plasmodium protein, unknown function
TGME49_115560 3.25 ATP-binding cassette G family transporter ABCG77 (ABCG77) PF14_0244 30 ABC transporter, (EPP family), putative
TGME49_115580 1.63 hypothetical protein PF11_0304 37 conserved Plasmodium protein, unknown function
TGME49_115600 7.53 DNA replication licensing factor, putative PFL0560c 31 minichromosome maintenance protein, putative
TGME49_115780 2.03 myosin regulatory light chain, putative PF10_0301 11 calmodulin, putative
TGME49_116280 3.25 hypothetical protein PF14_0260 44 metabolite/drug transporter, putative
TGME49_116400 9.97 tubulin alpha chain PFD1050w 31 alpha tubulin 2
TGME49_116540 2.03 hypothetical protein PF14_0578 42 conserved Plasmodium protein, unknown function
TGME49_116900 5.49 hypothetical protein PF13_0310 12 small subunit rRNA processing factor, putative
TGME49_117720 6.92 eukaryotic translation initiation factor 3 subunit 7, putative PF10_0077 11 eukaryotic translation initiation factor 3 subunit 7, putative
TGME49_118230 7.53 phosphoglycerate kinase, putative PFI1105w 22 phosphoglycerate kinase (PGK)
TGME49_118480 5.29 DNA repair protein, putative MAL13P1.216 28 DNA helicase, putative
TGME49_118590 5.49 mrp protein, putative PF11_0296 11 conserved protein, unknown function
TGME49_118690 5.08 RNA recognition motif-containing protein PFL0830w 48 snoRNA-associated small subunit rRNA processing protein, putative
TGME49_118700 5.69 eukaryotic translation initiation factor 6, putative PF13_0178 11 translation initiation factor 6, putative
TGME49_118710 7.93 ATP-binding cassette sub-family F member 1 PF11_0225 11 protein GCN20 (GCN20)
TGME49_118720 7.53 proline synthetase co-transcribed protein, putative PFI0965w 18 pyridoxal 5'-phosphate dependent enzyme class III, putative
TGME49_119310 12.00 hypothetical protein PFC0335c 24 conserved Plasmodium protein, unknown function
TGME49_119500 3.05 hypothetical protein PFB0770c 35 conserved Plasmodium membrane protein, unknown function
TGME49_119730 5.49 hypothetical protein PFB0620w 13 conserved protein, unknown function
TGME49_119850 5.90 hypothetical protein, conserved PF13_0147 11 RNA binding protein, putative
TGME49_119950 6.10 rRNA-processing protein FCF1, putative MAL8P1.67 11 nucleolar preribosomal assembly protein, putative (UTP24)
TGME49_120020 7.73 major facilitator superfamily domain-containing protein PFI0720w 6 transporter, putative
TGME49_120110 8.34 proliferating cell nuclear antigen, putative PFL1285c 35 proliferating cell nuclear antigen 2 (PCNA2)
TGME49_120450 5.49 ribosome biogenesis regulatory protein, putative PF11_0259 11 nuclear preribosomal assembly protein, putative
TGME49_120480 1.02 Rab 11b, putative MAL13P1.205 34 Rab GTPase 11b (RAB11b)
TGME49_120490 12.00 hypothetical protein PF11_0452 1 conserved Plasmodium protein, unknown function
TGME49_120570 7.12 G1 to S phase transition protein, putative PF11_0245 11 translation elongation factor EF-1, subunit alpha, putative
TGME49_120620 7.32 queuine tRNA-ribosyltransferase, putative PFL2030w 23 queuine tRNA-ribosyltransferase, putative
TGME49_121360 3.46 RNA recognition motif domain-containing protein MAL8P1.40 11 RNA binding protein, putative
TGME49_121500 5.90 CELF family protein, putative PF13_0315 11 rRNA associated RNA binding protein, putative
TGME49_121640 6.10 cell division protein 48, putative PF07_0047 23 AAA family ATPase, CDC48 subfamily (Cdc48)
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Table A.2: T. gondii and P. falciparum network analysis dataset of drCDC-UNK 
proteins and their potential protein interactions. A list of proteins and their predicted 
interactions from the network analysis of drCDC-UNK proteins is shown in Fig. 6.  
 
Pf#Gene#ID Function Tg#Gene#ID
PF14_0307 conserved1protein,1unknown1function TGME49_085950
PF14_0194 splicing1factor13B1subunit14,1putative1(SF3B4)
PF14_0513 RNA1binding1protein,1putative
PF10_0269 DNAOdirected1RNA1polymerase1II,1putative
PF13_0313 zinc1finger1protein,1putative1
PFB0370c RNA1binding1protein,1putative
PF13_0340 exosome1complex1exonuclease,1putative
PFE1085w DEAD/DEAH1box1ATPOdependent1RNA1helicase,1putative
PF13_0150 DNAOdirected1RNA1polymerase131largest1subunit
PF11_0483 farnesyltransferase1beta1subunit,1putative
MAL7P1.26 OOsialoglycoprotein1endopeptidase,1putative
PFl1130c conserved1Plasmodium1protein,1unknown1function
PF14_0068 fibrillarin,1putative1(NOP1)
MAL13P1.35 conserved1Plasmodium1protein,1unknown1function
PFL0665c RNA1polymerase1subunit18c,1putative
MAL6P1.193 transcription1or1splicing1factorOlike1protein,1putative
PFl0415c ribosomal1RNA1methyltransferase,1putative
PF13_0323 arginine1methyltransferase15,1putative1(PRMT5)
PF13_0259 cytidine1and1deoxycytidylate1deaminase,1putative
MAL13P1.204 exosome1complex1component1RRP42,1putative1(RRP42)
PFB0290c transcription1factor,1putative
PFA0480w phenylalanylOtRNA1synthetase,1putative
PF07_0098 dynactin14,1putative
PFL0330c DNAOdirected1RNA1polymerase1III1subunit,1putative
PF07_0059 4Onitrophenylphosphatase1(PNPase)1
PF10_0054 conserved1protein,1unknown1function TGME49_070960
MAL6P1.119 DEAD/DEAH1box1ATPOdependent1RNA1helicase1(Has1p)
MAL6P1.111 trancription1factor,1putative
PFA0330w small1ribosomal1subunit1assembling1AARP21protein1(AARP2)
PFE1140c G101protein,1putative
PF08_0130 rRNA1processing1WDOrepeat1protein,1putative1
PF14_0437 DEAD/DEAH1box1ATPOdependent1RNA1helicase,1putative
PFC0100c golgi1organization1and1biogenesis1factor,1putative
PF13_0341 DNAOdirected1RNA1polymerase12,1putative
PFC0485w protein1kinase,1putative
MAL6P1.296 nucleolar1GTPObinding1protein11,1putative1
MAL7P1.113 DEAD/DEAH1box1ATPOdependent1RNA1helicase,1putative1
PF14_0124 actin1II1(ACT2)
MAL13P1.271 VOtype1ATPase,1putative
PF13_0109 N2,N2Odimethylguanosine1tRNA1methyltransferase,1putative1
MAL13P1.14 DEAD/DEAH1box1ATPOdependent1RNA1helicase,1putative
PFD0750w nuclear1capObinding1protein,1putative
PFL2010c DEAD/DEAH1box1ATPOdependent1RNA1helicase,1putative
PF13_0178 translation1initiation1factor16,1putative
PFE1115c SOadenosylmethionineOdependent1methyltransferase,1putative1
PFL0665c RNA1polymerase1subunit18c,1putative
MAL6P1.193 transcription1or1splicing1factorOlike1protein,1putative
PFl0415c ribosomal1RNA1methyltransferase,1putative
PF13_0323 arginine1methyltransferase15,1putative1(PRMT5)
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Pf#Gene#ID Function Tg#Gene#ID
MAL8P1.105 conserved#protein,#unknown#function# TGME49_005740
PF10_0114 DNA*repair*protein*RAD23,*putative
PF14_0242 arginine*methyltransferase*1*(PRMT1)
PF10_0366 ADP/ATP*transporter*on*adenylate*translocase
PF14_0083 40S*ribosomal*protein*S8e,*putative
PFL0310c eukaryotic*translation*initiation*factor*3*subunit*8,*putative
PF08_0075 60S*ribosomal*protein*L13O2,*putative
PFL0815w DNAObinding*chaperone,*putative
PF13_0142 U6*snRNAOassociated*SmOlike*protein*LSm6,*putative*(LSM6)*
PFC0400w 60S*acidic*ribosomal*protein*P2,*putative*
PFC0870w elongation*factor*1*(EFO1),*putative
PFE0160c Ser/ArgOrich*splicing*factor,*putative
PFL1745c clusteredOasparagineOrich*protein
PF08_0019 receptor*for*activated*c*kinase*(RACK)
MAL7P1.81 eukaryotic*translation*initiation*factor*3*37.28*kDa*subunit,*putative
PF11_0260 60S*ribosomal*protein*L35,*putative
PF13_0214 elongation*factor*1Ogamma,*putative
PF11_0043 60S*ribosomal*protein*P1,*putative
PF10_0217 preOmRNA*splicing*factor,*putative*
PF08_0039 60S*ribosomal*protein*L22,*putative
PF13_0132 60S*ribosomal*protein*L23a,*putative*
PF13_0049 60S*ribosomal*protein*L24,*putative
MAL13P1.209 60S*ribosomal*protein*L18O2,*putative
PF07_0043 60S*ribosomal*protein*L34a,*putative
PF07_0117 eukaryotic*translation*initiation*factor*2*alpha*subunit,*putative
PFB0885w 40S*ribosomal*protein*S30,*putative
PFB0595w heat*shock*protein*40,*putative
PFL2305w conserved*Plasmodium*protein,*unknown*function TGME49_002360
PF13_0129 60S*ribosomal*protein*L6,*putative
MAL7P1.104 3'O5'*exoribonuclease*Csl4*homolog,*putative*
MAL13P1.92 40S*ribosomal*protein*S15/S19,*putative
PF14_0231 60S*ribosomal*protein*L7O3,*putative
PF14_0391 60S*ribosomal*protein*L1,*putative
PF14_0218 actinOrelated*protein*homolog,*arp4*homolog
PF14_0261 proliferationOassociated*protein*2g4,*putative
PFE1005w 40S*ribosomal*protein*S9,*putative
PF14_0104 eukaryotic*translation*initiation*factor*2*gamma*subunit,*putative
PF14_0585 40S*ribosomal*protein*S28e,*putative
PF11_0284 methyltransferase,*putative
PFC0200w 60S*ribosomal*protein*L44,*putative
PF14_0078 plasmepsin*III,histoOaspartic*protease*(HAP)*
PF13_0334 bifunctional*polynucleotide*phosphatase/kinase*(PNKP)
PF11_0313 60S*ribosomal*protein*P0
PFL0695c geranylgeranyltransferase*type2*beta*subunit,*putative
PF14_0370 DEAD/DEAH*box*helicase,*putative
PFL1745c clusteredOasparagineOrich*protein
PF08_0019 receptor*for*activated*c*kinase*(RACK)
MAL7P1.81 eukaryotic*translation*initiation*factor*3*37.28*kDa*subunit,*putative
PF11_0260 60S*ribosomal*protein*L35,*putative
PF13_0214 elongation*factor*1Ogamma,*putative
PF11_0043 60S*ribosomal*protein*P1,*putative
PF10_0217 preOmRNA*splicing*factor,*putative*
PF08_0039 60S*ribosomal*protein*L22,*putative
PF13_0132 60S*ribosomal*protein*L23a,*putative*
PF13_0049 60S*ribosomal*protein*L24,*putative
MAL13P1.209 60S*ribosomal*protein*L18O2,*putative
PF07_0043 60S*ribosomal*protein*L34a,*putative
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Pf#Gene#ID Function Tg#Gene#ID
MAL7P1.125 conserved#Plasmodium#protein,#unknown#function TGME49_005320
MAL6P1.65 ubiquitin/conjugating/enzyme/E2,/putative
PFB0815w calcium/dependent/protein/kinase/1/(CDPK1)
PFD0255w agM1/blood/stage/membrane/protein/homologue/(PfMAgM1)
PF14_0346 cGMPMdependent/protein/kinase/(PKG)
PFl1685w cAMPMdependent/protein/kinase/catalytic/subunit/(PKAc)/
PFL2225w myosin/light/chain/1,myosin/A/tail/domain/interacting/protein/(MTIP)
PFE1415w cell/cycle/regulator/with/znMfinger/domain,/putative/
PF14_0694 protein/disulfide/isomerase/(PDIM14)/
PF07_0072 calcium/dependent/protein/kinase/4/(CDPK4)
PF08_0129 serine/threonine/protein/phosphatase,/putative
PFC0945w protein/kinase,/putative
PFl0175w conserved#Plasmodium#protein,#unknown#function TGME49_089100
PFB0665w serine/threonine/protein/kinase,/putative
PF11_0416 myosin/F,/putative/(MyoF)
PFE0830c translation/initiation/factor/IFM2,sporozoite/surface/antigen/MB2/(MB2)
PFL0545w kinesinMlike/protein,/putative
PFL1435c myosin/D/(MyoD)/
PFl0255c UGA/suppressor/tRNAMassociated/antigenic/protein,/putative
PF07_0104 kinesinMlike/protein,/putative/
PF10_0224 dynein/heavy/chain,/putative
PFE0455w leucineMrich/repeat/protein/(LRR2)
PFL2250c RACMbeta/serine/threonine/protein/kinase/(PKB)
PFE0175c myosin/B/(MyoB)
PFD0255w agM1/blood/stage/membrane/protein/homologue/(PfMAgM1)
PFB0815w calcium/dependent/protein/kinase/1/(CDPK1)/
PFL2165w kinesinMlike/protein,/putative/
MAL13P1.148 myosin/C/(MyoC)/
PFA0535c kinesin,/putative/
PF08_0113 vacuolar/proton/translocating/ATPase/subunit/A,/putative
PFB0145c conserved/Plasmodium/protein,/unknown/function TGME49_046190
PFC0770c kinesinMlike/protein,/putative
PF13_0233 myosin/A/(MyoA)/
MAL6P1.145 choline/ethanolaminephosphotransferase,/putative/(CEPT)
MAL6P1.56 serine/threonine/protein/kinase/(ARK1)/
MAL6P1.286 myosin/E/(PfmyoE)
PFC0860w kinesin,/putative
PFL2250c RACMbeta/serine/threonine/protein/kinase/(PKB)
PFE0455w leucineMrich/repeat/protein/(LRR2)
PFC0370w conserved/Plasmodium/protein,/unknown/function/ TGME49_107020
PF14_0637 rhoptry/protein,/putative
PF10_0224 dynein/heavy/chain,/putative
PFl0255c UGA/suppressor/tRNAMassociated/antigenic/protein,/putative/
MAL13P1.152 conserved#Plasmodium#protein,#unknown#function# TGME49_111880
PF14_0637 rhoptry/protein,/putative/
PF11_0507 antigen/332,/DBLMlike/protein/(Pf332)
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Table A.3: Primers for endogenous tagging T. gondii drCDC-UNK genes. 
Primers designed to endogenously tag the drCDC-UNK genes listed in Table 2.1 and to 
verify endogenous tagging at the correct locus (Fig. 2.8). 
 
 
 
 
 
 
 
Description Sequence
LIC verification HA R 5'-GGCTATCCCTATGATGTGCCCGATTATGCG
TGME49_005320  F 5’-TACTTCCAATCCAATTTAAT GCAAGTGTTAGATACGGCAGTAAGTTGTG
TGME49_005320 R 5’-TCCTCCACTTCCAATTTTAGC CTCTTCGTCATCATCTTCGTCCGTG
TGME49_005320 verify 5’- GCAGATTTCCGGGCTGGCGAG
TGME49_005740 F 5’-TACTTCCAATCCAATTTAATGCACTCGTCGTCCCATCAGATTTACACC
TGME49_005740 R 5’-TCCTCCACTTCCAATTTTAGCTTTCCACTTGGCTGCCAAATCTGC
TGME49_025320 F 5’-TACTTCCAATCCAATTTAATGCT GTCTGTGCTCCAGGCGGTGC  
TGME49_025320 R 5’-TCCTCCACTTCCAATTTTAGCAAAGAAAAGAGCGATTGAGGCGACGGAGC
TGME49_028490 F 5’-TACTTCCAATCCAATTTAAT GAACACACTGAGCGAATCATTAGTG
TGME49_028490 R 5’-TCCTCCACTTCCAATTTTAGC GGAAGCCGCCTGCAACAC
TGME49_030160 F 5’-TACTTCCAATCCAATTTAAT GTTCTGTTGCAATGTAGCAGGCAAG
TGME49_030160  R 5’-TCCTCCACTTCCAATTTTAGC CGGCTCATGTTCCTCTGCAATG
TGME49_030160 F verify 5’-GCTACCGGGTTGAAGTACACGGAC
TGME49_030350 F 5’-TACTTCCAATCCAATTTAAT AAGACTGGAGGAGCTGCGTG
TGME49_030350 R 5’-TCCTCCACTTCCAATTTTAGC CACTCGCTCTCCAGGAATTGGTG
TGME49_033810 F 5’-TACTTCCAATCCAATTTAATGCA CGGTGAACAGAATGCAGTGAAGG 
TGME49_033810 R 5’-TCCTCCACTTCCAATTTTAGC TGAAAAATGCACGGGGTCCCTC
TGME49_035130 F 5’-TACTTCCAATCCAATTTAAT GGCTCACGTCAACAGAGGCTATC
TGME49_035130 R 5’-TCCTCCACTTCCAATTTTAGCCTGAGTAAAAAGTAAGGGTTGCT CCTC
TGME49_036510 F 5’-TACTTCCAATCCAATTTAATG CAAGGTTTGGAGTCCACGCACTC
TGME49_036510 R 5’-TCCTCCACTTCCAATTTTAGCGTAGAGCGAAGCGTCAGTTT GATG
TGME49_041000 F 5’ –TACTTCCAATCCAATTTAATGCA CGCTTTCCTCGGTTTTCGC
TGME49_041000 R 5’-TCCTCCACTTCCAATTTTAGCCGGAGTATCTTCTGCAAAAGACGG
TGME49_041000 F verify 5’ -CTAGATTCGGTGCACACTGAGCAC
TGME49_052430 F 5’-TACTTCCAATCCAATTTAAT CAGATGCTCGGCAACTTCCAC
TGME49_052430 R 5’-TCCTCCACTTCCAATTTTAGCATCTTGGAATTCCTCGCAGTTGAAGC
TGME49_052430 F verify 5’- GAACCTCTGCTTCGAAATGCGATG
TGME49_060820 (LIC positive control) F 5’-TACTTCCAATCCAATTTAATCGTTTATCAGCTCCACAAGTGACTG
TGME49_060820 (LIC positive control) R 5’-TCCTCCACTTCCAATTTTAGCTGCCTTCAGCTTCTTCAAAAGGTC
TGME49_064990 F 5’-TACTTCCAATCCAATTTAAT TCAACCCCGAGGACAGAATCTG
TGME49_064990 R 5’-TCCTCCACTTCCAATTTTAGC GTAGATGGGCAAGAGAGGGGGATAG
TGME49_089100 F 5’-TACTTCCAATCCAATTTAATGCAGTGCGCCATCTCTAGAGAGGACTACG
TGME49_089100 R 5’-TCCTCCACTTCCAATTTTAGC CGCCTCCCGAGGTGTGACAG
TGME49_094790 F 5’-TACTTCCAATCCAATTTAAT TTCCGTACTTCCACGTCACTG
TGME49_094790 R 5’-TCCTCCACTTCCAATTTTAGCCGAGGATACATGAGCTGCCGACAA GAG
TGME49_111880 F 5’-TACTTCCAATCCAATTTAAT CTCGATGTGGTCATGACACAAAGC
TGME49_111880 R 5’-TCCTCCACTTCCAATTTTAGC CGGAATATCGATGGCTTCAACCTG
TGME49_113860 F 5’-TACTTCCAATCCAATTTAATG CAGGAGGCGATGGCTTGGAC
TGME49_113860 R 5’-TCCTCCACTTCCAATTTTAGC GTCAAACTTTCTGTACGCCGACGG
